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Abstract 
Oxidative stress and inflammation are intricately interlinked, especially in the context of 
ageing/accelerated ageing, as well as several chronic disease states, where they are 
implicated as aetiological factors. In the past decade polyphenols have been investigated for 
their potent anti-oxidant as well as anti-inflammatory properties. Previous research by our 
group has highlighted the potential of a grape seed-derived polyphenol as both anti-oxidant 
and anti-inflammatory modality. However, no data has been generated in human models and 
the mechanism(s) of action is still largely unknown. Thus the aim of this study was to more 
comprehensively investigate potential anti-oxidant or anti-inflammatory mechanisms of a 
grape seed-derived polyphenol (PCO) on acute (as found with exercise) and chronic (as in 
ageing) models of oxidative stress. 
After obtaining ethical clearance, blood samples were obtained from healthy human subjects 
from two different groups (aged (n=7) and young (n=14). In the young group a further 
distinction was made between sedentary (n=8) and fit individuals (n=6) whom we exposed to 
an HIIT exercise intervention to induce acute oxidative stress. Oxidative status was assessed 
in plasma using validated photometric and colorimetric assays and plasma myeloperoxidase 
(MPO) assessed as baseline inflammatory indicator. Neutrophils were isolated at rest (and 
after exercise from young fit subjects) and treated with the polyphenol in vitro for 1 hour. The 
chemokinetic capacity of treated and control neutrophils in response to a chemotactic signal 
was then determined using a Dunn chamber and live cell imaging. In addition, neutrophils 
were analysed for the expression of functional capacity markers (intracellular MPO, Fcγ 
Receptor IIIb (CD16) and CEACAM 8 (CD66b)) via flow cytometry. Oxidative status of 
neutrophils were also performed on isolates.  
The results indicate that the aged population had significantly worse oxidative and 
inflammatory profiles than young sedentary controls - this was evident in their conjugated 
dienes content as well as decreased ferric reducing ability of plasma (FRAP). In neutrophils, 
aged and young subjects had increased chemokinetic accuracy and capacity after 1 hour of 
in vitro polyphenol treatment. The treatment was also associated with a shedding of CD16 and 
increased expression of CD66b - both linked to improved neutrophil motility. The intracellular 
MPO content of neutrophils indicated that PCO had an anti-inflammatory effect across groups. 
The exercise intervention did not induce measurable changes in oxidative stress or 
inflammation.  
We therefore concluded that grape seed-derived polyphenols modulate inflammation and 
oxidative responses by facilitating more efficient neutrophil motility. This decreases the 
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number of neutrophils required per response, effectively resulting in less secondary tissue 
damage, less oxidative stress and faster resolution of inflammation.    
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Uittreksel 
Oksidatiewe stres en inflammasie is fyn verweef, veral in die konteks van veroudering en 
versnelde veroudering. Verder word beide prosesse geïmpliseer in die etiologie van 
veroudering en verskeie kroniese siektes. In die verlede is polifenole al ondersoek vir hul 
aansienlike anti-inflammatoriese en anti-oksidant effekte. Vorige navorsing deur ons groep 
het die potensiaal van ‘n druif-afgeleide polifenool al bewys in hierdie konteks. Daar is tans 
nog geen data uit mensmodelle gegenereer nie en die meganisme waardeur hierdie effekte 
uitgevoer word, is nog grootliks onbekend. Die doel van hierdie studie was dus om op ‘n meer 
omvattende manier, die moontlike anti-inflammatoriese en anti-oksidant megansismes van ‘n 
druif-afgeleide polifenool te ondersoek, deur modelle van akute (soos na harde oefening) en 
kroniese (soos met veroudering) oksidatiewe stres.  
Nadat etiese klaring verkry is, is bloedmonsters verkry van gesonde vrywilligers in twee 
groepe (oud (n=7) en jonk (n=14)). In die jong groep is onderskeid ook getrek tussen fikse 
(n=6) en onfikse (n=8) individue. Die fikse groep is addisioneel onderwerp aan hoë intensiteit 
oefening om akute oksidatiewe stres te veroorsaak. Oksidatiewe status in plasma is bepaal 
duer erkende fotometriese en kolorimetriese toetse te gebruik, terwyl plasma MPO as 
indikasie van inflammasie getoets is. Neutrofiele is geïsoleer uit bloed wat in ‘n rustende 
toestand getrek is, asook na oefening in die fiske jong groep. Chemokinetiese kapasiteit van 
neutrofiele is voor en na 1 uur in vitro polifenool behandeling bepaal deur gebruik te maak van 
‘n Dunn kamer en lewende sel mikroskopie. Neutrofiel uitdrukking van merkers vir funksionele 
kapasiteit (intrasellulêre MPO, Fcγ Receptor IIIb (CD16) and CEACAM 8 (CD66b)) is ook met 
vloeisitometrie bepaal. Oksidatiewe status merkers is ook op geïsoleerde neutrofiele bepaal.  
Resultate dui aan dat die ouer populasie beduidend slegter oksidatiewe en inflammatoriese 
profiele gehad het as hulle jonger eweknieë – dit was bv. Die geval vir CD en FRAP in die 
plasma. In neutrofiele het beide ouer en jong vrywilligers verbeterde chemokinetiese kapasiteit 
en akkuraatheid getoon na polifenool blootstelling. Die polifenool blootstelling het ook 
verhoogde CD66b en verlaagde CD16 uitdrukking tot gevolg gehad, wat altwee met 
verbeterde neutrofiel beweeglikheid in verband gebring word. Verder het intrasellulêre MPO 
ook aangedui dat die polifenool ‘n anti-inflammatoriese effek in al die groepe gehad het 
deurdat selle minder MPO vrygestel het. Die oefening ingreep het nie beduidende verskille 
teweeggebring in die gekose merkers vir oksidatiewe stres of inflammasie nie.   
Ons gevolgtrekking is dus dat druif-afgeleide polifenole die oksidatiewe en inflammatoriese 
response moduleer, ten minste gedeeltelik deurdat dit neutrofiele meer effektief maak. Dit het 
tot gevolg dat minder neutrofiele per respons nodig is, dat minder sekondêre skade aan 
weefsel aangerig word en dat inflammasie vinniger opklaar.  
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Chapter 1 
Introduction 
There are various reasons why optimal bodily functions decline; disease, injury and lifestyle 
are just the broad categories which regulate this decline and are incidental when experienced 
during mid to early life. There is one factor which we cannot avoid and physiologically is the 
least understood phenomenon which causes the decline which ultimately leads to death that 
is ageing.  
With ageing, the capacity of the body to function optimally progressively declines. There are 
a combination of genetic and lifestyle factors which may either accelerate or slow down the 
ageing process. A number of chronic diseases are associated with advanced age:  including 
cardiovascular disease (CVD), diabetes, metabolic syndrome, and Alzheimer’s disease to 
mention a few. The result is an exponential increase in the disease burden on modern society, 
relative to a few decades ago, due to longer life expectancy. The World Health Organisation 
states that from 2015 to 2050, the proportion of the world’s population over 60 years will 
increase from 12% to 22% [1]. Taking into consideration that predominant research in the field 
of age-associated diseases considers the sixth decade of life to be a risk factor for the rapid 
progression and onset of age associated diseases, the disease burden will almost double in 
the next 35 years. It is thus vital not only to elucidate the causes and progression of these 
chronic conditions, but also to actively search and investigate potential preventative therapies 
that may slow the processes contributing to physiological ageing. Although the ageing-
associated chronic disease states are each uniquely complex in terms of their aetiology, 
development, and progression, they do share common aetiologies which stem from two main 
entities, namely, cumulative oxidative stress and chronic inflammation.  
Oxidative stress, briefly, results from oxidants which are produced by normal cell metabolism 
and various physiological responses. However, when the production of oxidants outweighs 
the capacity of endogenous antioxidant systems, oxidative stress is incurred. Furthermore, 
while inflammation is crucial for repair of tissue injury and primary defence against invading 
pathogens and chemicals, it also results in unintended detriment to previously uninjured cells 
due to the robust nature of the inflammatory mechanism. Although these are necessary 
systems in the body, both oxidative stress and the inflammatory response, if unchecked, can 
have detrimental consequences which have been linked to accelerated ageing and the 
progression of age-associated disease.  
We postulated that the effects of the inflammatory immune system and oxidative stress on 
allostatic load are interlinked. This has led us to investigate the potential of antioxidants as 
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treatment options to attenuate the cumulative effects of both oxidative stress and chronic low 
grade inflammation. Given the modern consumer bias for natural medicines, we decided to 
focus on a group of plant medicines which are consistently associated with beneficial effects 
on these processes in the literature, namely grape-derived polyphenols.  
Previous research done on a grape seed-derived proanthocyanidolic oligomer (PCO) by our 
group, coupled with anecdotal reporting on this supplement has led to research which 
elucidated potent anti-inflammatory mechanisms. This led me to investigate the links between 
oxidative stress, which can be alleviated by an anti-oxidant such as PCO, and inflammatory 
mechanisms to target. This investigation presents therapeutic possibilities for various 
diseases as described earlier which present with both cumulative oxidative stress and chronic 
low grade inflammation.  The prospect of a preventative or adjuvant therapy in this regard 
could be beneficial not only to ageing but all states which have inflammatory and oxidative 
stress components. 
Therefore we set out to investigate the mechanisms in the spectrum of oxidative stress and 
the inflammatory response affected by PCO. Firstly to address the potential ageing 
mechanisms of chronic cumulative oxidative stress and low grade inflammation and the effects 
PCO has on these. Secondly to elucidate the effect of PCO on a more acute state of oxidative 
stress and inflammation, such as induced by strenuous exercise. We believe this is the first 
step to elucidating the mechanisms of action of PCO. Once this is established, PCO can be 
investigated as an effective therapeutic strategy.   
This thesis will begin with a review of the literature, giving an over view of research done thus 
far with regard to ageing. Added to the review is further literature on exercise and the 
mechanisms of oxidative stress and inflammatory induced. Thereafter a detailed methods 
section will explain the subject groupings, parameters chosen and methods used to assess 
the chosen parameters. The results section then presents all the data obtained and 
comparisons made as well as statistical analysis of the data. Lastly a discussion of the results 
will be presented and the interpretation of the data along with what was elucidated. Future 
recommendations will presented to indicate our next steps.  
Stellenbosch University  https://scholar.sun.ac.za
3 
 
Chapter 2  
Literature review 
A truncated version of this review of the literature has been published in the journal of 
Oxidative Medicine and Cellular Longevity, under the title “Ageing-associated oxidative stress 
and inflammation: alleviated by products from grapes” (refer to appendix A for full text paper). 
In this chapter, I have added extra information pertaining to acute oxidative stress and 
experimental exercise protocols used in this context, to more fully encompass my whole thesis 
topic. 
2.1 Introduction 
In this review, we will provide a more in-depth review of interconnected molecular mechanisms 
of oxidative stress and inflammation in the physiological ageing process, before moving our 
focus to a discussion of the merits of these plant medicines as potential preventative therapies 
in this context. 
2.2 Contribution of Oxidative Stress to premature ageing 
In the context of ageing, reactive oxygen and nitrogen species (RONS) are generally the major 
molecules which contribute significantly to oxidative stress [2]. The most frequently studied 
free radicals are superoxide (O2−), hydrogen peroxide (H2O2), hydroxylradical (∙OH), 
peroxynitrite (ONO2−), and nitric oxide (NO). The generation of these free radicals is 
necessary as they are essential for host defence: phagocytic cells use reactive oxygen species 
(ROS) to digest invading pathogens and debris. Furthermore, they act as signalling molecules, 
regulating cell growth and apoptosis, adhesion, and differentiation. More specifically, RONS 
are formed during processes such as the mitochondrial electron transport chain as well as 
enzyme systems such as cytochrome P450, lipoxygenase  and cyclooxygenase, the NADPH-
oxidase complex, xanthine oxidase, and peroxisomes [3]. In contrast to these roles in growth, 
repair, and immune functions which are all beneficial to the host, these molecules also have 
the ability to oxidise signalling molecules, DNA, macromolecules, and cell structures such as 
lipid membranes of healthy host cells, all of which are to the detriment of these cells. Usually, 
each cell has defence mechanisms to counteract the occurrence of oxidative stress. These 
endogenous enzymatic antioxidant defences include superoxide dismutase (SOD), 
glutathione peroxidase, catalases, glutathione, thioredoxin reductase (TrxR), and 
peroxiredoxins. An appropriately nutritious diet is vital to maintain these systems, as these 
natural antioxidants are supplemented or replenished by antioxidant constituents of various 
fruits and vegetables. It is only when the capacity of the body’s antioxidant defences is 
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outweighed by the rate of production of free radicals that oxidative stress is incurred by 
unquenched free radicals which can alter surrounding cell structures and environment. With 
advancing age, various factors, among these is a natural progressive decline in endogenous 
antioxidant capacity, because disruption in the balance between pro- and antioxidant 
mechanisms and RONS accumulate beyond the normal endogenous antioxidant system’s 
quenching capacity, resulting in cumulative oxidative stress. Eventually this causes cell 
damage which cannot be repaired by internal mechanisms, leading to loss of organ mass and 
functionality, which ultimately culminates in system dysfunction [4]. Indeed, long-term 
oxidative stress states have been linked to various diseases associated with advanced age, 
most notably diabetes, chronic obstructive pulmonary disease (COPD), cardiovascular 
disease, cancer, diabetes, and asthma [5]. Many of these diseases are not only associated 
with ageing anymore, but also with the high-obesity, high stress, and sedentary modern 
lifestyle (albeit perhaps in milder form) [6]. It is thus vital to address the prevention of these 
detrimental long-term outcomes, as they affect not only the aged, but also relatively young 
populations, such as university students [7,8]. The aetiological mechanism(s) of the various 
chronic diseases mentioned are each different, as each disease has its own complexities. 
However, chronic cumulative oxidative stress is a common factor in these diseases, 
highlighting this system as a vital therapeutic and/or preventative medicine target [9]. Even in 
the absence of age-associated disease, various theories have linked oxidative stress directly 
to the normal ageing process. We briefly mention two here.  
Firstly, the Free Radial Theory of Ageing proposes that the presence of free radicals and their 
effects on cells are one of the causes of cell ageing and subsequent cell death, which in turn 
lead to loss of organ mass and other features of whole organism ageing. This theory was first 
suggested by Harman in 1956 [10], who hypothesized that irradiation of cellular components 
resulting from the liberation of ∙OH and ∙HO2 radicals would lead to dysfunction and mutations 
which cannot be reversed and thus result in ageing. This theory was later supported and 
expanded as research began elucidating the details of his proposed theory, for example, by 
describing the role of SOD [11]. Phenomenally, a very recent meta-analysis [12] confirmed 
the sustained validity of this theory, 60 years later. Of course, given the technological 
advances made over this period, it is no surprise that subsequent research has added more 
detail on mechanisms in support of this theory, although many unresolved questions remain 
[13]. 
Secondly, the Replicative Senescence Theory is based on the hypothesis that oxidative stress 
induces cell death and/or senescence, which necessitates an increase in the rate of cell 
replication. This in turn accelerates the detrimental effects associated with repeated cycles of 
mitosis. Telomere length and its accelerated shortening due to reparative replication is the 
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basis of this theory, which was first described by Hayflick in 1965, in response to the 
observation of a decline in functionality of cell cultures (fibroblasts) which had undergone 
numerous cycles of cell divisions [14]. This phenomenon was subsequently confirmed by 
experiments on primary peripheral blood mononuclear cells (PBMCs) and fibroblasts from a 
largely aged population with increased risk for vascular dementia [15]. In this report, 
decreased telomere length in both fibroblasts and PBMCs was correlated to risk for dementia 
induced by stroke. In addition, telomere shortening rate was reported to decrease with 
increasing antioxidant capacity in fibroblasts of the same population. 
This theory, together with the subsequent data, presents evidence that, firstly, oxidative stress 
is responsible for the accelerated shortening of telomeres brought about by more frequent 
reparative replication and secondly, that an increase in antioxidant defence capacity could 
slow down the ageing process. Note at this point that we do not infer that telomere shortening 
results only from oxidative stress: other mechanisms such as chromosomal instability have 
indeed been linked to both ageing and pathological conditions such as cancer [16]. However, 
to remain focused on the main topic of this review, we have limited this discussion to 
accelerated telomere shortening in the context of cumulative oxidative stress. Holistic 
interpretation of the two theories introduced above implicates oxidative stress as major 
causative role player in the damage to cell constituents by oxidising membranes, molecules, 
and DNA. This initiates a cascade of events leading to the need for either cell growth and 
replication for repair, or death. This implicates ROS as the rate determining factor of cell 
lifespan due to the direct damage it inflicts. Furthermore, oxidative stress is implicated in 
causing irreversible damage to the mechanism of replication through accelerated telomere 
shortening and thus ultimately decreases the capacity of the cell to replicate optimally. With 
both repair and replication affected, cell senescence is encouraged. In keeping with the idea 
of a holistic approach, consideration of oxidative stress in isolation is insufficient. A basic but 
practical example of the interplay between the oxidative stress system and another system 
implicated in ageing, inflammation [17], is data available on detrimental effects of cigarette 
smoking. In this context, both acute smoking and long-term smoking were shown to 
overwhelm the glutathione antioxidant defence system within the lungs, which was associated 
with significant infiltration of inflammatory immune cells in the lungs [18]. This study clearly 
shows system interaction. Furthermore, in the same study, the severity of this maladaptation 
increased with duration of habitual smoking (in years) and was exacerbated by natural 
decreases in antioxidant capacity as experienced with ageing, resulting in increased oxidative 
stress, illustrating the significance of cumulative damage. However, before considering these 
interactions in more detail, the literature providing proof of a role for chronic inflammation in 
the process of ageing will be briefly reviewed. 
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2.3. Chronic low grade inflammation facilitates premature ageing 
As is the case for oxidative stress, the inflammatory response is a system essential for normal 
body function. As component of the innate immune response, inflammation is a major first-line 
defence against infection and injury [19]. Apart from this largely independent, nonspecific role 
in immunity, inflammation is also vital for many specific immune responses to run its course 
[20]. However, in the process of repair and restoration after insult, the inflammatory response 
inadvertently disrupts cellular homeostasis of previously unharmed or unaffected cells 
[21,22].The injury repair cycle which inflammation regulates is an efficient system during 
youth, when optimal sensitivity and response to signalling molecules (such as cytokines, 
growth factors, prostaglandins, and peptides) maintain the general health of circulating 
immune cells and the tissue microenvironment, with minimum secondary damage. However, 
during natural chronological ageing, long-term, repeated stimulus response cycles change the 
receptor expression levels and thus sensitivity to these molecular stimuli [23]. This may 
necessitate relatively increased concentrations of any particular stimulus to maintain the 
required effect. Commonly reported characteristics of the natural ageing process include 
inflammation or oxidative stress-associated symptoms such as directionally inaccurate 
chemotaxis, premature or suboptimal respiratory burst, and increased pro-inflammatory 
signalling from immune cells, all of which form the basis of immunosenescence [24]. 
Immunosenescence is the term used to describe the ageing of immune cells and the 
functioning of the immune system as a whole. This occurs naturally with advancing 
chronological age or as result of lifestyle factors, as already mentioned. There is more than 
one way in which the immune system is compromised upon ageing. Firstly, immunocompetent 
cells are derived from hematopoietic stem cells. With ageing, a natural bias develops for stem 
cells to commit to expansion of the myeloid lineage at the cost of the lymphoid lineage [25]. 
This results in a shift in the balance of immune cells available to enter the circulation. Secondly, 
the chronic low grade inflammation associated with ageing recruits larger numbers of cells into 
circulation from the hematopoietic tissue. However, despite the higher circulating cell counts, 
phagocyte Toll-like receptor expression and phagocytic capacity are decreased in the aged 
[23], leaving the immune system with a lower capacity for becoming activated and for 
responding to a more acute insult, such as viral infection. These maladaptations, which 
together further predispose the individual to pro-inflammatory responses, are postulated to 
stem at least in part from alterations in hypothalamic pituitary adrenal (HPA)-axis signalling. 
The process of immunosenescence may be accelerated by unhealthy lifestyle, such as 
psychological stress and obesity. As mentioned before, lifestyle associated diseases share 
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clinical symptoms associated with normal ageing. Indeed rutin, a potent antioxidant, has been 
shown to protect against age-related metabolic dysfunction [26]. Thus, studies focused on 
these conditions may provide much insight in terms of ageing and the supplementation options 
to limit their progress. For example, in the context of obesity and/or inactivity, cytokine release 
from adipose tissue macrophages have been demonstrated by many researchers [27–30]. 
Tumour necrosis factor-𝛼 (TNF-𝛼), interleukin- (IL-) 1𝛽, and IL6 are among some of the 
cytokines shown to be released from resident macrophages in adipose tissue, resulting in a 
pro-inflammatory microenvironment [31]. Furthermore, chronic stress, and in particular 
psychological stress, is a generally accepted cause of chronic low grade inflammation. For 
example; in 38 medical students, psychological stress was associated with increased pro-
inflammatory cytokine (TNF𝛼, IL-6, IL-1Ra, and IFN-𝛾) levels, as well as decreased anti-
inflammatory regulators (IL-10 and IL-4) [32]. Interestingly, these effects were exacerbated by 
high anxiety proneness as trait, again suggesting that a cumulative stimulus (in this case 
lifelong anxiety) further exacerbates the undesirable adaptation. Also in posttraumatic stress 
disorder (as extreme form of chronic psychological stress), an initial glucocorticoid hyper 
response is followed by glucocorticoid hypo-responsiveness, which is associated with a pro-
inflammatory state. In this condition of continuous pro-inflammatory signalling, the feedback 
systems, which usually down regulate inflammation, adjust over time and result in 
maladaptations such as chronic but low grade upregulation of pro-inflammatory mediators 
(e.g.,IL-6,TNF-𝛼,IL-1𝛽,and prostaglandin E2) [33]. Incidentally, the secretion of the first three 
is mediated by the NF𝜅B pathway, which is activated in response to cellular stress [34]. In 
addition to increased pro-inflammatory signalling, other more mechanical cellular mechanisms 
also seem to be compromised over time. For example, inappropriate and/or insufficient 
neutrophil responses result from its decreased phagocytic capacity, increased basal levels of 
intracellular calcium, and the resulting reduction in capacity for chemotaxis [35]. The result is 
a chronic low grade inflammatory status in relative absence of a specific threat which can 
persist for extended periods of time and cause harm and inefficiency of the system. Thus, 
although varied in specific causative mechanism, the outcome of all of these suboptimal life 
events or lifestyle habits, for example, chronic stress leading to glucocorticoid resistance 
and/or cardiovascular disease and high-calorie diets and inactivity (obesity) leading to insulin 
resistance and diabetes, is that of a chronic inflammatory state [17]. Of particular interest in 
the context of ageing is the fact that, apart from the now notorious low grade inflammation as 
the primary culprit, this maladaptation results in a compromised capacity to mount an efficient 
inflammatory response to acute insults. As overviewed in the review by Weinberger and 
colleagues [36], several reports from clinical literature support the notion that, in the aged 
individual, there is a significant increase in the convalescence period required for recovery 
from injury and pathogen clearance, as well as a decrease in the quality of repair, thus 
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favouring disease progression and morbidity due to injury. Very recently, Bäehl and colleagues 
(2015) demonstrated, in a longitudinal study of elderly patients, that the acute stress of a hip 
fracture had a negative effect on neutrophil function immediately after injury. While some 
neutrophil functions (chemotaxis, phagocytosis) were recovered over time, several others 
(superoxide production, complement C5A and CD11b receptor level, and cytokine secretory 
profile) were still impaired even six months after injury. From this, the authors concluded that 
the acute stress had a long-term negative effect on neutrophil responses, which negatively 
influenced clinical outcomes, such as the resolution of long-term inflammation, recovery, and 
susceptibility to opportunistic infections [37]. It is thus clear that ageing is an inflammatory-
mediated process. However, from the inflammation/ageing literature, it is clear that 
inflammation and oxidative stress cannot be separated as causative factors in this context. 
For example, the ageing-related shift in balance between the glucocorticoid and inflammatory 
systems has been linked to increased ROS production, which in turn exacerbates low grade 
immune activation [38]. 
2.4 Links between Inflammation and Oxidative stress in the Ageing Process: Identifying 
therapeutic targets 
From the above sections it is evident that, during ageing, oxidative stress and inflammation 
are interdependent mechanisms. We postulate that the unravelling and understanding of 
these intricate links between the two responses hold the answer to identifying the major 
contributor(s) to allostatic load and maladaptation associated with ageing and age-related 
pathology. Generally, repeated exposure to RONS causes cell damage and thus a pro-
inflammatory signalling response. For example, in aged mice, unquenched RONS act as pro-
inflammatory signalling molecules and mediators of inflammation within the cell itself [39]. 
More specifically, oxidative damage to cells prompts the release of TNF𝛼 from these damaged 
cells [22]. Binding of TNF-𝛼 to cell surface TNF-𝛼 receptors activates the NF-𝜅B 
inflammasome, which results in the further production of other pro-inflammatory cytokines, 
most notably IL-1𝛽. Incidentally, TNF𝛼 specifically has also been implicated in ROS-mediated 
upregulation of adhesion molecules which facilitate the infiltration of immune cells into tissue 
[40], with more on this later. Upregulation of inflammation via the NF-𝜅B inflammasome is 
probably the main aetiological mechanism for age-related chronic conditions with an 
inflammatory component. Indeed, TNF-𝛼 upregulation, which is a direct result of increased 
flux through the inflammasome, has been implicated as causative factor in cardiovascular 
disease [41]. Of particular relevance to the topic of ageing, the NF-𝜅B inflammasome has 
regulatory roles in cell growth, survival, and proliferation. However, as recently reviewed [42], 
ROS production may have either inhibitory or stimulatory roles in the NF-𝜅B pathway, 
suggesting a dose dependency in the effects of ROS. This unfortunately also means that 
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development of an intervention strategy/product to modulate this target mechanism is no 
simple feat and will have to be approached in a very tightly controlled “modification range”. 
From the literature consulted, it is clear that bidirectional communication is in place. For 
example, both neutrophils and macrophages are producers of oxidants via the NADPH 
oxidase system [2]. The NADPH-oxidase (NOX) proteins aid the transport of electrons across 
biological membranes and are found in all cells [43]. They are also one of the major generators 
of ROS in all cells. Particularly, these proteins are the predominant ROS producers in 
phagocytic cells, a process required for the normal respiratory burst that phagocytes use to 
kill pathogens and digest cell debris. Furthermore, activated neutrophils release 
myeloperoxidase (MPO), which contributes to the formation of hypochlorous acid (HOCL) by 
acting as a catalyst when reacting with hydrogen peroxide (H2O2). This directly increases the 
production of ROS [44]. The oxidative burst of neutrophils in itself releases oxidants such as 
H2O2, which are harmful to healthy cells and tissue [45]. Besides directly increasing the 
production of ROS which itself causes damage to surrounding cells, MPO specifically has 
been implicated as a risk factor for coronary artery disease, due to its capacity for oxidation of 
lipid membranes [46]. The increased oxidant concentration due to immune cell functions, as 
well as the resultant cell damage, results in increased metabolism in surrounding healthy 
tissue. Also at a gene level, role players have been elucidated in the context of an oxidative 
stress-inflammation link. For example, sirtuins are Class III histone deacetylases which are 
responsible for the deacetylation at N-epsilon lysine residues, a reaction which consumes 
NAD+. SIRT1 specifically, is a sirtuin commonly associated with antioxidant function [47]. Its 
regulation of oxidative stress is threefold: firstly, it stimulates the expression of antioxidants 
via the fork-head box protein O (FOXO) pathway. Secondly, it is involved in inhibiting the NF-
𝜅B signalling pathway by deacetylating the p65 subunit of the NF-𝜅B complex which results in 
the inhibition of the NF-κB signaling. In contrast, however, excessive ROS can inhibit SIRT1 
activity by oxidatively modifying its cysteine residues and thereby releasing its inhibition of the 
NF-𝜅B pathway [48]. It is thus theoretically possible for cumulative stress to downregulate 
SIRT1 activity in the ageing process. Thirdly, SIRT1 has also been implicated in regulation of 
apoptosis by deacetylating p53 to inhibit p53 dependent transcription in models of cellular 
stress [48].This tripartite role defines SIRT1 as another important molecular target in the 
context of both normal and accelerated ageing. Apart from these targets related to cellular 
signalling, cell functional capacity should also be a focus. A striking example of the oxidative 
stress, inflammation link in ageing, is the decreased capacity for neutrophil chemokinesis 
reported in the elderly both in terms of motility and accuracy [49]. Normally, immune cells are 
attracted by chemotactic signals from injured tissue, to migrate to sites of injury or pathogen 
invasion. During this chemokinetic response, immune cells, typically neutrophils and 
classically activated macrophages, migrate through tissue toward the site of injury. This 
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movement is facilitated largely via adhesion molecules such as the beta-integrins and I-CAM1 
in the case of neutrophils [23]. However, as mentioned earlier, expression of adhesion 
molecules on neutrophils increases with ageing [37], so that their movement is slowed. In 
addition, due to yet unclear mechanisms, but most probably due to adaptation of cellular 
“homing” molecules, directional accuracy of neutrophil migration is also compromised in the 
elderly. Sapey et al (2014) showed that inaccurate neutrophil migration was causally 
associated with increased constitutive phosphoinositide 3-kinase (PI3K) signalling. This 
results not only in inefficient inflammation due to prolonged response time, but the directional 
inaccuracy of movement also results in mechanical and oxidative damage to relatively more 
cells in the path of the migrating inflammatory cell [49]. It is clear that both oxidative stress and 
inflammation are able to induce and exacerbate one another (both indirectly and directly). 
Furthermore, regardless of the primary signal or which pathway was activated first, these 
interrelated processes form a vicious cycle which is difficult to target therapeutically because 
of its complexity. However, it is also this interrelated nature of the two systems that has led us 
to investigate the possibilities of antioxidants as treatment options to attenuate the cumulative 
effects of oxidative stress and in turn low grade chronic inflammation. 
2.5 Practical considerations: information gained from acute oxidative stress protocols 
Traditionally it was believed that long duration endurance exercise induced oxidative 
perturbations due to metabolic stressors, as well as inflammatory stimuli which occur over 
time [50]. This is supported by the notion that endurance exercise increases one’s oxidative 
capacity [51]. The logic is that greater stressors over time elicit a greater response which 
results in adaptations. Recently though, acute protocols have been investigated as an effective 
stimulus of oxidative stress and inflammatory responses when the exercise intensity is high 
[52]. This poses as an appealing protocol as it can be used to elucidate the acute changes 
which occur and mimic other acute stressors such as injury and sickness, known to elicit 
higher responses in the more acute time frame. These protocols make use of what is known 
as high intensity interval training (HIIT) ,which consists of short bursts of high-maximal effort 
bouts of strenuous exercise with short rest periods in between and repeated cycles thereof 
[53]. This proposed method decreases protocol time, which enable the researchers to sample 
and elucidate data at earlier time points, capturing acute changes. It is also a protocol which 
is now popular amongst athletes and regularly fit persons making subject recruitment easier.  
Some other methods of inducing oxidative stress include training in hypoxic conditions [54] 
and resistance training resulting in delayed onset muscle soreness (DOMS) [50]. These 
methods have been shown to be effective but are not ethically justifiable for research of this 
manner. These methods also do not affect the less injurious induction of oxidative stress and 
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inflammatory which this project aims to investigate and have various other undesirable side 
effects. It also would not be appropriate to compare this type of stressor with an aged 
population as ethically it would not be viable and there is no way of mimicking this in a human 
population.    
Using a young population accompanied to exercise with an acute protocol thus seems as the 
most appropriate method to comprehensively assess these perturbations. A young fit 
population poses as a good group for two main reasons. Firstly a population accustomed to 
exercise means that the subjects will be able to complete the protocol safely and successfully 
[52], as HIIT protocols are being presented in training programmes as well as gym classes. 
We can thus be sure that the protocol will we completed. Secondly this population are 
expected to be free of confounding conditions or factors which would affect results, which is 
also why ethically this population is ideal. 
Taking this into consideration an acute protocol seems to be appealing to elucidate the acute 
responses which are not overly injurious but demonstrate perturbations to compare the chronic 
effects of oxidative stress as well as low grade inflammation.   
2.6 Are Grapes the Answer to Prevention of Ageing?  
Despite the huge range of non-steroidal and natural anti-inflammatory products on the market 
today, the scientific literature shows a conspicuous lack of consistent support for any specific 
medication. This is perhaps at least in part due to the fact that researches investigating these 
products cannot keep up with the rate at which new ones are pushed onto the market. 
Hopefully new legislation on the control of these substances will affect this trend to the benefit 
of the consumer, by allowing for (or demanding) appropriate testing of these products. 
Nevertheless, antioxidants are being used almost routinely by many individuals who wish to 
supplement for enhancement of general health or as adjuvant therapy in conjunction with more 
mainstream, pharmaceutical medication. Although they are generally not regarded as a 
primary therapeutic option, antioxidants may hold particular potential in the realm of 
preventative medicine. The potential benefits of appropriate antioxidant supplementation are 
vast, especially when considering the connection between oxidative stress and inflammation. 
An antioxidant with the capacity to modulate inflammatory status can thus be beneficial to both 
normal ageing individuals and those suffering from lifestyle associated diseases. A 
comprehensive search of the scientific literature revealed that grape-derived antioxidants are 
consistently reported to have high benefit and low risk in the context of both oxidative stress 
and inflammation. These positive results are further strengthened by the fact that these 
consistent findings were reported across many different models and using a variety of different 
preparations, ranging from relatively crude extracts to highly purified ones. For example, 
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scientific literature and anecdotal reporting, highlights resveratrol ,a purified polyphenol 
present in grapes as well as other plants, as having anti-inflammatory [55] and antioxidant 
[56,57] action ,and thus by implication anti-ageing effects. Indeed, a recent paper [58] 
elucidated a role for resveratrol to protect against inflammatory damage via SIRT1 inhibition 
of the NF𝜅B pathway (a mechanism discussed above in the context of ageing). In addition, 
more advanced studies have been undertaken on this polyphenol to better understand the 
relationship between the chemical structure of resveratrol and its biological activity, especially 
in terms of oxidant scavenging [59]. Also, pharmaceutical groups have been working on 
optimisation of delivery systems for resveratrol [60]. Such information may further advance 
the popularity of this very promising natural product with the pharmaceutical industry, to the 
benefit of consumers. The phenomenal frequency at which new papers on resveratrol appear, 
all providing evidence of positive effects in this context, suggests that this particular polyphenol 
should be investigated in the context of ageing as a matter of urgency. Even more promising 
than the many positive effects described for resveratrol above, is the fact that resveratrol is 
only one from a range of equally beneficial substances contained in grapes. The flavonoids 
quercetin and dihydroquercetin (DHQ), as well as proanthocyanidins and anthocyanins, all of 
which are present in grapes and a variety of other plant sources, have similarly been linked to 
both antioxidant and anti-inflammatory effects [55,56]. To date, despite appearance of a few 
very promising reports in this context, ageing specifically has not been the focus of many 
studies investigating these substances. Therefore, for the purpose of this review, we provide 
a comprehensive overview of the few existing ageing-related studies in this context that were 
available to us. Results from relevant papers that did not have ageing as a focus were also 
included, where those results contribute to our understanding of the role of grape derived 
polyphenols in oxidative stress and inflammation in the context of prevention or deceleration 
of the ageing process. When considering in vivo studies on ageing as a starting point, 
resveratrol (0.1 𝜇M to 2.5 𝜇M) exhibited a clear dose dependent effect on longevity in fish with 
known short lifespan: resveratrol supplemented fish almost doubled their expected 13-week 
lifespan and continued to produce healthy offspring long after all control fish had died. Even 
though resveratrol supplementation was only started in adulthood in this study (i.e., it 
compares to when humans might start to consider supplementation), it effectively delayed age 
dependent compromise of locomotor and cognitive performance and reduced expression of 
neurofibrillary degeneration in the brain [61]. This result of improved neural morphology was 
recently further substantiated in an aged rat model, where chronic resveratrol treatment 
prevented detrimental changes in dendritic morphology which is linked not only to ageing, but 
also to Alzheimer’s disease [62]. Similarly, two months of ingesting polyphenols in the form of 
10% grape juice resulted in enhanced potassium-evoked dopamine release and cognitive 
performance in aged rats [63]. 
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A more recent review [64] provides more insight into the potential mechanisms by which age-
related cognitive disorders may be curbed by grape polyphenols. Some of these mechanisms 
at first seem unrelated to the scope of this review, for example, preventing amyloid-beta 
deposition associated with Alzheimer’s dementia [65]. However, recent research suggests a 
role for inflammation in the development of the disease [66], while natural antioxidants have 
been linked to prevention of amyloid-beta deposition [67]. Together, these data suggest that 
even these seemingly unrelated mechanisms may be interconnected to either inflammation, 
oxidative stress, or both. However, more clearly in context of this review, resveratrol was 
reported to increase NO production, resulting in vasodilation [64,68], which may play a role in 
the maintenance of central circulation and thus perhaps slower degenerative central 
processes, as has indeed been reported for resveratrol, as mentioned earlier. However, the 
role of NO in the context of antioxidant status is much more complex, so that this effect of 
grape polyphenols should probably receive more attention before it can be interpreted fully in 
terms of mechanism(s) involved. Furthermore, recently in a co-culture simulation of the human 
blood-brain barrier, another grape polyphenol, proanthocyanidin, was associated with 
significant inhibition of monocyte infiltration and proinflammatory cytokine secretion in HIV-
associated neuroinflammation [69]. Such inhibition of neuroinflammation is associated with a 
better prognosis in terms of HIV-related neurodegeneration and dementia, further confirming 
the neuroprotective potential of grape-derived antioxidants. Taken together, these studies 
suggest that the neuroprotective effects of grape polyphenols involve both antioxidant and 
anti-inflammatory mechanisms, with the latter including not only modulated cytokine signalling, 
but also modulation of both motility and functional capacity of leukocytes, as previously 
illustrated by our group [69,70]. One may argue that both these results may be the result of 
decreased cell activation, perhaps as a result of the known altered cytokine environment. 
However, an age-associated lack of neutrophil chemokinetic accuracy in response to the 
chemotaxin fMLP has been reported [49], which suggests that the mechanism is probably 
related to age-induced compromise of specific cellular mechanisms, rather than activation. In 
addition, preliminary data from using Dunn chamber chemokinetic assays, suggest that grape 
polyphenols (specifically proanthocyanidin) may be able to correct this age-associated 
anomaly (unpublished data from my BSc Hons project). From Figure 2.1, which depicts typical 
digital images obtained for the path of individual neutrophils, it is clear that a more purposeful, 
directionally accurate movement was achieved in proanthocyanidin-treated neutrophils. This 
will ensure a more optimal inflammatory response (i.e., the response will be effective, resulting 
in relatively insignificant secondary damage, and be resolved in the minimum amount of time). 
In contrast the rather “aimless wander” of untreated neutrophils from aged individuals will 
result in not only ineffective immune cell infiltration to sites where they are required, but also 
relatively more secondary tissue damage and thus prolonged and exacerbated inflammation.   
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Turning attention to inflammation and oxidative stress again, the most probable targets for 
therapeutic intervention in the context of ageing have been described in Section 2.4. Since 
the ageing literature is relatively lacking in terms of papers on polyphenol intervention, we 
have tabulated effects of grape polyphenols reported for these identified targets in Table 2.1, 
citing relevant data that was mostly obtained in models other than ageing. The aim with this 
table was not to present all studies on grape-derived products; rather, it is an attempt to show 
the many models, species, and disease systems in which beneficial effects on oxidative stress 
and inflammatory status have consistently been reported. Also, although we have included 
doses used for in vivo studies for general comparison and again to illustrate the large 
variations in doses, these doses are product/extract specific and cannot be extrapolated 
across board. From Table 2.1 (page 15, legends on page 16), which is by no means a 
complete list of all studies reporting on grape-derived substances, grape derived products are 
undeniably beneficial in limiting the magnitude of the inflammatory response as well as to 
increase antioxidant activity and seem to have multiple targets. 
A C B 
Figure 2.1: Typical neutrophil chemotaxis pathways for (a) a young participant (<25yr), (b) an aged participant 
(>65yr), and (c) an aged participant after acute in vitro treatment with grape-deed derived proanthocyanidin. 
The Olympus Cell system IX-81 inverted fluorescent microscope system with an F view cooled CCD camera 
(Soft Imaging Systems) at 20x magnification was used to capture these images, which was analyzed using 
Image J (Java software). 
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Model Treatment Outcomes: inflammation Outcomes: oxidative status References 
IN VITRO:     
Glucose and LPS-induced inflammation 
in HUVEC cells 
Red grape polyphenols ↓IL-6, IL-8 and NF-κB at protein and mRNA levels 
↓PECAM and ICAM-1 levels 
↓ROS formation in dose-dependent manner [71]  
Primary human chondrocytes challenged 
with E.coli LPS (arthritis model) 
Grape extract containing resveratrol, 
hopeaphenol and viniferin 
↓PGE2 production ↑scavenging of DPPH radicals [72]  
Osteoblast-like cells (MC3T3-Ei), treated 
with TGF-β to induce VEGF synthesis  
Resveratrol ↓VEGF and VEGF mRNA, but 
no effect on p38 or SAPK/JNK, suggesting SIRT1 activation.  
n.a.   [73]  
Yeast models of sirtuin activation 
(c.elegans, D. melanogaster) 
Resveratrol ↑sirtuin (SIRT1) activation n.a. [74,75] 
Human adipose derived stem cells 
(hASCs) 
Red grape (muscarine) grape seed oil, in 
comparison to rice bran and olive oils 
↓adipogenetic factors (PPARγ and aP2) 
↓IL-6 and IL-8 response to LPS 
↓proinflammatory gene expression in adipocytes 
Shown to be source of γ-tocopherol [76]  
High-glucose induced oxidative stress in 
porcine proximal tubule cells (LLC-PK1) 
Grape seed polyphenols ↓NF- κB pathway ↓intracellular ROS [77] 
IN VIVO ANIMAL:     
Rats exposed to localised bowel 
irradiation 
Grape polyphenols OR pure quercitin 3-O-β-
glucoside (10mg/ml, 7.14ml/kg body mass) 
by oral gavage for 5 days prior to irradiation 
↓MPO activity 
↓CINC-1 levels 
 
↓SOD activity 
No change in glutathione peroxidase (GSHPx) activity 
No change in plasma malondialdehyde (MDA) concentration 
[78]  
Rats subjected to E.coli-induced septic 
shock 
75 and 200 mg/kg/day grape seed 
procyanidin, by ip. injection for 15 days pre-
E.coli challenge 
↓IL-6 gene expression ↓NO in liver, spleen, plasma and RBCs 
↓iNos gene expression 
↓GSSG:total Glutathione ratio 
[79]  
Rat model of osteoarthritis 500mg/kg body mass of grape extract daily 
for 28 days 
Prevented joint deterioration n.a. [72]  
Rat model of skeletal muscle contusion 
injury 
Acute OR 2-week supplementation, 
proanthocyanidins 
↓pro-inflammatory cytokine signalling (TNF-α; IL-6) 
↓neutrophil migration capacity 
Earlier macrophage switch from pro- to anti-inflammatory phenotype 
↑ plasma and skeletal muscle ORAC [55,80] 
Rat model of ageing Drinking water supplemented with 15g/l 
grape powder for 3 weeks 
↓age-associated increase in corticosterone 
 
↓plasma 8-isoprostane [81]  
Rat model of obesity Grape procyanidin B2 ↓IL-1β and NLRP3 levels in pancreas n.a. [82]  
Middle-aged mice on high-calorie diet Diet supplemented with 0.04% resveratrol ↓IGF-1 
 
↑AMPK and PGC-1α activity 
↑ mitochondrial number 
[87]  
Mouse model of pulmonary fibrosis 7-day oral resveratrol (50mg/kg/day) OR 
quercetin OR dihydroquercitin (both 
10mg/kg/day) 
↓neutrophil infiltration into lung tissue 
↓inflammatory cells in bronchoalveolar lavage fluid 
↓COX-2 and ↓ NF- κBp65 translocation 
↓iNOS 
↓oxidative lung damage (↓nitrotyrosine and poly-ADP-ribose 
polymerase levels) 
[84] 
Rabbit model of acute (E.coli) 
inflammatory arthritis 
500 mg/kg body mass of extract acutely 
prior to E.coli challenge 
↓PGE2 production n.a. [72]  
IN VIVO HUMAN:     
Non-diabetic haemodialysis patients Grape powder (500mg polyphenols/day) for 
5 weeks 
Prevented increase in plasma CRP levels ↑glutathione peroxidase activity [85]  
Humans at risk for metabolic syndrome, 
aged 30-65 
16-weeks of 20g wine grape pomice powder 
(822mg polyphenols) per day 
n.a. ↑γ- and δ-tocopherol  [86]  
Hypertensive, T2DM males, aged ≈55-65   8mg grape extract daily for 1 year ↓Alkaline phosphatase 
↓TNF-α, IL-1β, IL-6 and CCL3 levels 
↑transcriptional repressor LRRFIP-1 in PBMCs 
Modulation of miRNAs known to regulate inflammatory response 
n.a. [87]  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 16 
 
Table 2.1. Representative reports on antioxidant and anti-inflammatory effects of grape-derived crude 
extracts and purified products. 
Footnote to table 2.1: 
Abbreviations: ADP, adenosine diphsophate; AMPK, adenosine monophosphate-activated protein 
kinase; CCL3, chemokine(C-C motif) ligand 3;  CINC-1, cytokine-induced neutrophil chemoattractant1; 
COX-2, cyclooxygenase-2 ; DPPH, 2,2-diphenyl-1-picrylhydrazyl; HUVEC, human umbilical vein 
endothelial cells; iNOS, inducible nitric oxide;  ICAM-1,intercellular adhesion molecule-1; IGF-1, insulin 
growth factor-1; IL, interleukin; JNK, c-Jun N-terminal kinase; LPS, lipopolysaccharides; LRRFIP-1, 
leucine-rich repeat in flii-interacting protein-1; NO, nitric oxide; NF-κB, nuclear factor-kappa beta; 
ORAC, oxygen radical absorbance capacity; PECAM, Platelet endothelial adhesion molecule; PGC-1, 
peroxisome proliferator activated receptor gamma co-activator 1-alpha; PGE2, prostaglandin E2; ROS, 
reactive oxygen species; SAPK, stress activated protein kinase;  VEGF, vascular endothelial growth 
factor  
Of course, when considering potential anti-ageing modalities, it is also of interest to include 
evaluation of changes in quality of life. Since ageing is associated with natural muscle wasting 
or sarcopenia [88], it is important to note that, in this context, supplementation with grape 
polyphenols (50mg/kg/day) for 4 weeks mitigated skeletal muscle atrophy in a mouse model 
of chronic inflammation [89]. This was achieved via modulation of two distinct pathways: one 
directly linked to inflammation (decreased NF-𝜅B activation) and the other due to antioxidant 
function (limited ROS-associated mitochondrial damage and caspase-3 and -9 activation). 
Since caspase-3 activation is also a known pro-apoptotic signal [90], reduced activation and 
thus apoptosis may result in fewer mitotic cycles. This, in the context of the telomere 
hypothesis, may point to deceleration of ageing by the polyphenols. Very recently, grape 
proanthocyanidin treatment in rats was reported to have an anti-apoptotic effect which reduced 
damage after ischemia/reperfusion of the liver [91], which further substantiates this theory. 
Interestingly, a study in mice fed a high-fat diet indicated that grape polyphenols may modify 
gut microbial community structure to result in lower intestinal and systemic inflammation 
[92].This extraordinary result serves to remind us of the potential complexity of plant medicines 
and the requirement for comprehensive investigation of mechanisms of actions and 
interactions of any potential product via the traditional clinical trial process followed for new 
pharmaceutical drugs. 
2.7 Summary  
Ageing and accelerated ageing are not new concepts, but rather the norm in modern society. 
With a population that is growing relatively older due to advances in medicine, we are however 
pressed for answers on how to alleviate the symptoms or slow the progression of this 
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inevitable phenomenon. From the literature consulted, no negative effects of grape-derived 
products became evident, while beneficial effects in the context of oxidative stress and 
inflammation were consistently reported in the context of numerous cellular targets. Huge 
variation in product content and prescribed dosage complicates interpretation of the fast 
growing body of literature on this topic. A recommendation for future in vivo studies is the 
inclusion of more parameters per study, so that a more comprehensive interpretation of 
specific mechanisms becomes possible. Measurement of only basic indicators of either 
antioxidant status or inflammatory status, while providing proof of efficacy of the product, does 
not contribute much information on its mechanism of action.  
Given the relative complexity of making firm conclusions with regard to mechanisms of action 
from in vivo data, the focus of this thesis was to further investigate mechanisms by which 
grape-derived PCO may achieve the beneficial effect reported from in vivo studies, using a 
human in vitro treatment intervention model.  
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2.8 Hypothesis and Aims 
From the literature consulted, I have formulated the following hypothesis: 
Firstly, I hypothesise that an aged sedentary population will have relatively higher levels of 
oxidative stress and a relatively worse pro-inflammatory profile than a younger sedentary 
population. 
Secondly, I hypothesise that the grape seed-derived polyphenol (PCO) in vitro treatment will 
be beneficial to both populations, but more so in the aged population. 
Thirdly, I hypothesise that in a normally fit young population, an acute bout of high-intensity 
exercise will effectively simulate acute inflammatory and oxidative stress, of higher magnitude 
than the cumulative stress elucidated in an aged population, which will also be alleviated by 
PCO.  
Aims:  
1. To characterise changes in our selected markers for inflammation and oxidative 
stress in an aged population. 
2. To investigate whether fitness in a young fit population may result in a more 
favourable oxidative stress and/or inflammatory profile. 
3. To assess the effect of an acute bout of high-intensity exercise on our chosen 
oxidative stress and inflammation markers. 
4. To assess effects of in vitro PCO treatment on neutrophil functional capacity and 
oxidative stress parameters in all populations. 
Objectives: 
 Recruit healthy subjects in the following groups with the criteria;  
o Young (sedentary) between 18 and 25 years old healthy, not on medication or 
supplementation and does not partake in regular exercise. No chronic 
conditions   
o Aged over 65 years of age, healthy, not on medication or supplementation and 
does not have any chronic conditions.  
o Young (fit) between 18 and 25 years old healthy, not on medication or 
supplementation, partakes in habitual exercise at least 3 times per week and 
does not have any chronic conditions or injuries. 
 Analysis of the oxidative status of plasma from all three groups at rest, by first 
measuring anti-oxidant capacity via ORAC, FRAP and TEAC as well as the GSH: 
GSSG ratio in whole blood. Then measure oxidative damage parameters, namely 
Stellenbosch University  https://scholar.sun.ac.za
 19 
 
conjugated dienes(an early marker of lipid peroxidation) and TBARS measurement of 
MDA (a late marker of lipid peroxidation)  
 Isolate neutrophils and administer in vitro treatment of PCO (or placebo) for one hour, 
then track migratory capacity of neutrophils of all three groups at rest. 
 Measure inflammatory markers expression of CD16 and CD66b on the surface of 
isolated neutrophils and MPO (intracellular) to attain neutrophil inflammatory 
functionality with and without in vitro treatment for all three groups at rest. 
 Measure changes in neutrophil anti-oxidant capacity with ORAC and FRAP assays and 
changes in oxidative damage (CD) after in vitro treatment with PCO (or control placebo) 
for all three groups at rest. 
 Induce acute oxidative stress with a HIIT exercise protocol in the young fit group and 
obtain blood samples before and after exercise. 
 Perform above mentioned analysis on plasma from pre- and post-exercise samples. 
 Isolate neutrophils from before and after exercise samples and perform above 
mentioned analyses.  
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Chapter 3  
Methods  
3.1 Ethical considerations 
Ethical clearance was obtained for this research from the Subcommittee C Health Research 
Ethics Committee 1 of Stellenbosch University prior to initiation of the study protocol (reference 
number N14/02/007). Research was conducted in accordance with South African Medical 
Research Council guidelines and the Declaration of Helsinki. All volunteers were informed 
about the study verbally and in writing. Informed consent was obtained from all subjects prior 
to their enrolment into the study, the informed consent form can be found in Appendix B. 
3.2 Subject characteristics and experimental categories 
Subjects were recruited from two age categories, namely young adult (18-25 yr) and geriatric 
(over the age of 65 yr, n=7). In the young adult category, a distinction was made between 
sedentary (n=8) and competitively active (n=6) individuals (more information on this group to 
follow). Subject inclusion criteria included a) non-smokers, b) no medication use, c) no 
nutritional supplements, including vitamins or anti-oxidants and d) no diagnosed inflammatory 
or other chronic disease. The young sedentary subjects were selected as a control population. 
The aged individuals were selected to simulate chronic oxidative stress, as the onset of this 
has been reported to occur at the 6th decade of life [49]. The young fit population were selected 
to partake in an exercise intervention to simulate acute oxidative stress [50]. 
3.3. Experimental acute oxidative stress-inducing exercise protocol  
Fit subjects were subjected to a running VO2max treadmill (TechnoGym, Italy) test to establish 
the appropriate exercise intensity with which to induce acute oxidative stress. A pre-exercise 
lactate measurement was taken from a finger prick blood sample (Accucheck). A lactate 
reading of higher than 3 mmol/l required a 15 min rest period before re-testing to ensure the 
subject did not have residual lactate above normal resting level (0.5-1 mmol/l) due to caffeine 
or alcohol intake or prior exercise. Subjects were given 5 minutes to warm up on the treadmill 
at preferred speed (fast walking to slow jogging pace, ± 5km/hr) where after the Oxycon 
(Jaeger, Germany) mask was applied and the test was begun at 7 km/hr. The incremental test 
administered had incremental increases of 0,5 km/hr every 30 seconds until voluntary 
exhaustion, from which maximal oxygen uptake was measured. After maximum was reached, 
exercise intensity was established whilst subjects were given 3 minutes of active rest. 
Thereafter the subject was subjected to a high intensity interval exercise protocol consisting 
of one minute of treadmill running at 80% VO2max, followed immediately by one minute of 
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treadmill running at 50% VO2max. This cycle was repeated until voluntary exhaustion.  Three 
minutes after reaching voluntary exhaustion, a post-exercise lactate measurement was taken 
following the same protocol (refer to Appendix C for the detailed procedure). 
3.4 Sample collection 
Phlebotomy. One blood sample was obtained from all subjects except the fit subjects who had 
a blood draw before as well as after the exercise intervention, i.e. 2 samples. For each sample, 
six ml of blood was drawn from antecubital area of the arm by an experienced phlebotomist, 
and collected into sterile Lithium Heparin- and EDTA-containing vacutainer tubes (Vacuette, 
Lasec).The tubes were gently inverted 8-10 times before specialised processing as required 
for each analysis.  
For oxidative stress sample preparation, EDTA whole blood was aliquoted into three 50 µl 
Eppendorf tubes and frozen immediately at -80 °C. Three Eppendorf tubes of 100µl whole 
blood plus 10 µl M2VP was aliquoted and frozen immediately at -80 °C. The remaining EDTA 
sample was processed the same as the heparin sample for oxidative stress analysis on 
isolated neutrophils. Heparinised blood samples earmarked for neutrophil isolation, were kept 
at room temperature until isolation of neutrophils, which had to be performed within four hours 
from collection. 
3.5 Neutrophil isolation  
Neutrophils were isolated from blood using density centrifugation. Briefly, 2 ml of 
Histopaque1077 (Sigma) (at room temperature) was pipetted into a 15 ml falcon tube. A double 
volume (4 ml) heparin anti-coagulated whole blood was added by carefully pipetting it down 
the side of each tube onto the Histopaque layer. Tubes were transferred to the centrifuge 
machine with swinging rotor and spin at speed of 652xg for 30 minutes at 21 °C, 1800 rpm. 
The sediment containing the neutrophils and erythrocytes was taken by discarding the 
supernatant layers. Sediment was mixed with equal volume 6 % (room temperature) filtered 
dextran (in Normal Saline) and incubated at 37 °C for 45 minutes. Pellet containing the 
erythrocytes was discarded and the neutrophil rich supernatant was collected and mixed with 
10 ml of PBS. Mixture was centrifuged at 290xg for 10 minutes at 4 °C, 1500 rpm. Neutrophil 
pellet was collected by removing the supernatant. The final neutrophil pellet was then re-
suspended into 1 ml RPMI 1640 media to obtain an automated cell count (CellDyne 3700CS, 
Abbott Diagnostics, Germany). Neutrophils are re-suspended to a 2 × 10-6 cells per ml. (Please 
refer to Appendix D for a more detailed method.) 
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3.6 Grape seed-derived polyphenol  
The grape seed-derived polyphenol used was analysed by an independent laboratory (LC- MS 
laboratory, Central Analytical Facility, Stellenbosch University) to be a proanthocyanidolic 
oligomer made up of catechin, epicatechin and proanthocyanidin B. This water soluble 
compound was dissolved in purified distilled water to make up a stock concentration of 1 mg/ml 
later diluted with RPMI 1640 to treat cells at a concentration of 100 µg/ml. According to the 
supplier’s Certificate of Analysis, the PCO content of Oxiproven™ is 70 mg per capsule. The 
daily recommended dosage is 1-2 capsules with water after meals. Previous studies have 
elucidated the optimal dosage [69] via MTT-assay mitochondrial viability studies and 
concluded that 100 µg/ml is the highest dosage which does not result in a significant reduction 
in mitochondrial viability. 
3.7 In vitro PCO treatment protocol 
The neutrophil suspension was divided into two groups of 500 µl each. The control group had 
500 µl RPMI 1640 media added.  The treated group had 400 µl RPMI and 100 µl aqueous 
PCO at concentration 100 µg/ml added. Cells were incubated for one hour at 37 C, 95% CO2 
and 5% N2.  
3.8 Neutrophil chemotaxis assay 
Neutrophil migration is an indicator of its functional capacity, as aberrant neutrophil 
chemokinesis has been identified as a main contributing factor to secondary tissue damage 
[20]. This is characterised by damage done to surrounding healthy tissue by the release of 
elastins and oxidative molecules [93]. This secondary damage can lengthen the recovery time 
and perpetuate perturbations in homeostasis as is the nature of the robust inflammatory 
response. In the context of ageing this explanation of inefficient neutrophil function has been 
linked to various disease pathologies most notably arthritis [94].    
A Dunn chamber was used to assess the migratory capacity of neutrophils (in terms of distance 
and directional accuracy) toward a chemotaxin. 10 µl of neutrophils in suspension were 
seeded on coverslip and left to adhere for one minute. Their migratory capacity up a 
chemotactic gradient was then assessed by filling both annular wells of the Dunn migration 
Chamber (figure 3.1) with media (RPMI 1640). The coverslip with cells was then placed 
inverted onto chamber and sealed with hot wax mixture (Vaseline: Paraffin: beeswax, 1:1:1). 
The media was then drained out of the outer well using filter paper. The outer well was and 
filled with the chemoattractant fMLP (100 µl solution with HBSS). A gradient was allowed to 
form for 20 minutes before imaging.  
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Figure 3.1: Dunn Chamber (Hawksley) which was used for visualisation of neutrophil migration 
 
Neutrophil migratory paths were visualized by combining time lapse images taken at 20X 
magnification using an Olympus Cell® system IX-81 inverted fluorescent microscope system 
with an F-view cooled CCD camera (Soft Imaging Systems). Images were acquired every 20 
seconds for a total time of 20 minutes. Image J (Java Software) was used to track the 
movement of neutrophils and, measure distance covered as well as distance from start using 
the Mtrack J plugin. Neutrophil tracks were quantified by measuring the total distance they 
moved (from point to point) and the linear distance they covered (a straight path from start to 
finish) as depicted in Figure 3.2. 
 
 
 
 
 
 
 
 
Figure 3.2: Illustrative neutrophil migratory track as obtained from live cell microscopy and cell 
tracking software. Actual cell path is presented in red, while the black line indicates the straight-line 
distance travelled from the starting point, in the direction of the chemotactic signal. The ratio of linear 
to total distance indicates accuracy of movement. 
Linear Distance 
Total Distance 
Ratio = 
𝐿𝑖𝑛𝑒𝑎𝑟 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒
𝑇𝑜𝑡𝑎𝑙 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒
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3.9 Neutrophil functional capacity 
We chose two markers for assessment of neutrophil activation status, namely CD16 - a marker 
for the Fcγ Receptor IIIb (an IgG receptor), which is shed upon activation as described by 
Fossati et al. [116] – and CAECAM 8 (CD66b) – an adhesion molecule required for neutrophil 
extravasation and migration into tissue, which is exocytosed after activation, as described by 
Nair et al. [96]. In addition, intracellular MPO was assessed as marker of neutrophil functional 
capacity. After treatment; control and PCO-treated samples were prepared and stained with 
MPO (BD-Anti–Myeloperoxidase PE), FcƴRIIIb (BD-Human CD16 ALEXA 647) and CEACAM 
8 (BD-Human CD66b PERCP-CY5.5) antibodies after being permeabilised and fixed with 
CytoFix Cytoperm (BD Biosciences). The fluorescence was analysed on the BDFacs Aria Cell 
Sorter (Beckton Dickinson, San Jose, CA, USA) flow cytometer and analysed with BD 
FACSDiVa v6.1.3. Software to assess the expression of MPO, FcƴRIIIb and CEACAM 8 
expression on neutrophils treated with PCO versus control. Consult appendix E for detailed 
staining method and flow cytometry analysis guidelines. 
3.10 Plasma Myeloperoxidase  
Plasma myeloperoxidase was measured using an enzyme-linked immunoassays (Abcam 
Myeloperoxidase (MPO) human ELISA kit (ab119605, Abcam, ROW)) .The assay was 
performed on plasma samples separated from whole blood collected in EDTA vacutainer 
tubes. MPO was measured to assess inflammatory status as is reported in the literature. A 
detailed method of the ELISA can be found in appendix F. 
3.11 Oxidative stress profile  
Oxygen radical anti-oxidant capacity (ORAC) assay was performed on EDTA-anticoagulated 
blood plasma as well as isolated neutrophils after in vitro treatment with PCO or control. This 
assay is used to assess the peroxyl radical absorbance capacity (hydrogen atom transfer 
(HAT) mechanism of anti-oxidant action) of the endogenous antioxidant systems within plasma 
or cells in comparison to Trolox, the known anti-oxidant standard. It is measured via kinetic 
flourometric reading changes over time of β-phycoerythrin damage caused by peroxyl or 
hydroxyl radical attack which changes the absorbance of UV light. A detailed standard 
operating protocol can be found in appendix G. 
Ferric Reducing Ability of Plasma Assay (FRAP) assay was performed on plasma separated 
from EDTA blood as well as isolated neutrophils treated in vitro with PCO and a control. This 
assay is used to assess the Fe3+  to Fe2+ reducing capacity (single electron transfer (SET) 
mechanism of anti-oxidant action) of a sample (plasma or cells) using colorimetric changes 
compared to Vitamin C. The full detailed protocol can be found in appendix H. 
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Conjugated dienes (early marker of oxidative damage) assay was used to assess the level of 
conjugated dienes present in samples (in plasma and cells).Conjugated dienes are formed as 
a product of the initial steps of lipid peroxidation. Conjugated dienes absorb light at 233 nm 
and this absorbance is measured compared to a cyclohexane standard. The full protocol for 
the assay with cells and plasma is detailed in appendix I 
2-Thiobarbituric Acid Reactive Substances (late marker of oxidative damage) was used to 
assess the amount of malondialdehyde (MDA) present in plasma samples. Malondialdehyde 
is formed as an end product of lipid peroxidation, and can be detected spectrophotometrically 
at absorption of 532–572 nm. Thiobarbituric acid (TBA) is used in this assay to form a pink 
MDA-TBA complex which is then measured. The detailed protocol can be found in appendix 
J. 
2,2’-azino-di-3-ethylbenzthialozine sulphonate (ABTS) Trolox equivalent anti-oxidant capacity 
(TEAC) assay was used to measure the total antioxidant status of plasma samples 
(combination of HAT and SET mechanisms of anti-oxidant action). This assay assesses the 
ability of ABTS•+ to scavenge and form a colour (green) of which absorbance is measured at 
734 nm. The protocol can be found in appendix K.  
Glutathione redox analysis (GSH/GSSG) measures the ratio of reduced (GSH) to oxidised 
(GSSG) glutathione as an indicator of oxidative stress status and DNA damage. Whole blood 
from subjects was used for this assay as well as whole blood treated with 1-methyl-2-vinyl-
pyridinium triflouromethane sulfonate (M2VP) used to stop the formation of GSH and maintain 
GSSG. GSH is an antioxidant that provides reducing equivalents for the glutathione 
peroxidase. This reaction results in the formation of a disulfide bond between two GSH 
molecules to form GSSG. Exposure to increased levels of oxidative stress results in GSSG 
accumulating and the ratio of GSSG to GSH increases. An increased ratio of GSSG-to-GSH 
is an indication of oxidative stress. GSH is oxidised by the sulfhydryl reagent 5, 5′-dithio-bis 
(2-nitrobenzoic acid) (DTNB) to form the yellow which is measured at 412 nm for five minutes. 
GSSG formed can be recycled to GSH by glutathione reductase in the presence of NADPH 
which is added to stop the reaction. The ratio of GSH to GSSG is then measured by taking 
GSHtotal (taken from first reading) and subtracting two multiplied by GSSG (taken from second 
reading) divided by GSSG reading ( GSH/GSSG ratio = GSH total – (2 x GSSG)). The full 
sample preparation and assay protocol can be found in appendix L. 
All oxidative status analysis were performed at the Oxidative Stress Research Centre at the 
Cape Peninsula University of Technology under the supervision of Dr Fanie Rautenbach.  
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3.12 Statistical analysis 
Statistical analysis was performed by an experienced biostatistician (detail) using the Statistica 
64 v.13 (Stat Soft Software). Data were analysed for normalcy of distribution, where after main 
effects of treatments and age were assessed by parametric or non-parametric ANOVA and 
Post hoc Fisher’s LSD tests. A p ≤ 0.05 was considered significant. Effects of exercise was 
assessed using the student t-test. 
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Chapter 4 
Results 
Table 4.1 illustrates group averages for leukocyte counts performed to confirm apparent 
health of all volunteers. Counts were similar across all populations. 
 WBC 
(109/l) 
Neut 
(109/l) 
Lymph 
(109/l) 
Mono 
(109/l) 
Eos 
(109/l) 
Baso 
(109/l) 
RBC 
(1012/l) 
Young 
sedentary 
6.64(0.97) 3.91(0.72) 2.12(0.45) 0.48(0.08) 0.18(0.14) 0.10(0.04) 4.62(0.18) 
Aged 6.13(2.74) 2.64(1.09) 1.79(0.38) 0.24(0.13) 0.10(0.04) 0.04(0.02) 5.36(0.67) 
Young fit 6.69(1.83) 2.92(1.11) 2.42(1.05) 0.43(0.11) 0.27(0.12) 0.06(0.04) 5.45(0.80) 
 
Table 4.1. Whole blood leukocyte counts at the point of sample collection. Values are means (SD). 
 
4.1 Ageing and habitual strenuous exercise both increase oxidative stress and worsen the 
inflammatory profile 
We set out to characterize our three populations and elucidate the baseline status of oxidative 
stress and inflammatory profile of groups. Firstly to establish whether our use of an aged 
population to simulate chronic oxidative stress was rational. Secondly we wanted to elucidate 
the oxidative stress status of the young fit population who are under the influence of habitual 
strenuous exercise as well as characterize their inflammatory profile. Both of these were done 
in comparison to the young sedentary group which we used as controls. The data presented 
in Table 4.2 displays the changes in anti-oxidant capacity as well as the level of level of 
oxidative damage present measured by content of lipid peroxidation by-products in the plasma.  
From the data we were able to establish that the aged population had a significantly increased 
level of conjugated dienes (an early marker of oxidative stress), while having no significant 
increases in anti-oxidant capacity. The fit population did not display any statistically significant 
increase in parameters when compared to the controls but displayed a tendency to have higher 
anti-oxidant capacity as well as conjugated dienes. Although the aged population displayed 
higher levels of oxidative stress, this was not matched to increased anti-oxidant capacity, 
which could indicate a relatively pro-oxidative stress state. 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 28 
 
 
Table 4.2. Selected parameters indicative of oxidative stress status in plasma. ORAC, FRAP and TEAC 
are measures of anti-oxidant capacity and CD (an early marker) and TBARS (late marker) are markers 
of oxidative damage. Data is presented as group mean(SEM). Statistical analysis: * and **, indicates 
significant differences between young sedentary vs. aged sedentary, P<0.05 and P<0.001 respectively. 
Abbreviations: TE, Trolox equivalent; VitC E, Vit C equivalent; ORAC, oxygen radical absorbance 
capacity; FRAP, ferric radical absorbance capacity; TEAC, trolox equivalent absorbance capacity; CD, 
conjugated diene; TBARS(MDA), thiobarbituric acid reactive substances (malondialdehyde). 
 
The ratio between GSH and GSSG was measured in whole blood to give an indication of 
glutathione content. A lower ratio indicates oxidative stress and has been linked to the 
presence of DNA damage [93]. In Figure 4.1, the ratios are displayed in a scatter plot to display 
the trends within and between groups. There was no significant difference between groups. 
 
 
 
 
 
 
 
Figure 4.1. Whole blood ratio of GSH to GSSG content in the three study populations. Data for each 
subject is presented individually, with the group mean indicated by the corresponding group colour 
line. 
 
To characterize baseline inflammatory profile plasma MPO was measured using an enzyme 
linked immunoassay. The measurement of MPO to characterize inflammatory profile is an 
established method in literature as described by Meuwese et al. [102]. In Figure 4.2 it is evident 
 
 
ORAC 
(TE µmol/ml) 
FRAP 
(VitC E µmol/ml) 
TEAC 
(TE µmol/ml) 
CD 
(nmol/ml) 
TBARS(MDA) 
(µmol/ml) 
Control: Young 
(sedentary) 
1411(78) 429(28) 0.62(0.15) 0.006(0.001) 2.32(0.44) 
Aged (sedentary) 1762(232) 411(28) 0.77(0.10) 0.021(0.007)*  0.47(0.44)** 
Young (fit) 1943(895) 413(34) 1.00(0.34) 0.008(0.002)  1.98(0.14)  
Young( Sed) Young (Fit) Aged
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that the aged population displayed a significantly higher plasma MPO content in comparison 
to the young sedentary controls. While the young fit population displayed a tendency to have 
increased MPO levels in comparison to the young sedentary controls this was not to the same 
extent as the aged population.  
 
 
 
 
 
 
 
 
Figure 4.2. Plasma MPO content for the three populations. Values are means and error bars indicate 
SD. Statistical analysis: *, P<0.05.  
 
The elevated plasma MPO levels in the aged population confirm that their inflammatory profile 
is worse than the young sedentary controls. Since baseline leukocytes did not suggest any 
evident inflammatory condition, we are confident that this is an ageing-associated result. 
4.2 Acute high intensity exercise did not affect parameters of oxidative stress or neutrophil 
function significantly in the young fit population 
The young fit group was exposed to an exercise intervention to induce acute oxidative stress. 
Anti-oxidant capacity, oxidative damage, inflammatory profile as well as neutrophil functional 
capacity was measured to assess the effect of the stimulus on this population and if oxidative 
stress was in fact induced. 
Firstly we measured lactate as well as VO2max to confirm the exercise intensity was in line 
with what the literature reports as evidence that exercise was sufficiently stressful to induce 
oxidative stress. We found that lactate was significantly increased after the exercise protocol, 
which suggests that oxidative stress was indeed successfully induced (Table 4.3).  
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Age 24(1.00) 
VO2max (ml.kg.min) 52.35 (9.18) 
Lactate pre-exercise (mmol/l) 0.63(0.33)  
Lactate post-exercise (mmol/)  6.1(3.16) * 
Total duration of protocol (min) 19.31(3.12) 
Table 4.3. Subject characteristics and parameters indicative of oxygen consumption and substrate 
utilisation. Data is presented as means (SD). Statistical analysis: *, pre- vs. post-exercise, P<0.005. 
The results of characterization of the plasma from young, fit subjects before and after the 
exercise intervention with regard to anti-oxidant capacity (ORAC, FRAP, TEAC), oxidative 
damage (CD and TBARS) and inflammatory status (MPO). As displayed in the data in Table 
4.4, no significant changes of the parameters were observed after exercise. Similarly, the ratio 
of GSH to GSSG in whole blood before and after exercise was unchanged (and similarly 
variable between individuals) after exercise (Figure 4.3). 
Table 4.4. A summary of results for oxidative stress status (including anti-oxidant capacity and 
oxidative damage) and inflammatory profile of plasma samples of the fit young group before and after 
exercise. Data is presented as means (SEM). 
 
 
 
 
 
 
 
 
Figure 4.3: Ratio of GSH to GSSG content in whole blood of the subjects before and after exercise - 
each data point represents a subject, with the corresponding line indicating the mean.   
 
Turning attention to cellular measures of oxidative stress within neutrophils specifically, results 
echo those of plasma measures, with no apparent effect of exercise (Table 4.5).  
 
 ORAC  
(TE 
µmol/ml) 
FRAP  
(VitC E 
µmol/ml) 
TEAC  
(TE µmol/ml) 
CD 
(nmol/ml) 
TBARS 
(µmol/ml) 
Plasma 
MPO 
(ng/ml) 
Pre-
exercise 
1943(895) 413(33.97) 1.01(0.34) 0.008(0.002) 1.98(0.14) 15.64(6.01) 
Post-
exercise 
1904(915) 457(51.41) 0.94(0.34) 0.007(0.001) 2.13(0.17) 9.85(1.78) 
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Table 4.5. Neutrophil anti-oxidant capacity (ORAC and FRAP) and oxidative damage (CD) of the young 
fit group before and after exercise. Data is represented as the mean (SEM). 
 
In terms of neutrophil functional capacity, intracellular MPO, FcƴRIIIb (CD16) and CEACAM 8 
(CD66b) expression indicated no effect of exercise (Table 4.6). 
 
 
 
 
Table 4.6. Functional parameters of isolated neutrophils before and after exercise. Data is presented 
as means (SEM).  
 
In addition, the migratory capacity of neutrophils isolated from subjects was assessed using a 
Dunn migration chamber. In Table 4.7 the results indicate the total distance travelled, the linear 
distance travelled and the ratio of linear distance to total distance, a measure of directional 
accuracy of migration. No change was observed after the exercise intervention in any of the 
mentioned parameters. 
 
 
 
 
Table 4.7. Measurements of total distance (µm), linear distance (µm) and the ratio of linear/total 
distance of neutrophil migration before and after exercise. Data is presented as means (SEM).  
 
In summary, very few significant changes were noted in the parameters selected to indicate 
inflammation, oxidative stress or neutrophil functionality, from before to after the HIIT exercise 
protocol. This suggests that the exercise protocol did not induce perturbations sufficient to alter 
these parameters, or the sampling was done before these perturbations were physiological 
detectable. 
 ORAC 
(TE µmol/ml) 
FRAP 
(VitCE µmol/ml) 
CD 
(nmol/ml) 
Pre-exercise 655(94.98) 146(24.52) 0.009(0.001) 
Post-exercise 759(57.94) 155(22.21) 0.008(0.001) 
 MPO (MFI) CD16 (MFI) CD66b (MFI) 
Pre exercise 361(61.62) 2955(575) 639(158) 
Post exercise 339(48.89) 2849(482) 620(104) 
 TD (µm) LD (µm) Ratio LD/TD 
Pre-exercise 188(11.89) 16.15(4.87)  0.08(0.02)  
Post-exercise 195(14.28) 25.07(8.82) 0.12(0.05) 
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4.3 PCO beneficially modulates oxidative stress and neutrophil function across groups 
Previous research conducted in our group highlighted neutrophils as targets for investigation, 
as both in vivo (in a rodent model) and in vitro treatment with PCO had resulted in a number 
of beneficial effects in the context of inflammation. Thus we set out to elucidate the targets of 
PCO on various functional parameters of neutrophils, namely activation, migration and 
inflammatory capacity. Therefore we assessed the expression of Fcγ Receptor IIIb (CD16) – 
an IgG receptor responsible for activation and apoptosis of neutrophils (Figure 4.4) – as well 
as CEACAM 8 (CD66b), a transmembrane glycoprotein [95] (Figure 4.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 FcγRIIIb (CD16) expression on isolated control and PCO-treated neutrophils. Values are means ± 
standard error of the mean. Statistical analysis: * indicates treatment effect in young fit population, p<0.05. 
**indicates baseline difference between young controls and fit groups p<0.005. *** indicates treatment effect 
in young sedentary group p>0.001 and baseline difference between the young control group and aged group 
p>0.001. Post hoc result indicates difference between groups under control conditions, P<0.00005 and 
p<0.005. 
 
Both age-related differences and a significant PCO treatment effect was recorded for both 
these parameters. There are marked decreases in all groups for CD16 after in vitro treatment 
with PCO, although not reaching statistical significance in the aged group. CEACAM 8 
expression was higher in the aged population, but only significantly different from the young 
sedentary group, with expression increased after in vitro treatment with PCO in all three 
groups. 
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Figure 4.5: CD66b (CEACAM 8) expression on isolated control and PCO-treated neutrophils for all 
three groups. Statistical analysis: *** and ** indicate treatment effect of PCO of p<0.0005, p<0.005 
respectively,*indicates significant difference between aged and young sedentary group under 
control conditions, p < 0.05. 
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4.4 Neutrophil migration is improved after in vitro treatment with PCO across all age groups.  
Representative images for neutrophil chemokinesis (over a 20-minute period) are presented 
below (Figures 4.6, 4.7 and 4.8), for each subject group separately. There are clear differences 
in neutrophil migration patterns between the young and aged images (most notably when 
comparing the young fit and the aged populations), with less efficient migration in the aged. 
Also, both sedentary groups showed improved neutrophil migration after PCO treatment, while 
for the young fit group, no significant effect of PCO was observed.   
  
 
 
 
 
 
 
 
Figure 4.6. Representative images of neutrophil tracks, in a Dunn chamber, of a young sedentary 
subject treated with (a) placebo and (b) PCO. The Olympus Cell® system IX-81 inverted fluorescent 
microscope system with an F-view cooled CCD camera (Soft Imaging Systems) at 20x magnification 
was used to capture these images. White arrows indicate the direction of most accurate migration. 
 
 
 
 
 
 
 
 
Figure 4.7. Representative images of neutrophil tracks, in a Dunn chamber, of a young fit subject 
treated with (a) placebo and (b) PCO. The Olympus Cell® system IX-81 inverted fluorescent microscope 
system with an F-view cooled CCD camera (Soft Imaging Systems) at 20x magnification was used to 
capture these images. White arrows indicate the direction of most accurate migration. 
 
 
a b 
a b 
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Figure 4.8: Representative images of neutrophil tracks, in a Dunn chamber, of an aged subject treated 
with (a) placebo and (b) PCO. The Olympus Cell® system IX-81 inverted fluorescent microscope system 
with an F-view cooled CCD camera (Soft Imaging Systems) at 20x magnification was used to capture 
these images. White arrows indicate the direction of most accurate migration. 
 
Quantified results in support of the visual results are presented in Figures 4.9 and 4.10.  In 
addition to observations above, statistical analysis revealed that both the fit population and the 
aged population had significantly increased control total distances when compared to the 
young sedentary controls. Although PCO treatment did not significantly affect total distance, 
this difference was not maintained after PCO treatment. The linear distances of the both young 
and aged sedentary populations showed significant improvements after treatment with PCO, 
which is in line with our observations above. 
A       B 
 
 
 
 
 
 
 
 
 
Figure 4.9. Total (a) and linear distances (b) travelled by neutrophils from the three groups before 
and after treatment with PCO. Data are means and error bars indicate SD. Statistical analysis: *, 
p<0.05; **, p<0.05. 
When considering both linear and total distance as a ratio to indicate directional accuracy, the 
aged group exhibits a significant improvement after in vitro PCO treatment (Figure 4.10). A 
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similar effect was noted in the young sedentary group, although relatively higher variability in 
this group resulted in statistical analysis returning a tendency for PCO effect only (p=0.06). 
 
 
 
 
 
 
 
 
Figure 4.10. Ratio of linear distance/total distance, an indication of accuracy, travelled by neutrophils 
from the three groups before and after treatment with PCO. Data is presented as means and error 
bars indicate standard deviation. Statistical analysis: *, p<0.05. 
 
Intracellular MPO, another indicator of neutrophil functional capacity, was lower in the fit young 
group when compared to the young sedentary group under control conditions (Figure 4.11), 
which may suggest either greater MPO release into the interstitial space which is pro-
inflammatory, or less MPO production, an anti-inflammatory effect.  
 
 
 
 
 
 
 
 
 
Figure 4.11. Intracellular MPO expression of neutrophils isolated from all three groups for control 
(placebo only) and in vitro PCO treated groups. Values are means and error bars SEM. Statistical 
analysis: *, p<0.05. 
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As seen with the results for total neutrophil migratory distance, this difference was no longer 
statistically significant after PCO treatment. The fact that intracellular MPO increased in all 
groups after PCO treatment (ANOVA main effect of treatment P<0.05), supports our first 
interpretation, that lower intracellular MPO indicates less release of MPO from cells – an anti-
inflammatory effect.  
 
4.5 Anti-oxidant capacity in neutrophils was improved with in vitro PCO treatment 
Both ORAC and FRAP (Figure 4.12) indicated improvements in anti-oxidant capacity in 
neutrophils after PCO treatment, with significant effects recorded in the young fit group for both 
measures, and for ORAC only in the aged (tendency only for FRAP in this group, P=0.07).  
A      B 
 
 
 
 
 
Figure 4.12. ORAC (a) and FRAP (b) for all three groups, both control (placebo) and after treatment 
with PCO. Values are means and error bars indicate SEM. Statistical analysis: *, P<0.05; **, p<0.005.  
 
In terms of intracellular conjugated dienes, there was no significant differences between 
groups and no treatment effect, although the (placebo-treated) aged group had a tendency for 
lower intracellular conjugated dienes (p=0.064) than the young control group (Figure 4.13).  
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Figure 4.13. Conjugated dienes in neutrophils from subjects (for all groups) before and after 
treatment (with PCO). Values are means and error bars indicate SEM. 
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Chapter 5 
Discussion 
Our group has previously established that PCO has a potent anti-inflammatory potential [55, 
69, 70,80], adding to the available literature which has already established grape-derived 
polyphenols as potent antioxidants. With this thesis, given the interrelated nature of oxidative 
stress and inflammation, we aimed to investigate the effects of in vitro PCO treatment on 
various oxidative and inflammatory parameters in models of chronic oxidative stress (as found 
in ageing) and acute oxidative stress (as found with exercise). In order to do this we first 
wanted to establish if our models of chronic oxidative stress and acute oxidative stress, did 
indeed differ in oxidative and inflammatory profile from a young healthy sedentary control 
population. We therefore analysed the effect of ageing and habitual strenuous exercise and 
how these affected oxidative and inflammatory profile. We then tried to induce an acute 
oxidative stress stimulus with exercise to elucidate acute responses. After this we investigated 
the effects of in vitro PCO treatment on isolated neutrophils to elucidate the mechanisms 
involved in the immune modulatory effects of PCO. Our main findings are discussed below, in 
terms of age-related changes seen, the success of inducing oxidative stress via exercise and 
the modulating effect of PCO. 
5.1 Effects of ageing  
Ageing has been characterised as having a generally less desirable oxidative stress profile 
such as decreased anti-oxidant capacity and increased free radical presence [2, 4]. The main 
reasons as summarized by MacNee et.al. [5] for this is the decline in anti-oxidant capacity, an 
increased exposure to stimulating stressors and repeated cell cycling – as explained by the 
Free Radical Theory of ageing [9]. In our study, aged individuals similarly had significantly 
worse outcome for several indicators of oxidative stress when compared to our younger 
population. For example, this is evident when looking at the content of conjugated dienes, 
which was significantly higher in the aged population (Table 4.2), indicating that the presence 
of (chronic) oxidative stress even at rest. This finding is in line with literature which shows that 
as one ages, oxidative stress is accumulated due to endogenous anti-oxidant saturation [96]. 
Coupled with this finding is the FRAP result. FRAP, another measure of anti-oxidant capacity, 
was lower in the aged population. Reports of decreased capacity with age is very broad and 
non-specific and thus it is not clear which mechanisms ageing affects and at what time frame 
this occurs. In our study, more pronounced effects of ageing was seen for plasma FRAP than 
for ORAC. A potential explanation for this is that the FRAP assay which measures the single 
electron transfer (SET) anti-oxidant mechanism may be more sensitive to ageing-associated 
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changes than the ORAC, which indicates hydrogen atom transfer (HAT) anti-oxidant function. 
Nevertheless, when taking these two parameters into account it does suggest that the aged 
population indeed had a worse oxidative status than the young (control) sedentary population. 
Interestingly, not all selected parameters gave unequivocal evidence of undesired outcome 
with ageing. For example, the aged population had significantly lower levels of MDA (a late 
marker of oxidative stress) and better ORAC and TEAC capacity in comparison to the young 
sedentary controls in their plasma. TEAC is a measure of the combination of both HAT and 
SET mechanisms, and is often used as total antioxidant measure [98]. Since it is highly unlikely 
that ageing results in improved anti-oxidant capacity, especially given the CD and FRAP 
results, a more feasible explanation is that the young control population in our study may have 
been making relatively poorer lifestyle choices than the older population, which may have 
negatively affected their MDA result. This phenomenon of poor lifestyle choices in the majority 
of a population similar to the one used in this study has indeed been reported previously [6]. 
The selection criteria – which included no use of chronic medication – likely caused a natural 
selection of an aged population at the higher end of the scale in terms of general health status 
relative to the total aged population, which translated to less pronounced age-related 
inflammatory and oxidative stress perturbations, as assessed by MDA, ORAC and TEAC.  
This interpretation is supported by relevant literature. Our inclusion criteria was sound, as 
similar criteria have been used in other ageing studies [22, 36, and 99].  Also, healthy lifestyle 
choices (diet and activity) in the aged has been directly linked to longevity [5, 100,101].  
Although these lifestyle habits were not recorded quantitatively, they were informally 
communicated to the researcher by subjects. Thus, in studies of this nature, caution should 
be exercised when interpreting data – it is my opinion that the physiological profile reported 
here, may actually be significantly less healthy across the total population. This should be kept 
in mind when recommendations are made. 
In terms of inflammation, plasma MPO was measured to give a general indication of the 
inflammatory status at baseline of subjects (Figure 4.2). Although not ideal, assessment of 
plasma MPO as an inflammatory marker is standard practise in literature which do not have 
detailed immunological assessment as primary focus [102], which allows contextualisation of 
results from our current study. The aged population had a significantly higher content of 
plasma MPO in comparison to the young sedentary control group, indicating a higher baseline 
inflammatory profile, which supports our hypothesis and previous reports in literature. The 
literature reports that aged individuals display elevated levels of MPO years before onset of 
disease (or cardio vascular events) and thus it is used to predict clinical outcomes [102,103]. 
Interestingly, increased MPO is also often reported during chronic disease, such as 
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cardiovascular disease, diabetes and metabolic syndrome, reporting levels as high as 704 
pmol/L (≈102 ng/ml) in a population which is above 65 years of age.  [102]. This is significantly 
higher than the ≈20 mg/ml measured in our older population, suggesting that the MPO in the 
current study indeed indicates ageing-related changes, as subjects clearly do not have high 
enough levels to suggest presence of illness. This data also therefore indicates that even in a 
healthy population, the 6th decade of life shows an enhanced inflammatory profile, which can 
be accurately reflected by plasma MPO in the absence of illness. 
The intracellular MPO seen in neutrophils indicate that the aged population had similar levels 
to the young sedentary controls as there was no statistical difference between these two 
groups. This result is different from the plasma MPO, which showed clear age-related 
differences. Most likely, this suggests that under control conditions, neutrophils do not 
sequester MPO intracellularly, or that ageing in itself does not modify this capacity. 
Simultaneous assessment of intracellular and plasma MPO would provide more information 
here, but the current study design did not allow for matching time points, so that a more definite 
conclusion cannot be made with the present data.   
In our investigations of immunosenescence, with focus on neutrophil functional ability, we 
observed results similar to that of the plasma. Immunosenescence has been identified as a 
key factor in the progression of age-related diseases and correlated with high mortality rates 
of aged persons experiencing bacterial infections [104, 105], with neutrophil dysfunction 
implicated as a main contributing factor [106]. We therefore investigated neutrophil functional 
capacity to elucidate the effects in these primary responders of innate immunity. In isolated 
neutrophils, ORAC capacity was once again higher in the aged population, but not so with 
FRAP, which again echo’s the plasma result.  This indicates clear changes between our aged 
populations in comparison to the young controls, and shows how population selection can alter 
the outcome of a study. One should thus be careful to consider these confounders in data 
interpretation in order to derive the correct conclusions. Also, this result indicates that relatively 
more acute factors, such as dietary choices, may affect plasma MDA, TEAC and ORAC, while 
other factors such as plasma FRAP and CD may be more indicative of chronic adaptation. 
Despite higher plasma CD in the aged population, neutrophil conjugated diene content was 
similar in the aged and young control group. Since plasma CD may originate from all cell types, 
this result points to a more systemic oxidative stress state rather than a primary specific 
response mounted by neutrophils. To our knowledge, this study is the first to assess CD 
content in neutrophils, so that a more informed interpretation is not possible at this point.  
Although neutrophil CD content does not suggest excessive oxidative processes in this cell 
type when considering measures of inflammatory status, significant ageing-associated 
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changes indeed indicate a relatively more pro-inflammatory state within neutrophils. For 
example, our results on neutrophil FcƴRIIIb (Figure 4.4), CEACAM 8 (Figure 4.5), intracellular 
MPO (Figure 4.11) and chemokinesis (Figure 4.9 and 4.10) confirms that ageing is indeed a 
pro-inflammatory phenomenon, as also supported by the ageing-literature [95,106]. In terms 
of CD16 and CAECAM 8, our results is in agreement with the literature, which  report that 
CD16 expression decreases and CAECAM 8 increases with age and that there is an 
association between these changes and age-associated pathology [95,107,108,109]. Given 
the similarities between ageing and accelerated ageing as outlined in the literature review, it 
may be useful to monitor CD16 decline and CAECAM 8 increase over time in apparently 
healthy younger populations, in order to identify people at risk of accelerated ageing and its 
associated pathologies, so that preventative treatment can be timeously implemented. This 
warrants further investigation.  
Since CAECAM 8 is an important signalling molecule of the integrin cascade within neutrophils 
which dictate migration directionality as well as accuracy [96], our data indicating 
maladaptation with ageing suggested that neutrophil chemokinetic capacity may also be 
aberrant.   
Indeed, the accuracy of neutrophils of aged subjects show little to no directional activity and in 
fact appeared to be “stuck” in one spot in the Dunn chambers – a result in line with the 
increased surface expression of CAECAM8.This results together suggests that in the aged, 
neutrophils would be exerting pro-oxidant inflammatory effects in otherwise healthy tissue.  
From these results, we can conclude that in our study population, ageing-associated 
adaptations in terms of cumulative oxidative stress and inflammation is probably best reflected 
by CD, FRAP, CD16, CAECAM 8, MPO and neutrophil chemokinetic capacity.    
 
5.2 Acute oxidative stress simulation by exercise  
Our aim was to induce a relatively more acute oxidative stress insult, to facilitate investigations 
into acute (exercise-induced) versus chronic (ageing-associated) responses/adaptation to 
oxidative stress. The significant increase in lactate post-exercise (Table 4.3) is in line with 
reports which indicate that exercise induces an oxidative stress response. Lactate is produced 
when metabolic demand is increased during exercise and has previously been used to assess 
exercise intensity and metabolic response [110]. Our lactate response confirms that oxidative 
stress was achieved. 
Despite the significant increase in lactate – suggestive of anaerobic energy production - there 
were no significant changes in anti-oxidant capacity before and after exercise, nor in markers 
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of oxidative damage. The exercise protocol used was adapted from the exercise science 
literature [52, 53] which reported that HIIT induces oxidative stress and an inflammatory 
response sufficiently severe to result in muscle damage and to prolong recovery time. We 
therefore combined the VO2max testing with a HIIT protocol. Severe acute intensity exercise 
was reported by [52] to increase oxidative after 30 minutes and included incremental exercise 
similar to that of a VO2max and HIIT protocol. We anticipated that the combined time of the 
VO2max and HIIT would exceed this time point, but the subjects did not respond as anticipated, 
with total time to fatigue much shorter than the expected 30 minutes. It is possible that the 
exercise protocol was too severe for this population. However, their VO2max results suggest 
that they are of sufficient standard to be able to perform such an exercise and that lack of 
motivation may have confounded the outcome.  
This may have resulted in blood being sampled too soon after initiation of exercise, as previous 
work reports that MPO release occurs ≈4 hours post cessation of exercise [80], a time point 
that was not feasible in this study – as neutrophil migration was a focus here, it was imperative 
to sample and conduct analysis as soon as possible after cessation of exercise as this is the 
time of neutrophil extravasation and infiltration into damaged tissue. Furthermore, previous 
studies such as Syu et. al. [52] and Quindry et. al. [53] assessed multiple time points after 
exercise and their protocol was repeated on more than one occasion. We deviated from this 
for two reasons: firstly the cost of multiple time points was not feasible, and secondly, we did 
not want the training effect potentially achieved by multiple bouts.  A future recommendation 
would be to elucidate training techniques of subjects and take this into consideration before 
prior to exercise stressor to ensure the subject can successfully complete protocol, or to offer 
incentives to elicit maximal effort and thus ensure longer time to voluntary fatigue.   
The changes normally observed in MPO and neutrophil MPO levels were thus not observed 
in this study. We therefore recommend that blood sampling should be postponed to a time 
point at least 2-4 hours post exercise as reported by Quindry et al. [53] and Myburgh et al. [80] 
to investigate these parameters in particular. Future considerations would be an exercise 
protocol of longer duration as well as sampling at various time points taken hours after exercise 
intervention. The effect of habitual strenuous exercise we observed gave us more insight into 
the effect acute bouts of exercise over a period of time in the young population which was 
interesting. We therefore looked at the young fit group in comparison to the sedentary control 
and aged populations to ascertain their baseline status and found interesting results. 
The young fit group displayed a tendency to have higher TEAC and ORAC readings (Table 
4.2), measures of anti-oxidant capacity of their plasma. Fitness is known to increase the 
endogenous anti-oxidant capabilities of persons [50] and this was seen here. The results 
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though were not statistically significant which we attribute to a small subject group number 
allows for larger variation, which we observed. Future considerations would be to have larger 
subject recruitment as well as stricter assessment of subjects. This is warranted as well to 
exclude overtraining and injury as these factors would affect oxidative stress and therefore 
anti-oxidant capacity [50] which could account for the variations we observed.  
With regard to oxidative damage we noted that both conjugated dienes and MDA content of 
the plasma in the young fit group did not differ from the young sedentary (control) group, which 
indicates that this population has effective anti-oxidant capacity. We did however observe a 
slightly increased inflammatory state of the fit population relative to the sedentary group, as 
they exhibited higher levels of plasma MPO, although once again with large inter-individual 
variation. We postulate that this may be due to overtraining or insufficient rest and recovery 
time, as has been observed with competitive athletes.   
In the neutrophils of young fit subjects we noted that intracellular MPO was significantly 
decreased while their plasma MPO had a tendency to be increased. Considering once again 
that these assessments were done in unstimulated neutrophils this indicates a more pro-
inflammatory state, as this indicates MPO release. When taken into account with the trends 
seen in the CEACAM 8 and FcƴRIIIb, the basal state of neutrophils in this population indicate 
a pro-inflammatory state similar to the aged population but not to the same extent. FcƴRIIIb 
was decreased in the fit population, who considering are in the same age group as sedentary 
controls indicates that they are engaging in an inflammatory stimulating activity. CEACAM 8 
expression is in line with the young controls, indicating that their activation status is stable, 
which is favourable.   
The fit population displayed a tendency to have less accurate neutrophil migration when 
compared to the young sedentary group which ties in with the differences in FcƴRIIIb 
expression and highlights the possible mechanism which affects migration. Overall this group 
displays a tendency have a worse inflammatory profile than the young sedentary group. 
Overtraining, insufficient recovery time and recurring injuries can all attribute to this. 
Unfortunately injury history and training routine were not taken into account when subjects 
were recruited, by majority of the subjects within this group are competitive athletes. This 
warrants further investigations on the inflammatory profiles of competitive athletes.   
To assess comprehensively and for completeness, assessment of all parameters previously 
measured within neutrophils of both pre- and post-exercise neutrophils with in vitro PCO 
treatment and control conditions was done. This data can be found in appendix M. 
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5.3 Modulatory effects of PCO 
Polyphenols have been identified to have potent anti-ageing effects [111] and ageing is 
associated with various disease states. Thus we set out to elucidate the extent of effect our 
extract has and if this differs from relatively acute to more chronic exposure to oxidative stress. 
For this project we investigated the in vitro effects on neutrophils only, supplementation of 
subjects will be carried out in future studies. We observed that in vitro treatment with PCO had 
an effect on both the aged as well as fit groups in more than one parameter on isolated 
neutrophils. 
We saw that PCO treatment significantly increased ORAC across age groups. This suggests 
that there is room for improvement in both the fit and aged populations, even though large 
differences were not initially noted before treatment in the case of neutrophils, which we 
already identified as cells which are victim to perturbations. The same trend was observed in 
the fit group in the FRAP assay, which we noted showed the most change for this group for 
assays which assessed anti-oxidant capacity. This highlights FRAP as a parameters to further 
investigate for this group.  
I postulate that an increasing anti-oxidant capacity observed in these groups are indicative of 
the need to increase endogenous capacity to facilitate the larger or continued exposure to 
oxidative stress incurred with ageing and strenuous exercise. The young sedentary group did 
not display significant changes, suggesting that they did not have a significant need for an 
exogenous anti-oxidant. This result also confirms that our control group was a suitable control 
for our experiment. Overall we can conclude that PCO can improve anti-oxidant abilities in 
aged and young populations. This is in line with related relevant literature [85, 86, 87], but 
importantly our data also adds to existing knowledge by showing neutrophil-specific anti-
oxidant outcome, which has not been done before in the context of ageing an/or accelerated 
ageing. 
Also in terms of oxidative damage indicators, PCO treatment was associated with better 
outcome, with the aged populations’ neutrophil intracellular conjugated dienes increasing. This 
supports our earlier assumption that CD are released into plasma, so that intracellular 
sequestration of CD would have a desired clinical outcome. This assumption is made with the 
knowledge that intracellular conjugated dienes are able to be recycled [98] but once excreted 
into the plasma it is more likely to have negative effects as a free radical. This mechanism 
could thus be investigated as a possible target of PCO or other antioxidants, by which to 
alleviate oxidative damage.  
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The young fit group on the other hand had higher levels of conjugated dienes in the neutrophil 
when compared to the young sedentary groups. Their presence at an increased level in the 
cells from this population may indicate that their immune cells are also under oxidative stress, 
as observed in the plasma. Furthermore, as described above, endogenous systems are 
capable of recycling thus sequestering conjugated dienes in the cells [112] and thus hinder 
their release. After treatment with PCO the young sedentary and young fit conjugated dienes 
both decreased – considering that PCO is an anti-oxidant with radical scavenging capabilities, 
suggests that PCO is effective in affecting the lipid peroxidation cycling. Considering that this 
was an unstimulated assessment, this is a likely explanation. The exact mechanisms involved 
is however yet to be elucidated in future studies. 
With regard to inflammation, our group has previously done work on macrophages and 
cytokine levels regarding PCO and this project was motivated by the very significant effect of 
PCO on the progression and resolution of inflammation, which was characterised by very 
limited neutrophil infiltration into tissue [70]. The hypothesis of the authors were that this 
outcome resulted from more efficient neutrophil function, which necessitated fewer neutrophils 
to achieve the required effect and which would have limited neutrophil-associated secondary 
damage [20] and result in faster resolution of inflammation, which was also reported in rodent 
models [80]. In the current thesis, rather than performing comprehensive cytokine analyses – 
since our previous studies have already shown an anti-inflammatory outcome in this context 
[70, 80] – neutrophil functional parameters were assessed in order to elucidate mechanisms 
by which these desired effects are achieved.  
Firstly, MPO is one of the enzymes released from a neutrophil’s azurophilic granules upon 
activation and is a key catalysing enzyme in the formation of HOCL [113]. MPO mediates 
neutrophil activation by association with CD11bCD18 integrin’s [108]. MPO-derived oxidants 
in low concentrations have been implicated in the modulation of signalling pathways such as 
activation of the mitogen-activated protein kinases (MAPK), the induction of translocation to 
the nucleus of transcription factors, the regulation of cell growth via the activation of tumor-
suppressor proteins as well as the modulation of metalloproteinases activity. Neutrophil 
intracellular MPO was significantly lower in the young fit population compared to the young 
sedentary controls, whereas the aged population was not different from the young sedentary 
controls. The fact that the young fit groups’ plasma MPO had a tendency to be higher than 
sedentary controls (albeit not significantly) suggests that the young fit group had a higher 
baseline inflammatory profile due to residual inflammatory stimuli, such as strenuous exercise 
in the 24 hours prior to sampling, which we explored above. A factor to consider is that these 
neutrophils are unstimulated and thus the release of MPO is not likely. Therefore one has to 
consider that the decrease observed in intracellular MPO is due to decreased production. The 
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same observation can be made in the aged group, who displayed a tendency (p = 0,062) for 
lowered MPO after treatment with PCO. Overexpression of MPO has been associated with 
neutrophil dysfunction and is a key regulator of secondary damage [114].  
Secondly, PCO treatment significantly decreased expression of FcƴRIIIb across groups. This 
acute decreased in expression which is due to shedding of this receptor from the surface of 
neutrophils is an initial step in activation of neutrophils and necessary for their effective 
functioning, the acute shedding of FcƴRIIIb is replaced via intracellular stores which maintain 
levels after the initial activation and allow the neutrophil to complete its other actions for 
example phagocytosis [115, 116]. The decrease seen resulted in all groups showing an 
expression similar to the young sedentary controls, which we assumed was the optimum level. 
Unlike the aged population whose basal level is decreased which indicates a pathological 
chronic lack or efficient replenishment of this receptor on the surface. This data facilitates the 
improvement in migration of neutrophils after treatment.   
Thirdly, CEACAM 8 expression was increased after in vitro PCO treatment. Considering that 
this marker is often used as a marker of activation we can assume that the post-treatment 
level reached is the optimal expression, as both the aged and fit group showed similar 
expression when compared to the young sedentary controls. CEACAM 8 is used as a marker 
of activation because its expression is the initiating step of neutrophils binding to the 
endothelial tissue for extravasation, and thereafter facilitates the migration through tissue. 
CEACAM 8 presence on the tissue chronically is indicative of constant activation as it is only 
exocytosed upon activation – this is what we see in the aged population – whereas an acute 
increase indicates activation to facilitate migration. Both these results aid the improvement of 
migration seen with treatment. Interestingly, PI3K is found as an important molecule in both 
FcƴRIIIb and CAECAM 8 mechanisms. PI3K has been demonstrated in the literature to be a 
molecule of investigation with regard to polyphenol action [49]. Therefore I think that this is the 
key effector to target for further investigation. The fact that both CEACAM 8 (CD66b) and 
FcƴRIIIb (CD16) expression has been investigated in the context of arthritis [95,116], supports 
the importance of these markers as good indicators for studying the mechanism of pathological 
neutrophil function. 
Finally, neutrophil migration was improved across groups after in vitro treatment with PCO. 
These changes are most notably in the aged population who as described above showed very 
little directional accuracy, while the young sedentary group exhibited a statistical tendency for 
improvement as well. This ties in with the improvements in CEACAM 8 and FcƴRIIIb 
expressions already discussed.   Also, with migrational accuracy being linked to the limitation 
of secondary damage, the improved migration efficacy  reported here, can then account for 
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previously reported improvements in recovery of muscle damage [55], and the data suggests 
this that improvement is facilitated by PCO-modulated CEACAM 8 and FcƴRIIIb expression. 
It is clear that PCO in vitro treatment effects improvements across groups, but these changes 
are different for each. This highlights that this extract has multiple mechanisms of action to 
affect changes in both the chronic and acute models. Further investigations are warranted, in 
my opinion in an in vivo models to definitively elucidate these mechanisms.  
5.4 Broader applicability of results 
Given the consistency of positive results observed here with an anti-oxidant, anti-inflammatory 
intervention, we are confident that current results may be extrapolated to include broader 
application to spheres other than ageing. For example, it is possible to draw comparisons 
between ageing and chronic diseases and the possibility that PCO (or a similar anti-
inflammatory/anti-oxidant treatment) can alleviate the progression of both. With regard to 
oxidative status, it is reported that oxidative stress is increased by the presence of free radicals 
which exert damage [38]. In chronic disease this is caused by increased metabolism, 
excessive inflammatory action and ineffective/insufficient anti-oxidant capacity. We see with 
this research that PCO is capable of increasing anti-oxidant capacity. The use of anti-oxidant 
to treatment ischemic injury [117] displays the potential of a polyphenol anti-oxidant to be 
beneficial for chronic disease.  
Secondly, with chronic diseases there is a chronic low grade inflammation present which 
results in maladaptation facilitating disease progression. The effect on intracellular MPO 
already gives us an indication of improved inflammatory response of neutrophils. 
Comprehensive further investigations are warranted to elucidate the exact flux and secretion 
of MPO from neutrophils but this data suggests that this is an important mechanism. 
5.5 Conclusions 
This thesis, while elucidating potential mechanisms that could account for the desirable effects 
of PCO previously reported, also identified potential therapeutic targets to consider for the 
alleviation or limitation of ageing and accelerating ageing. 
In terms of the extract employed here, and considering how closely linked oxidative stress and 
inflammation are, PCO displays therapeutic potential for many diseases with an inflammatory 
or oxidative stress component in their aetiology.  
In addition, plasma MPO was highlighted as an accurate indicator of ageing-associated 
inflammation in the absence of other illness, while plasma CD and FRAP best indicated chronic 
oxidative stress. Our data on CAECAM8 and FcƴRIIIb in the context of ageing adds to the 
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available literature on these parameters, and suggests that these mechanisms in the 
neutrophil migratory response should be further investigated as targets for therapeutic 
interventions aiming to alleviate ageing, accelerated ageing and inflammatory disease in 
general.  
5.6. Future studies 
Given the focus of the thesis and the fact that an in vitro model was used in the current study, 
there was limitations with regard to timing of samplings and parameters that could be assessed 
– as discussed above. An in vivo study is thus necessary to further elucidate mechanisms and 
investigate some of the data which was not conclusive in this study. In terms of investigations 
related to inflammatory disease, I believe that we have now generated sufficient data on PCO 
to warrant a human in vivo study. However, given the logistical difficulty of ageing studies, I 
propose that an animal model would be best to comprehensively assess systemic and 
compartment effects of PCO in context of oxidative stress as well as inflammation, and in 
particular the gradual maladaptation over time. 
  
Stellenbosch University  https://scholar.sun.ac.za
 50 
 
Chapter 7 
References 
 
[1] WHO, "WHO Fact sheet," 2015 (15 October 2015), http://www.who.int. 
[2] T. Finkel and N. J. Holbrook, "Oxidants, oxidative stress and the biology of ageing", 
NATURE, vol. 408, no. 1,  pp. 239-247, 2000 . 
[3] B. F. Oliveira, Nogueira-Machado,J.A. and Chaves,M.M., "The Role of Oxidative 
Stress in the Aging Process", The Scientific World Journal, vol. 10, no. 1,  pp. 1121-
1128, 2010. 
[4] D. P. Jones, V. C. Mody Jr., J. L. Carlson, et al., "Redox analysis of human plasma 
allows separation of pro-oxidant events of aging from decline in antioxidant defenses", 
Free Radical Biology & Medicine, vol. 33, no. 9, pp. 1290-1300, 2002. 
[5] W. MacNee, Rabinovich, R.A. and Choudhury, G., "Ageing and  the border between 
health and disease.",  European Respiratory Society., vol. 44, pp. 1055-1068, 2014. 
[6] E. Ekblom-Bak, B. Ekblom, M. Vikström, et al., "The importance of non-exercise 
physical activity for cardiovascular health and longevity.", British Journal of Sports 
Medicine, vol. 48, pp. 233-238., 2014. 
[7] C. Smith and M. F. Essop, "Gender differences in metabolic risk factor prevalence in a 
South African student population", Cardiovascular Journal Of Africa, vol. 20, no. 3, pp. 
178–182, 2009. 
[8] C. E. Ottobelli, W. M. De Souza, T. Paz da Silva, et al., "Adipocytokines, inflammatory 
and oxidative stress markers of clinical relevance altered in young overweight/obese 
subjects.", Clinical Biochemistry, vol. 01, no. 003, pp. 1-6, 2016. 
[9] K. Venkataraman, S. Khurana and T. C. Tai, "Oxidative Stress in Aging-Matters of the 
Heart and Mind.",  International Journal of Molecular Sciences, vol. 14, no.1, pp. 17897-
17925, 2013. 
[10] D. Harman, "Ageing: A theory based on free radical and radiation chemistry.",  Journal 
of Gerontology, vol. 11 no. 3,  pp. 298-300, 1956. 
[11] J. M. McCord, and I. Fridovich, "Superoxide Dismutase: An enzymic function for 
erythrocuprein(hemocuprien)", Journal of Biological Chemistry, vol. 244, no. 22, pp. 
6049-6055, 1969. 
[12] B. Schöttker, H. Brenner, E. Jansen, et al., "Evidence for the free radical/oxidative 
stress theory of ageing from the CHANCES consortium: a meta-analysis of individual 
participant data.", BMC Medicine, vol. 13, no. 300, pp. 1-15, 2015. 
Stellenbosch University  https://scholar.sun.ac.za
 51 
 
[13] B. A. I. Payne and P. F. Chinnery, "Mitochondrial dysfunction in aging: Much progress 
but many unresolved questions.",  Biochimica et Biophysica Acta, vol. 1847,  pp. 1347-
1353, 2015. 
[14] L. Hayflick, "The limited in vitro lifetime of human diploid cell strains", Experimental Cell 
Research, vol. 37, no. pp. 614-636, 1965. 
[15] T. von Zglinicki, V. Serra, M. Lorenz, et al., "Short Telomeres in Patients with Vascular 
Dementia: An Indicator of Low Antioxidative Capacity and a Possible Risk Factor?",  
Laboratory Investigation, vol. 80, no. 11, pp. 1739-1747, 2000. 
[16] S. Venkatesana, A. T. Natarajanb and M. P. Hande, "Chromosomal instability—
mechanisms and consequences.", Mutation Research/Genetic Toxicology and 
Environmental Mutagenesis, vol. 793, pp. 176-184, 2015. 
[17] N. Khansari, Shakiba,Y. and M. Mahmoudi, "Chronic Inflammation and Oxidative 
Stress as a Major Cause of Age- Related Diseases and Cancer.", Recent Patents on 
Inflammation & Allergy Drug Discovery, vol. 3, pp. 73-80, 2008. 
[18] K. Nagai, T. Betsuyaku, T. Kondo, et al., "Long term smoking with age builds up 
excessive oxidative stress in bronchoalveolar lavage fluid.", Thorax, vol. 61, pp. 496-
502, 2006. 
[19] L. Sherwood, "Human Physiology " From Cells to Systems”,  7th Edition. ISBN-10: 0-
495-39184-0. 2010 
[20] M. E. Kotas and R. Medzhitov, "Homeostasis, Inflammation, and Disease 
Susceptibility.", Cell Research, vol. 160, pp. 816-827, 2015. 
[21] J. G. Tidball, "Inflammatory processes in muscle injury and repair",  American Journal 
of Physiology Regulatory Integrative and Comparative Physiology, vol. 288, no. 2, pp. 
R345-53, 2005. 
[22] C. Smith, Kruger, M.J., Smith, R.M. and  Myburgh, K.H., "The inflammatory Response 
to Skeletal Muscle Injury: Illuminating Complexities," Sports Medicine, vol. 38, no. 11, 
pp. 947-969, 2008. 
[23] A. Panda, A. Arjona, E. Sapey, F. Bai, E. Fikrig, R.R. Montgomery, J.M. Lord and A.C.  
Shaw, "Human innate immunosenescence: causes and consequences for immunity in 
old age", Trends in Immunology, vol. 30, no. 7, pp. 325-333, 2009. 
[24] T. Fulop, A. Larbi, N. Douziech, C. Fortin, K. Guérard, O. Lesur, A.Khalil and G. Dupuis, 
"Signal transduction and functional changes in neutrophils with aging", Aging Cell, vol. 
3, no. 4,  pp. 217-226, 2004. 
[25] I. Beerman, D. Bhattacharya, S. Zandi, et al., "Functionally distinct hematopoietic stem 
cells modulate hematopoietic lineage potential during aging by a mechanism of clonal 
expansion", Proceedings of the National Academy of Sciences, vol. 107, no. 12, pp. 
5465-5470, 2010. 
Stellenbosch University  https://scholar.sun.ac.za
 52 
 
[26] T. Li, S. Chen, T. Feng, et al., "Rutin protects against aging-related metabolic 
dysfunction",  Food & function, vol. 7, no. 2, pp.1147-1154,  2016.  
[27] A. A. Hill, E. K. Anderson-Baucum, A. J. Kennedy, et al., "Activation of NF-kB drives 
the enhanced survival of adipose tissue macrophages in an obesogenic environment.", 
Molecular Metabolism, vol. 4, no. pp. 665-677, 2015. 
[28] J. H. Huh, Y. J. Park, M. Ham, et al., "Crosstalk between Adipocytes and Immune Cells 
in Adipose Tissue Inflammation and Metabolic Dysregulation in Obesity", Molecules 
and Cells, vol. 37, no. 5, pp. 365-371, 2014. 
[29] S. P. Weisberg, D. McCann, M. Desai, et al., "Obesity is associated with macrophage 
accumulation in adipose tissue.", The Journal of Clinical Investigation, vol. 112, no. 12, 
pp. 1796-1808, 2003. 
[30] D. C. K. Borato, G. C. Parabocz, J. T. Ribas, et al., "Biomarkers in obesity: serum 
myeloperoxidase and traditional cardiac risk parameters", Experimental and Clinical 
Endocrinology and Diabetes, vol. 124,  pp. 49-54, 2016. 
[31] H. Khodabandeloo, S. Gorgani-Firuzjaee, S. Panahi, et al., "Molecular and cellular 
mechanisms linking inflammation to insulin resistance and b-cell dysfunction", 
Translational Research, vol. 167, no. 1,  pp. 228-256, 2015. 
[32] M. Maes, C. Song, A. Lin, et al., "The effects of psychological stress on humans: 
Increased production of pro-inflammatory cytokines and a Th1-like response in stress-
induced anxiety.",  Cytokine, vol. 10, no. 4, pp. 313-318, 1998. 
[33] H. Bruunsgaard, "The clinical impact of systemic low-level inflammation in elderly 
populations.", Danish Medical Bulletin, vol. 53, no. 3, pp. 285-309, 2006. 
[34] N. Sallam and I. Laher, "Exercise Modulates Oxidative Stress and Inflammation in 
Aging and Cardiovascular Diseases", Oxidative Medicine and Cellular Longevity, vol. 
2016, article ID. 7239639, 2015. 
[35] C. Wenisch, S. Patruta, F. Daxbock, et al., "Effect of age on human neutrophil 
function.", Journal of Leukocyte Biology, vol. 67, pp. 40-45, 2000. 
[36] B. Weinberger, D. Herndler-Brandstetter, A. Schwanninger, et al., "Biology of immune 
responses to vaccines in elderly persons", Clinical infectious diseases : an official 
publication of the Infectious Diseases Society of America, vol. 46, no. 7, pp. 1078-84, 
2008. 
[37] S. Baëhl, H. Garneau, A. Le Page, et al., "Altered neutrophil functions in elderly patients 
during a 6-month follow-up period after a hip fracture", Experimental Gerontology, vol. 
65, pp. 58-68, 2015. 
[38] P. H. Naccache and J.S. Lefebvre.  "A straight neutrophil path to healthy aging?",  
Blood, vol. 123, pp. 154-156, 2014. 
Stellenbosch University  https://scholar.sun.ac.za
 53 
 
[39] M. Mittal, M. R. Siddiqui, K. Tran, et al., "Reactive Oxygen Species in Inflammation and 
Tissue Injury",  Antioxidants & Redox Signaling, vol. 20, no. 7, pp. 1126-1167, 2014. 
[40] H. Kim, J. Hwang, C. Woo, et al., "TNF-α-induced up-regulation of intercellular 
adhesion molecule-1 is regulated by a Rac-ROS-dependent cascade in human airway 
epithelial cells",  Experimental and Molecular Medicine, vol. 40, no. 2, pp. 167-175, 
2008. 
[41] H. Zhang , Y. Park, J. Wu, X.P. Chen, S. Lee, Y. Yang, K.C. Dellsperger and C. Zhang, 
"Role of TNF-α in vascular dysfunction.",  Clinical Science, vol. 116, pp. 219-230, 2009. 
[42] M. J. Morgan and L. Zheng-gang, "Crosstalk of reactive oxygen species and NF-κB 
signaling",  Cell Research, vol. 21, pp. 103-115, 2011. 
[43] K. Bedard and K.-H. Krause, "The NOX Family of ROS-Generating NADPH Oxidases: 
Physiology and Pathophysiology",  Physiology Review: American Physiological 
Society, vol. 87, pp. 245–313, 2007. 
[44] A. P. Levine, M. R. Duchen, S. de Villiers, et al., "Alkalinity of neutrophil phagocytic 
vacuoles is modulated by HVCN1 and has consequences for myeloperoxidase 
activity.",  PLoS one, vol. 10, no. 4, pp. 1-20, 2015. 
[45] M. J. Berridge, "Cell Stress, Inflammatory Responses and Cell Death", Cell Signalling 
Biology, vol. no. pp. 11.1-11.29, 2012. 
[46] R. Zhang, M. Brennan, X. Fu, et al., "Association between Myeloperoxidase levels and 
Risk of Coronary Artery Disease",  Journal of the American Medical Association , vol. 
286, no. 17, pp. 2136-2142, 2001. 
[47] A. Salminen, K. Kaarniranta and A. Kauppinen, "Crosstalk between Oxidative Stress 
and SIRT1: Impact on the Aging Process", International Journal  of Molecular 
Sciences, vol. 14, pp. 3834-3859, 2013. 
[48] N. Poulose and R. Raju, "Sirtuin regulation in aging and injury", Biochimica et 
Biophysica Acta, vol. 1852, no.2015, pp. 2442-2455, 2015 . 
[49] E. Sapey, H. Greenwood, G. Walton, E. Mann,  A. Love, N.  Aaronson, R.H. Insall, 
R.M. Stockley and J.M. Lord, " Phosphoinositide 3-kinase inhibition restores neutrophil 
accuracy in the elderly: toward targeted treatments for immunosenescence",  Blood, 
vol. 123, no. pp. 239-248, 2014. 
[50]  S.K. Powers, W. B. Nelson and M.B. Hudson, “Exercise-induced oxidative stress in 
humans: Cause and consequences”, Free Radical Biology & Medicine vol. 51.pp 942–
950., 2011. 
[51]  R. J. Bloomer and A. H. Goldfarb, “Anaerobic Exercise and Oxidative Stress: A 
Review.”, Canadian Journal of Applied Physiology, vol. 29, no.3, pp. 245-263, 2004. 
Stellenbosch University  https://scholar.sun.ac.za
 54 
 
[52]  G.D. Syu, H. Chen, C.J. Jen, “Severe Exercise and Exercise Training Exert Opposite 
Effects on Human Neutrophil Apoptosis via Altering the Redox Status.”,  PLoS one, 
vol. 6, no.9, 2011. 
[53]  J.C. Quindry, W.L. Stone, J. King, et al., “The Effects of Acute Exercise on Neutrophils 
and Plasma Oxidative Stress.”, Medicine & Science in Sports and exercise, vol. 35, no. 
7, pp. 1139-1145, 2003. 
[54] G. McGinnis, B. Kliszczewiscz, M. Barberio, et al., “Acute Hypoxia and Exercise-
Induced Blood Oxidative Stress.”, International Journal of Sport Nutrition and Exercise 
Metabolism, vol. 24, pp. 684 -693, 2014. 
[55] M. J. Kruger and C. Smith "Postcontusion Polyphenol Treatment Alters Inflammation 
and Muscle Regeneration", Medicine & Science in Sports & Exercise, vol. 44, no.5,  
pp. 872-880, 2012. 
[56] L. Carrera-Quintanar, L. Funes, N. Vicente-Salar, et al., "Effect of polyphenol 
supplements on redox status of blood cells: a randomized controlled exercise training 
trial," European Journal of  Nutrition, vol. 54, no. 7,  pp. 1081-1093, 2014. 
[57] M. R. De Oliveira, N. R. Nabavi, A. Manayi, et al., "Resveratrol and themitochondria: 
Fromtriggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a 
mechanistic view.",  Biochimica et Biophysica Acta, vol. 1860, pp. 727-745, 2016 . 
[58] W. Pan, H. Yu, S. Huang, et al., "Resveratrol Protects against TNF-α-Induced Injury in 
Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of 
NF-KB and p38 MAPK.", PLoS one, vol. 11, no. 1, pp. 1-21, 2016. 
[59] P. Kotora, F. Šeršen, J. Filo, et al., "The Scavenging of DPPH, Galvinoxyl and ABTS 
Radicals by Imine Analogs of Resveratrol.", Molecules, vol. 21, no. 127, 2016. 
[60] G. F. Balata, E. A. Essa, H. A. Shamardl, et al., "Self-emulsifying drug delivery systems 
as a tool to improve solubility and bioavailability of resveratrol.", Drug Design, 
Development and Therapy, vol. 10, pp. 117-128, 2016. 
[61] D. R. Valenzano, E. Terzibasi, T. Genade, A. Cattaneo, L. Domenici, and A. Cellerino, 
"Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-
lived vertebrate", Current biology : CB, vol. 16, no. 3, pp. 296-300, 2006. 
[62] E. M. Hernández-Hernández, C. Serrano-García, R. A. Vázquez-Roque, et al., 
"Chronic administration of resveratrol prevents morphological changes in prefrontal 
cortex and hippocampus of aged rats", Synapse, vol. no. pp. 2016. 
[63] B. Shukitt-Hale, A. Carey, L. Simon, et al., "Effects of Concord grape juice on cognitive 
and motor deficits in aging",  Nutrition, vol. 22, no. 3, pp. 295-302, 2006. 
Stellenbosch University  https://scholar.sun.ac.za
 55 
 
[64] E. P. Cherniack, "A berry thought-provoking idea: the potential role of plant polyphenols 
in the treatment of age-related cognitive disorders," The British Journal of Nutrition, vol. 
108, no. 5, pp. 794-800, 2012. 
[65] Y. J. Wang, P. Thomas, J. H. Zhong, et al., "Consumption of grape seed extract 
prevents amyloid-beta deposition and attenuates inflammation in brain of an 
Alzheimer's disease mouse", Neurotoxicity Research, vol. 15, no. 1, pp. 3-14, 2009. 
[66] M. C. Kizilarslanoglu, O. Kara, Y. Yesil, et al., "Alzheimer disease, inflammation, and 
novel inflammatory marker: resistin", Turkish Journal of Medical Sciences, vol. 45, no. 
5, pp. 1040-1046, 2015. 
[67] M. Awasthi, S. Singh, V. P. Pandey, et al., "Alzheimer's disease: An overview of 
amyloid beta dependent pathogenesis and its therapeutic implications along with in 
silico approaches emphasizing the role of natural products.", Journal of the 
Neurological Sciences, vol. 361, no. pp. 256-271, 2016. 
[68] F. Cacciapuoti, "Opposite effects of metabolic syndrome and calorie restriction on 
thrombotic disease: heads and tails of the same coin-resveratrol's role", Metabolic 
Syndrome and Related Disorders, vol. 7, no. 5, pp. 397-400, 2009. 
[69] L. D. Africa and C. Smith, "Using a simulated blood-brain barrier to investigate potential 
modulators of HIV-1-associated neuro-inflammatory processes in vitro", Journal of 
Research in Biology, vol. 5, no. A, pp. 5-20, 2015. 
[70] M. J. Kruger, K. H. Myburgh and C. Smith, "Contusion Injury with Chronic In vivo 
Polyphenol Supplementation: Leukocyte Responses", Medicine & Science in Sports & 
Exercise, vol.46, no. 2, pp. 225-231, 2014. 
[71] G. D. Noratto, G. Angel-Morales, S. T. Talcott, et al., "Polyphenolics from acai ( Euterpe 
oleracea Mart.) and red muscadine grape (Vitis rotundifolia ) protect human umbilical 
vascular Endothelial cells (HUVEC) from glucose- and lipopolysaccharide (LPS)-
induced inflammation and target microRNA-126," Journal of Agricultural and Food 
Chemistry, vol. 59, no. 14, pp. 7999-8012, 2011. 
[72] C. F. Tsai, K. T. Wang, L. G. Chen, et al., "Anti-inflammatory effects of Vitis thunbergii 
var. taiwaniana on knee damage associated with arthritis", Journal of Medicinal Food, 
vol. 17, no. 4, pp. 479-86, 2014. 
[73] G. Kuroyanagi, T. Otsuka, N. Yamamoto, R. Matsushima-Nishiwaki, O. Kozawa and 
H. Tokuda, "Resveratrol suppresses TGF-beta-induced VEGF synthesis in 
osteoblasts: Inhibition of the p44/p42 MAPKs and SAPK/JNK pathways", Experimental 
and Therapeutic Medicine, vol. 9, no. 6, pp. 2303-2310, 2015. 
[74] J. G. Wood, B. Rogina, S. Lavu, et al., "Sirtuin activators mimic caloric restriction and 
delay ageing in metazoans", NATURE, vol. 430, no. 7000, pp. 686-689, 2004. 
Stellenbosch University  https://scholar.sun.ac.za
 56 
 
[75] K. T. Howitz, K. J. Bitterman, H. Y. Cohen, et al., "Small molecule activators of sirtuins 
extend Saccharomyces cerevisiae lifespan", NATURE, vol. 425, no. 6954, pp. 191-
196, 2003. 
[76] L. Zhao, Y. Yagiz, C. Xu, et al., "Muscadine grape seed oil as a novel source of 
tocotrienols to reduce adipogenesis and adipocyte inflammation", Food & function, vol. 
6, no. 7, pp. 2293-2302, 2015. 
[77] H. Fujii, T. Yokozawa, Y. A. Kim, et al., "Protective effect of grape seed polyphenols 
against high glucose-induced oxidative stress", Bioscience, biotechnology, and 
biochemistry, vol. 70, no. 9, pp. 2104-2111, 2006. 
[78] L. Younes-Sakr, P. Senesse, C. Laurent, et al., "Validation of a surgical technique for 
rat intestinal irradiation: potential side effects prevention by dietary grape phenolics", 
Digestive diseases and sciences, vol. 57, no. 10, pp. 2562-2570, 2012. 
[79] V. Pallares, A. Fernandez-Iglesias, L. Cedo, et al., "Grape seed procyanidin extract 
reduces the endotoxic effects induced by lipopolysaccharide in rats", Free Radical 
Biology & Medicine, vol. 60, pp. 107-114, 2013. 
[80] K. H. Myburgh, M. J. Kruger and C. Smith, "Accelerated skeletal muscle recovery after 
in vivo polyphenol administration", Journal of  Nutritional Biochemistry, vol. 23, no. 9, 
pp. 1072-1079, 2012. 
[81] G. Patki, Q. Ali, I. Pokkunuri, et al., "Grape powder treatment prevents anxiety-like 
behavior in a rat model of aging", Nutrition research, vol. 35, no. 6, pp. 504-511, 2015. 
[82] W. Yin, B. Li, X. Li, et al., "Anti-inflammatory effects of grape seed procyanidin B2 on 
a diabetic pancreas", Food & function, vol. 6, no. 9, pp. 3065-3071, 2015. 
[83] J. A. Baur, K. J. Pearson, N. L. Price, et al., "Resveratrol improves health and survival 
of mice on a high-calorie diet", NATURE, vol. 444, no. 7117, pp. 337-342, 2006. 
[84] D. Impellizzeri, E. Talero, R. Siracusa, et al., "Protective effect of polyphenols in an 
inflammatory process associated with experimental pulmonary fibrosis in mice", The 
British Journal of Nutrition, vol. 114, no. 6, pp. 853-865, 2015. 
[85] A. G. Janiques, O. Leal Vde, M. B. Stockler-Pinto, et al., "Effects of grape powder 
supplementation on inflammatory and antioxidant markers in hemodialysis patients: a 
randomized double-blind study", Jornal brasileiro de nefrologia : 'orgao oficial de 
Sociedades Brasileira e Latino-Americana de Nefrologia, vol. 36, no. 4, pp. 496-501, 
2014. 
[86] I. Urquiaga, S. D'Acuna, D. Perez, et al., "Wine grape pomace flour improves blood 
pressure, fasting glucose and protein damage in humans: a randomized controlled 
trial", Biological Research, vol. 48, pp. 49, 2015. 
[87] J. Tome-Carneiro, M. Larrosa, M. J. Yanez-Gascon, et al., "One-year supplementation 
with a grape extract containing resveratrol modulates inflammatory-related microRNAs 
Stellenbosch University  https://scholar.sun.ac.za
 57 
 
and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and 
hypertensive patients with coronary artery disease", Pharmacological Research, vol. 
72, pp. 69-82, 2013. 
[88] M. Zamboni, G. Mazzali, F. Fantin, et al., "Sarcopenic obesity: a new category of 
obesity in the elderly", Nutrition, Metabolism, and Cardiovascular Diseases : NMCD, 
vol. 18, no. 5, pp. 388-395, 2008. 
[89] K. Lambert, M. Coisy-Quivy, C. Bisbal, et al., "Grape polyphenols supplementation 
reduces muscle atrophy in a mouse model of chronic inflammation", Nutrition, vol. 31, 
no. 10, pp. 1275-1283, 2015. 
[90] S. W. Lee, G. Dai, Z. Hu, et al., "Regulation of muscle protein degradation: coordinated 
control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 
kinase", Journal of the American Society of Nephrology : JASN, vol. 15, no. 6, pp. 
1537-45, 2004. 
[91] Z. C. Xu, J. Yin, B. Zhou, et al., "Grape seed proanthocyanidin protects liver against 
ischemia/reperfusion injury by attenuating endoplasmic reticulum stress", World 
Journal of Gastroenterology : WJG, vol. 21, no. 24, pp. 7468-7477, 2015. 
[92] D. E. Roopchand, R. N. Carmody, P. Kuhn, et al., "Dietary Polyphenols Promote 
Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-
Induced Metabolic Syndrome", Diabetes, vol. 64, no. 8, pp. 2847-2858, 2015. 
[93]  M. Asensi, J. Sastre, F. V. Pallardo, et al., “Ratio of reduced to oxidized glutathione as 
indicator of oxidative stress status and DNA damage.”, Methods in Enzymology. vol 
299, pp. 267–276,1999.  
[94] V. Witko-Sarsat, P. Rieu, B. Descamps-Latscha, et al., “Neutrophils: Molecules, 
Functions and Pathophysiological Aspects.”, Laboratory Investigation. vol 80, no. 5, 
pp. 617–653, 2000. 
[95]  I. Torsteinsdoâttir, N.-G. Arvidson, R. Hallgren, “Enhanced Expression of Integrins and 
CD66b on Peripheral Blood Neutrophils and Eosinophils in Patients with Rheumatoid 
Arthritis, and the Effect of Glucocorticoids.”, Scandinavian Journal of Immunology, vol. 
50, pp. 433-439, 1999 
[96] K. S. Nair and S.M. Zingde, “Adhesion of Neutrophils to Fibronectin: Role of the CD66 
Antigens.”, Cellular Immunology vol. 208, pp. 96–106, 2001. 
[97]  G. Saretzki and T. Von Zglinicki, “Replicative Aging, Telomeres, and Oxidative Stress.”, 
Annals New York Academy of Sciences, vol. 959, pp 24–29, 2002. 
 
Stellenbosch University  https://scholar.sun.ac.za
 58 
 
[98] A. Karadag ,B. Ozcelik and S. Saner, “Review of Methods to Determine Antioxidant 
Capacities.” Food Analytical Methods, vol. 2, pp. 41–60, 2009. 
[99] S. Ponnappan and U. Ponnappan,” Aging and Immune Function: Molecular 
Mechanisms to Interventions.”, Antioxidants & Redox Signalling, vol. 14 no. 8, pp.1151-
1585, 2011. 
[100]  N. Sallam and I. Laher, “Exercise Modulates Oxidative Stress and Inflammation in 
Aging and Cardiovascular Diseases.” Oxidative Medicine and Cellular Longevity, vol. 
2016, 2016. 
[101] C. Guo, J. Wei and J. Yang, “Pomegranate juice is potentially better than apple juice 
in improving antioxidant function in elderly subjects.”, Nutrition Research, vol. 28, no. 
2, pp. 72-77, 2008. 
[102] M.C. Meuwese, E. S. G. Stroes, S. L. Hazen, et al., “Serum Myeloperoxidase Levels 
Are Associated With the Future Risk of CoronaryArtery Disease in Apparently Healthy 
Individuals.” Journal of the American College of Cardiology, vol. 50, no 2, pp. 159–65, 
2007. 
[103] S. Giovannini, G. Onder, C. Leeuwenburgh et al., “Myeloperoxidase Levels and 
Mortality in Frail Community-Living Elderly Individuals.”, Journals of Gerontology 
Series A: Biological Sciences and Medical Sciences, vol. 65A, no.4, pp. 369–376, 
2010. 
[104] M. Torrente Goncąlves, T. J. Mitchell and J.M. Lord, “Immune ageing and susceptibility 
to Streptococcus Pneumonia”, Biogerontology,  vol. 17, pp. 449–465, 2016. 
[105] B. Weinberger, D. Herndler-Brandstetter, A. Schwanninger, et al., “Biology of Immune 
Responses to Vaccines in Elderly Persons.” Clinical Infectious Diseases, vol. 46, pp. 
1078–1084, 2008. 
[106] M.E Bauer and M. De la Fuente, “The role of oxidative and inflammatory stress and 
persistent viral infections in immunosenescence.” Mechanisms of Ageing and 
Development, vol. 158, pp. 27-37, 2016.   
[107] V.Fattori, F. A. Amaral and W. A. Verri Jr., “Neutrophils and arthritis: Role in disease 
and pharmacological perspectives.” Pharmacological Research, vol. 112, pp.84-89, 
2007 
[108]  D. Lau, H. Mollnau, J. P. Eiserich, et al., “Myeloperoxidase mediates neutrophil 
activation by association with CD11b/CD18 integrins.” Proceedings of the National 
Academy of Sciences, vol. 102, no. 2,  pp. 431–436, 2005. 
Stellenbosch University  https://scholar.sun.ac.za
 59 
 
[109]  S.K. Butcher, H. Chahal, L. Nayak, et al., “Senescence in innate immune responses: 
reduced neutrophil phagocytic capacity and CD16 expression in elderly humans.” 
Journal of Leukocyte Biology, vol. 70, pp.886, 2001. 
[110] S.R. McAnulty, P.A. Hosick, L.S. McAnulty, et al., “Effect of pharmacological lowering 
of plasma urate on exercise-induced oxidative stress.”, Applied  Physiology, Nutrition 
and Metabolism, vol.32, pp.1148-1155, 2007. 
[111] B. L. Queen and T.O. Tollesfbol, “Polyphenols and Aging.” Current Aging Sciences, 
vol.3, no.1, pp. 34-42, 2010.  
[112] M. L. Urso and P. M. Clarkson, “Oxidative stress, exercise, and antioxidant 
supplementation.” Toxicology, vol. 189, pp.41-54, 2003. 
[113] R. P. Wilkie-Grantham, N. J. Magon, D. T. Harwood, et al., “Myeloperoxidase-
dependent Lipid Peroxidation Promotes the Oxidative Modification of Cytosolic 
Proteins in Phagocytic Neutrophils.” The Journal of Biological Chemistry, vol.  290, no. 
15, pp. 9896–9905, 2015. 
[114] R. Aroca, C. Chamorro., A. Vega, et al., “Immunotherapy Reduces Allergen-Mediated 
CD66b Expression and Myeloperoxidase Levels on Human Neutrophils from Allergic 
Patients.” PLoS one, vol. 9, no. 4, 2014. 
[115] P.J. Middelhoven, J.D. Van Buul, P.L Hordijk, et al., “Different proteolytic mechanisms 
involved in FcƴRIIIb shedding from human neutrophils.”, Clinical Experimental 
Immunology, vol. 125, pp. 169-175, 2001. 
[116] G. Fossati, R. J. Moots, R. C. Bucknall, et al., “Differential Role of Neutrophil Fc_ 
Receptor IIIb (CD16) in Phagocytosis, Bacterial Killing, and Responses to Immune 
Complexes.” Arthritis & Rheumatism, vol. 46, no. 5, pp 1351–1361, 2002.  
[117] L.Tan, J.T. Yu and H.S. Guan, “Resveratrol exerts pharmacological preconditioning by 
activating PGC-1a.” Medical Hypotheses, vol. 71, pp. 664–667, 2008. 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
60 
Appendices 
Appendix A – Literature Review 
Hindawi Publishing Corporation
Oxidative Medicine and Cellular Longevity Volume 2016, Article ID 6236309, 12 pages http://dx.doi.org/10.1155/2016/6236309
Review Article
Ageing-Associated Oxidative Stress and Inflammation Are
Alleviated by Products from Grapes
K. S. Petersen and C. Smith 
Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South Africa
Correspondence should be addressed to C. Smith; csmith@sun.ac.za 
Received 23 October 2015; Revised 3 February 2016; Accepted 7 February 2016 
Academic Editor: Hesham A. El Enshasy 
Copyright © 2016 K. S. Petersen and C. Smith. This is an open access article distributed under the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Advanced age is associated with increased incidence of a variety of chronic disease states which share oxidative 
stress and inflammation as causative role players. Furthermore, data point to a role for both cumulative oxidative 
stress and low grade inflammation in the normal ageing process, independently of disease. Therefore, arguably 
the best route with which to address premature ageing, as well as age-associated diseases such as diabetes, 
cardiovascular disease, and dementia, is preventative medicine aimed at modulation of these two responses, 
which are intricately interlinked. In this review, we provide a detailed account of the literature on the 
communication of these systems in the context of ageing, but with inclusion of relevant data obtained in other 
models. In doing so, we attempted to more clearly elucidate or identify the most probable cellular or molecular 
targets for preventative intervention. In addition, given the absence of a clear pharmaceutical solution in this 
context, together with the everincreasing consumer bias for natural medicine, we provide an overview of the 
literature on grape (Vitis vinifera) derived products, for which beneficial effects are consistently reported in the 
context of both oxidative stress and inflammation. 
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1. Introduction 
With ageing, the capacity of the body to function 
optimally declines. There is a combination of genetic 
and lifestyle factors which may either accelerate or 
slow down the ageing process. A number of chronic 
diseases are associated with advanced age: these 
include cardiovascular disease (CVD), diabetes, 
metabolic syndrome, and Alzheimer’s disease. This 
results in an exponential increase in the disease 
burden on modern society, relative to a few decades 
ago, due to longer life expectancy. The World Health 
Organisation states that from 2015 to 2050, the 
proportion of the world’s population over 60 years 
will increase from 12% to 22% [1]. Taking into 
consideration that predominant research in the field 
of age-associated diseases considers the sixth decade 
of life to be a risk factor for the rapid progression and 
onset of age-associated diseases, the disease burden 
will almost double in the next 35 years. It is thus vital 
not only to elucidate the causes and progression of 
these chronic conditions, but also to actively search 
and investigate potential preventative therapies that 
may slow the processes contributing to physiological 
ageing. 
Although the ageing-associated chronic disease 
states are each uniquely complex in terms of their 
aetiology, development, and progression, they do 
share common aetiologies which stem from two main 
entities, namely, cumulative oxidative stress and 
chronic inflammation. Briefly, oxidants are produced 
by normal cell metabolism and various physiological 
responses. However, when the production of 
oxidants outweighs the capacity of endogenous 
antioxidant systems, oxidative stress is incurred. 
Furthermore, while inflammation is crucial for repair 
of tissue injury and primary defence against invading 
pathogens and chemicals, it also results in 
unintended detriment to previously uninjured cells. 
Although these are necessary systems in the body, 
both oxidative stress and the inflammatory response, 
if unchecked, can have detrimental consequences 
which have been linked to accelerated ageing and the 
progression of age-associated disease. We postulated 
that the effects of the inflammatory immune system 
and oxidative stress on allostatic load are interlinked. 
This has led us to investigate the potential of 
antioxidants as treatment options to attenuate the 
cumulative effects of both oxidative stress and 
chronic low grade inflammation. Given the modern 
consumer bias for natural medicines, we focused on a 
group of plant medicines which are consistently 
associated with beneficial effects on these processes 
in the literature, grape-derived polyphenols. In this 
review, we will provide a more in-depth review of 
interconnected molecular mechanisms of oxidative 
stress and inflammation in the physiological ageing 
process, before moving our focus to a discussion of 
the merits of these plant medicines as potential 
preventative therapy in this context. 
2. Contribution of Oxidative Stress 
to Premature Ageing 
In the context of ageing, reactive oxygen and 
nitrogen species (RONS) are generally the major 
molecules which contribute significantly to oxidative 
stress. The most frequently studied free radicals are 
superoxide (O2−), hydrogen peroxide (H2O2), hydroxyl 
radical (∙OH), peroxynitrite (ONO2−), and nitric oxide 
(NO). The generation of these free radicals is 
necessary as they are essential for host defence: 
phagocytic cells use ROS to digest invading pathogens 
and debris. Furthermore, they act as signalling 
molecules, regulating cell growth and apoptosis, 
adhesion, and differentiation. More specifically, 
RONS are formed during processes such as the 
mitochondrial electron transport chain as well as 
enzyme systems such as cytochrome P450, 
lipoxygenase and cyclooxygenase, the NADPH-
oxidase complex, xanthine oxidase, and peroxisomes 
[2]. In contrast to these roles in growth, repair, and 
immune functions which are all beneficial to the host, 
these molecules also have the ability to oxidise 
signalling molecules, DNA, macromolecules, and cell 
structures such as lipid membranes of healthy host 
cells, all of which are to the detriment of these cells. 
Usually, each cell has defence mechanisms to 
counteract the occurrence of oxidative stress. These 
endogenous enzymatic antioxidant defences include 
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superoxide dismutase (SOD), glutathione peroxidase, 
catalases, glutathione/TrxR, and peroxiredoxins. An 
appropriately nutritious diet is vital to maintain these 
systems, as these natural antioxidants are 
supplemented or replenished by antioxidant 
constituents of various fruits and vegetables. It is only 
when the capacity of the body’s antioxidant defences 
is outweighed by the rate of production of free 
radicals that oxidative stress is incurred by 
unquenched free radicals which can alter surrounding 
cell structures and environment. 
With advancing age, various factors, among these is a 
natural progressive decline in endogenous 
antioxidant capacity, cause disruption in the balance 
between pro- and antioxidant mechanisms and RONS 
accumulate beyond the normal endogenous 
antioxidant system’s quenching capacity, resulting in 
cumulative oxidative stress. Eventually this causes 
cell damage which cannot be repaired by internal 
mechanisms, leading to loss of organ mass and 
functionality, which ultimately culminates in system 
dysfunction [3]. Indeed, long-term oxidative stress 
states have been linked to various diseases 
associated with advanced age, most notably diabetes, 
chronic obstructive pulmonary disease (COPD), 
cardiovascular disease, cancer, diabetes, and asthma 
[4]. Many of these diseases are not only associated 
with ageing anymore, but also with the high-obesity, 
high-stress, and sedentary modern lifestyle (albeit 
perhaps in milder form) [5]. It is thus vital to address 
the prevention of these detrimental long-term 
outcomes, as they are afflicting not only the aged, 
but also relatively young populations, such as 
university students [6, 
7]. 
The aetiological mechanism(s) of the various chronic 
diseases mentioned are each different, as each 
disease has its own complexities. However, chronic 
cumulative oxidative stress is a common factor in 
these diseases, highlighting this system as a vital 
therapeutic and/or preventative medicine target [8]. 
Even in the absence of age-associated disease, 
various theories have linked oxidative stress directly 
to the normal ageing process. We briefly mention 
two here. Firstly, the Free Radial Theory of Ageing 
proposes that the presence of free radicals and their 
effects on cells are one of the causes of cell ageing 
and subsequent cell death, which in turn lead to loss 
of organ mass and other features of whole organism 
ageing. This theory was first suggested by Harman in 
1956 [9], who hypothesized that irradiation of cellular 
components resulting from the liberation of ∙OH and 
∙HO2 radicals would lead to dysfunction and 
mutations which cannot be reversed and thus result 
in ageing. This theory was later supported and 
expanded as research began elucidating the details of 
his proposed theory, for example, by describing the 
role of SOD [10]. Phenomenally, a very recent meta-
analysis [11] confirmed the sustained validity of this 
theory, 60 years later. Of course, given the 
technological advances made over this period, it is no 
surprise that subsequent research has added more 
detail on mechanisms in support of this theory, 
although many unresolved questions remain 
[12]. 
Secondly, the Replicative Senescence Theory is based 
on the hypothesis that oxidative stress induces cell 
death and/or senescence, which necessitates an 
increase in the rate of cell replication. This in turn 
accelerates the detrimental effects associated with 
repeated cycles of mitosis. Telomere length and its 
accelerated shortening due to reparative replication 
is the basis of this theory, which was first described 
by Hayflick in 1965, in response to the observation of 
a decline in functionality of cell cultures (fibroblasts) 
which had undergone numerous cell divisions [13]. 
This phenomenon was subsequently confirmed by 
experiments on primary peripheral blood 
mononuclear cells (PBMCs) and fibroblasts from a 
largely aged population with increased risk for 
vascular dementia [14]. In this report, decreased 
telomere length in both fibroblasts and PBMCs was 
correlated to risk for dementia induced by stroke. In 
addition, telomere shortening rate was reported to 
decrease with increasing antioxidant capacity in 
fibroblasts of the same population. 
This theory, together with the subsequent data, 
presents evidence that, firstly, oxidative stress is 
responsible for the accelerated shortening of 
telomeres brought about by more frequent 
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reparative replication and, secondly, that an increase 
in antioxidant defence capacity could slow down the 
ageing process. Note at this point that we do not 
infer that telomere shortening results only from 
oxidative stress: other mechanisms such as 
chromosomal instability have indeed been linked to 
both ageing and pathological conditions such as 
cancer [15]. However, to remain focused on the main 
topic of this review, we have limited this discussion to 
accelerated telomere shortening in the context of 
cumulative oxidative stress. 
Holistic interpretation of the two theories introduced 
above implicates oxidative stress as major causative 
role player in the damage to cell constituents by 
oxidising membranes, molecules, and DNA. This 
initiates a cascade of events leading to the need for 
either cell growth and replication for repair, or death. 
This implicates ROS as rate determining factor of cell 
lifespan due to the direct damage it inflicts. 
Furthermore, oxidative stress is implicated in causing 
irreversible damage to the mechanism of replication 
through accelerated telomere shortening and thus 
ultimately decreases the capacity of the cell to 
replicate optimally, or at all. With both repair and 
replication affected, cell senescence is encouraged. 
In keeping with the idea of a holistic approach, 
consideration of oxidative stress in isolation is 
insufficient. A basic but practical example of the 
interplay between the oxidative stress system and 
another system implicated in ageing, inflammation 
[16], is data available on detrimental effects of 
cigarette smoking. In this context, both acute 
smoking and long-term smoking were shown to 
overwhelm the glutathione antioxidant defence 
system within the lungs, which was associated with 
significant infiltration of inflammatory immune cells 
in the lungs [17]. This study clearly shows system 
interaction. Furthermore, in the same study, the 
severity of this maladaptation increased with 
duration of habitual smoking (in years) and was 
exacerbated by natural decreases in antioxidant 
capacity as experienced with ageing, resulting in 
increased oxidative stress, illustrating the significance 
of cumulative damage. 
However, before considering these interactions in 
more detail, the literature providing proof of a role 
for chronic inflammation in the process of ageing will 
be briefly reviewed. 
3. Chronic Low Grade Inflammation 
Facilitates Premature Ageing 
As is the case for oxidative stress, the inflammatory 
response is a system essential for normal body 
function [18]. As component of the innate immune 
response, inflammation is a major first-line defence 
against infection and injury [18]. Apart from this 
largely independent, nonspecific role in immunity, 
inflammation is also vital for many specific immune 
responses to run its course [19]. However, in the 
process of repair and restoration after insult, the 
inflammatory response inadvertently disrupts cellular 
homeostasis of previously unharmed or unaffected 
cells [20, 21]. The injury-repair cycle which 
inflammation regulates is an efficient system during 
youth, when optimal sensitivity and response to 
signalling molecules (such as cytokines, growth 
factors, prostaglandins, and peptides) maintain the 
general health of circulating immune cells and the 
tissue microenvironment, with minimum secondary 
damage. However, during natural chronological 
ageing, long-term, repeated stimulus-response cycles 
change the receptor expression levels and thus 
sensitivity to these molecular stimuli [22]. This may 
necessitate relatively increased concentrations of any 
particular stimulus to maintain the required effect. 
Commonly reported characteristics of the natural 
ageing process include inflammation or oxidative 
stress-associated symptoms such as directionally 
inaccurate chemotaxis, premature or suboptimal 
respiratory burst, and increased pro-inflammatory 
signalling from immune cells, all of which form the 
basis of immunosenescence [23]. 
Immunosenescence is the term used to describe 
ageing of immune cells and the functioning of the 
immune system as a whole. This occurs naturally with 
advancing chronological age or as result of lifestyle 
factors, as already mentioned. There is more than 
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one way in which the immune system is 
compromised upon ageing. Firstly, 
immunocompetent cells are derived from 
hematopoietic stem cells. With ageing, a natural bias 
develops for stem cells to commit to expansion of the 
myeloid lineage at the cost of the lymphoid lineage 
[24]. This results in a shift in the balance of immune 
cells available to enter the circulation. Secondly, the 
chronic low grade inflammation associated with 
ageing recruits larger numbers of cells into circulation 
from the hematopoietic tissue. However, despite the 
higher circulating cell counts, phagocyte Toll-like 
receptor expression and phagocytic capacity are 
decreased in the aged [22], leaving the immune 
system with a lower capacity for becoming activated 
and for responding to a more acute insult, such as 
viral infection. These maladaptations, which together 
further predispose the individual to pro-inflammatory 
responses, are postulated to stem at least in part 
from alterations in HPA-axis signalling. 
The process of immunosenescence may be 
accelerated by unhealthy lifestyle, such as 
psychological stress and obesity. As mentioned 
before, lifestyle-associated diseases share clinical 
symptoms associated with normal ageing. Indeed 
rutin, a potent antioxidant, has been shown to 
protect against ageing-related metabolic dysfunction 
[25]. Thus, studies focused on those conditions may 
provide much insight in terms of ageing and the 
supplementation options to limit its progress. 
For example, in the context of obesity and/or 
inactivity, cytokines release from adipose tissue 
macrophages has been demonstrated by many 
researchers [26–29]. Tumour necrosis factor-α (TNF-
α), interleukin- (IL-) 1β, and IL6 are among some of 
the cytokines shown to be released from resident 
macrophages in adipose tissue, resulting in a pro-
inflammatory microenvironment [30]. Furthermore, 
chronic stress, and in particular psychological stress, 
is a generally accepted cause of chronic low grade 
inflammation. For example, in 38 medical students, 
psychological stress was associated with increased 
pro-inflammatory cytokine (TNF-α, IL-6, IL-1Ra, and 
IFN-γ) levels, as well as decreased anti-inflammatory 
regulators (IL-10 and IL-4) [31]. Interestingly, these 
effects were exacerbated by high anxiety proneness 
as trait, again suggesting that a cumulative stimulus 
(in this case lifelong anxiety) further exacerbates the 
undesirable adaptation. 
Also in posttraumatic stress disorder (as extreme 
form of chronic psychological stress), an initial 
glucocorticoid hyper-response is followed by 
glucocorticoid hyporesponsiveness, which is 
associated by a relatively pro-inflammatory state. In 
this condition of continuous pro-inflammatory 
signalling, the feedback systems, which usually 
downregulate inflammation, adjust overtime and 
result in maladaptations such as chronic but low 
grade upregulation of pro-inflammatory mediators 
(e.g., IL-6, TNF-α, IL-1β, and prostaglandin E2) [32]. 
Incidentally, the secretion of the first three is 
mediated by the NF-κB pathway, which is activated in 
response to cellular stress 
[33]. 
In addition to increased pro-inflammatory signalling, 
other more mechanical cellular mechanisms also 
seem to be compromised over time. For example, 
inappropriate and/or insufficient neutrophil 
responses result from its decreased phagocytic 
capacity, increased basal levels of intracellular 
calcium, and the resulting reduction in capacity for 
chemotaxis [34]. The result is a chronic low grade 
inflammatory status in relative absence of a specific 
threat which can persist for extended periods of time 
and cause harm and inefficiency of the system. Thus, 
although varied in specific causative mechanism, the 
outcome of all of these suboptimal life events or 
lifestyle habits, for example, chronic stress leading to 
glucocorticoid resistance and/or cardiovascular 
disease and high-calorie diets and inactivity (obesity) 
leading to insulin resistance and diabetes, is that of a 
chronic inflammatory state 
[16]. 
Of particular interest in the context of ageing is the 
fact that, apart from the now notorious low grade 
inflammation as primary culprit, this maladaptation 
results in a compromised capacity to mount an 
efficient inflammatory response to acute insults. As 
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overviewed in the review by Weinberger and 
colleagues [35], several reports from clinical 
literature support the notion that, in the aged 
individual, that there is a significant increase in the 
convalescence period required for recovery from 
injury and pathogen clearance, as well as a decrease 
in the quality of repair, thus favouring disease 
progression and morbidity due to injury. Very 
recently, Baehl¨ and colleagues (2015) demonstrated, 
in a longitudinal study of elderly patients, that the 
acute stress of a hip fracture had a negative effect on 
neutrophil function immediately after injury. While 
some neutrophil functions (chemotaxis, 
phagocytosis) were recovered over time, several 
others (superoxide production, complement C5A and 
CD11b receptor level, and cytokine secretory profile) 
were still impaired even 6 months after injury. From 
this, the authors concluded that the acute stress had 
a long-term negative effect on neutrophil responses, 
which negatively influenced clinical outcomes, such 
as the resolution of long-term inflammation, 
recovery, and susceptibility to opportunistic 
infections [36]. 
It is thus clear that ageing is an inflammatory-
mediated process. However, from the 
inflammation/ageing literature, it is clear that 
inflammation and oxidative stress cannot be 
separated as causative factors in this context. For 
example, the ageing-related shift in balance between 
the glucocorticoid and inflammatory systems has 
been linked to increased ROS production, which in 
turn exacerbates low grade immune activation [37]. 
4. Links between Inflammation and 
Oxidative Stress in the Ageing Process: 
Identifying Therapeutic Targets 
From the above sections it is evident that, in ageing, 
oxidative stress and inflammation are 
interdependent mechanisms. We postulate that 
unravelling and understanding of these intricate links 
between the two responses hold the answer to 
identification of the major contributor(s) to allostatic 
load and maladaptation associated with ageing and 
age-related pathology. 
Generally, repeated exposure to reactive oxygen and 
nitrogen species causes cell damage and thus a pro-
inflammatory signalling response. For example, in 
aged mice, unquenched reactive oxygen and nitrogen 
species act as pro-inflammatory signalling molecules 
and mediators of inflammation within the cell itself 
[38]. More specifically, oxidative damage to cells 
prompts the release of TNF-α from these damaged 
cells [21]. Binding of TNF-α to cell surface TNF-α 
receptors activates the NF-κB inflammasome, which 
results in the further production of other pro-
inflammatory cytokines, most notably IL-1β. 
Incidentally, TNF-α specifically has also been 
implicated in ROS-mediated upregulation of adhesion 
molecules which facilitate the infiltration of immune 
cells into tissue [39], with more on this later. 
Upregulation of inflammation via the NF-κB 
inflammasome is probably the main aetiological 
mechanism for age-related chronic conditions with 
an inflammatory component. Indeed, TNF-α 
upregulation, which is a direct result of increased flux 
through the inflammasome, has been implicated as 
causative factor in cardiovascular disease [40]. Of 
particular relevance to the topic of ageing, the NF-αB 
inflammasome has regulatory roles in cell growth, 
survival, and proliferation. However, as recently 
reviewed [41], ROS production may have either 
inhibitory or stimulatory roles in the NF-�B pathway, 
suggesting a dose dependency of the effects of ROS. 
This unfortunately also means that development of 
an intervention strategy/product to modulate this 
target mechanism is no simple feat and will have to 
be approached in a very tightly controlled 
“modification range.” 
From the literature consulted, it is clear that 
bidirectional communication is in place. For example, 
both neutrophils and macrophages are producers of 
oxidants via the NADPH-oxidase system [42]. The 
NADPH-oxidase (NOX) proteins aid the transport of 
electrons across biological membranes and are found 
in all cells [43]. They are also one of the major 
generators of ROS in all cells. Particularly, these 
proteins are the predominant ROS producers in 
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phagocytic cells, a process required for the normal 
respiratory burst that phagocytes use to kill 
pathogens and digest cell debris. 
Furthermore, activated neutrophils release 
myeloperoxidase (MPO), which contributes to the 
formation of hypochlorous acid (HOCL) by acting as a 
catalyst when reacting with hydrogen peroxide 
(H2O2). This directly increases the production of ROS 
[44]. The oxidative burst of neutrophils in itself 
releases oxidants such as H2O2, which are harmful to 
healthy cells and tissue [45]. Besides directly 
increasing the production of reactive oxygen species 
itself which causes damage to surrounding cells, MPO 
specifically has been implicated as a risk factor for 
coronary artery disease, due to its capacity for 
oxidation of lipid membranes [46]. The increased 
oxidant concentration due to immune cell functions, 
as well as the resultant cell damage, results in 
increased metabolism in surrounding healthy tissue. 
Also at gene level, role players have been elucidated 
in the context of a ROS-inflammation link. For 
example, sirtuins are Class III histone deacetylases 
which are responsible for the deacetylation at N-
epsilon lysine residues, a reaction which consumes 
NAD+. SIRT1 specifically is a sirtuin commonly 
associated with antioxidant function [47]. Its 
regulation of oxidative stress is threefold: firstly, it 
stimulates the expression of antioxidants via the 
fork-head box protein O (FOXO) pathway. Secondly, it 
is involved in inhibiting the NF-κB signalling pathway. 
In contrast, however, excessive ROS can inhibit SIRT1 
activity by oxidatively modifying its cysteine residues 
and thereby releasing its inhibition of the NF-κB 
pathway [47]. It is thus theoretically possible for 
cumulative stress to downregulate SIRT1 activity in 
the ageing process. Thirdly, SIRT1 has also been 
implicated in regulation of apoptosis by deacetylating 
p53 to inhibit p53dependent transcription in models 
of cellular stress [48]. This tripartite role defines 
SIRT1 as another important molecular target in the 
context of both normal and accelerated ageing. 
Apart from these targets related to cellular signalling, 
cell functional capacity should also be a focus. A 
striking example of the oxidative stress, inflammation 
link in ageing, is the decreased capacity for neutrophil 
chemokinesis reported in the elderly both in terms of 
motility and accuracy [49]. Normally, immune cells 
are attracted by chemotactic signals from injured 
tissue, to migrate to sites of injury or pathogen 
invasion. During this chemokinetic response, immune 
cells, typically neutrophils and classically activated 
macrophages, migrate through tissue toward the site 
of injury. This movement is facilitated largely via 
adhesion molecules such as the beta-integrins and I-
CAM1 in the case of neutrophils [21]. However, as 
mentioned earlier, expression of adhesion molecules 
on neutrophils increases with ageing [39], so that 
their movement is slowed. In addition, due to yet 
unclear mechanisms, but most probably due to 
adaptation of cellular “homing” molecules, 
directional accuracy of neutrophil migration is also 
compromised in the elderly. Sapey et al. showed that 
inaccurate neutrophil migration was causally 
associated with increased constitutive 
phosphoinositide 3-kinase (PI3K) signalling [49]. This 
results not only in inefficient inflammation due to 
prolonged response time, but the directional 
inaccuracy of movement also results in mechanical 
and oxidative damage to relatively more cells in the 
path of the migrating inflammatory cell 
[49]. 
It is clear that both oxidative stress and inflammation 
are able to induce and exacerbate one another (both 
indirectly and directly). Furthermore, regardless of 
the primary signal or which pathway was activated 
first, these interrelated processes form a vicious cycle 
which is difficult to target therapeutically because of 
its complexity. However, it is also this interrelated 
nature of the two systems that has led us to 
investigate the possibilities of antioxidants as 
treatment options to attenuate the cumulative 
effects of oxidative stress and in turn low grade 
chronic inflammation. 
5. Are Grapes the Answer to 
Prevention of Ageing? 
Despite the huge range of nonsteroidal and natural 
product anti-inflammatories on the market today, the 
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scientific literature shows a conspicuous lack of 
consistent support for any specific medication. This is 
perhaps at least in part due to the fact that 
researches investigating these products cannot keep 
up with the rate at which new ones are pushed onto 
the market. Hopefully new legislation on the control 
of these substances will affect this trend to the 
benefit of the consumer, by allowing for (or 
demanding) appropriate testing of these products. 
Nevertheless, antioxidants are being used almost 
routinely by many individuals who wish to 
supplement for enhancement of general health or as 
adjuvant therapy in conjunction with more 
mainstream, pharmaceutical medication. Although 
they are generally not regarded as a primary 
therapeutic option, antioxidants may hold particular 
potential in the realm of preventative medicine. The 
potential benefits of appropriate antioxidant 
supplementation are vast, especially when 
considering the connection between oxidative stress 
and inflammation. An antioxidant with the capacity 
to modulate inflammatory status can thus be 
beneficial to both normal ageing individuals and 
those suffering from lifestyle-associated diseases. 
A comprehensive search of the scientific literature 
revealed that grape-derived antioxidants are 
consistently reported to have high benefit and low 
risk in the context of both oxidative stress and 
inflammation. These positive results are further 
strengthened by the fact that these consistent 
findings were reported across many different models 
and using a variety of different preparations, ranging 
from relatively crude extracts to highly purified ones. 
For example, in terms of purified polyphenols, 
resveratrol, one of the best-known polyphenols 
present in grapes as well as other plants, is 
commonly linked to anti-inflammatory [50], 
antioxidant [51, 52], and thus by implication anti-
ageing effects in the scientific literature, as well as 
anecdotally. Indeed, a recent paper [53] elucidated a 
role for resveratrol to protect against inflammatory 
damage via SIRT1 inhibition of the NF-κB pathway (a 
mechanism discussed above in the context of ageing). 
In addition, more advanced studies have been 
undertaken on this polyphenol to better understand 
the relationship between the chemical structure of 
resveratrol and its biological activity, especially in 
terms of oxidant scavenging [54]. Also, 
pharmaceutical groups have been working on 
optimisation of delivery systems for resveratrol [55]. 
Such information may further advance the popularity 
of this very promising natural product with the 
pharmaceutical industry, to the benefit of consumers. 
The phenomenal frequency at which new papers on 
resveratrol appear, all providing evidence of positive 
effects in this context, suggests that this particular 
polyphenol should be investigated in the context of 
ageing as a matter of urgency. 
Even more promising than the many positive effects 
described for resveratrol above is the fact that 
resveratrol is only one from a range of equally 
beneficial substances contained in grapes. The 
flavonoids quercetin and dihydroquercetin (DHQ), as 
well as proanthocyanidins and anthocyanins, all of 
which are present in grapes and a variety of other 
plant sources, have similarly been linked to both 
antioxidant and anti-inflammatory effects [50, 52]. To 
date, despite appearance of a few very promising 
reports in this context, ageing specifically has not 
been the focus of many studies investigating these 
substances. Therefore, for the purpose of this review, 
we provide a comprehensive overview of the few 
existing ageing-related studies in this context that 
were available to us. Results from relevant papers 
that did not have ageing as a focus were also 
included, where those results contribute to our 
understanding of the role of grape derived 
polyphenols in the oxidative stress, inflammation link 
in the context of prevention or deceleration of the 
ageing process. 
When considering in vivo studies on ageing as a 
starting point, resveratrol (0.1 µM to 2.5 µM) 
exhibited a clear dose-dependent effect on longevity 
in fish with known short lifespan: resveratrol 
supplemented fish almost doubled their expected 13-
week lifespan and continued to produce healthy 
offspring long after all control fish had died. Even 
though resveratrol supplementation was only started 
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in adulthood in this study (i.e., it compares to when 
humans might start to consider supplementation), it 
effectively delayed age-dependent compromise of 
locomotor and cognitive performance and reduced 
expression of neurofibrillary degeneration in the 
brain [56]. This result of improved neural morphology 
was recently further substantiated in an aged rat 
model, where chronic resveratrol treatment 
prevented detrimental changes in dendritic 
morphology which is linked not only to ageing, but 
also to Alzheimer’s disease [57]. Similarly, 2 months 
of ingesting polyphenols in the form of 10% grape 
juice resulted in enhanced potassium-evoked 
dopamine release and cognitive performance in aged 
rats 
[58]. 
A more recent review [59] provides more insight into 
the potential mechanisms by which age-related 
cognitive disorders may be curbed by grape 
polyphenols. Some of these mechanisms at first seem 
unrelated to the scope of this review, for example, 
preventing of amyloid-beta deposition associated 
with Alzheimer’s dementia [60]. However, recent 
research suggests a role for inflammation in the 
development of the disease [61], while natural 
antioxidants have been linked to prevention of 
amyloid-beta deposition [62]. Together, these data 
suggest that even these seemingly unrelated 
mechanisms may be interconnected to either 
inflammation, or oxidative stress, or both. However, 
more clearly in context of this review, resveratrol was 
reported to increase NO production, resulting in 
vasodilation [59, 63], which may play a role in the 
maintenance of central circulation and thus perhaps 
slower degenerative central processes, as has indeed 
been reported for resveratrol, as mentioned earlier. 
However, the role of NO in the context of antioxidant 
status is much more complex, so that this effect of 
grape polyphenols should probably receive more 
attention before it can be interpreted fully in terms 
of mechanism(s) involved. Furthermore, recently in a 
co-culture simulation of the human blood-brain 
barrier, another grape polyphenol, proanthocyanidin, 
was associated with significant inhibition of 
monocyte infiltration and pro-inflammatory cytokine 
secretion in HIV-associated neuroinflammation [64]. 
Such inhibition of neuroinflammation is associated 
with a better prognosis in terms of HIV-related 
neurodegeneration and dementia, further confirming 
the neuroprotective potential of grape-derived 
antioxidants. Taken together, these studies suggest 
that the neuroprotective effects of grape polyphenols 
involve both antioxidant and anti-inflammatory 
mechanisms, with the latter including not only 
modulated cytokine signalling, but also modulation of 
both motility and functional capacity of leukocytes, as 
previously illustrated by our group [64, 65]. 
One may argue that both these results may be the 
result of decreased cell activation, perhaps as a result 
of the known altered cytokine environment. 
However, an age-associated lack of neutrophil 
chemokinetic accuracy in response to the chemotaxin 
fMLP has been reported [49], which suggests that the 
mechanism is probably related to age-induced 
compromise of specific cellular mechanisms, rather 
than activation. In addition, in an ongoing study by 
our group, we have been able to illustrate by using 
Dunn chamber chemokinetic assays that grape 
polyphenols (specifically proanthocyanidin) are able 
to correct this age-associated anomaly (unpublished 
data). From Figure 1, which depicts typical digital 
images obtained for the path of individual 
neutrophils, it is clear that a more purposeful, 
directionally accurate movement was achieved in 
proanthocyanidin-treated neutrophils. This will 
ensure a more optimal inflammatory response (i.e., 
the response will be effective, result in relatively 
insignificant secondary damage, and be resolved in 
the minimum amount of time). In contrast the rather 
“aimless wander” of untreated neutrophils from aged 
individuals will result in not only ineffective immune 
cell infiltration to sites where they are required, but 
also relatively more secondary tissue damage and 
thus prolonged and exacerbated inflammation. 
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Turning attention to inflammation and oxidative 
stress again, the most probable targets for 
therapeutic intervention in the context of ageing 
have been described in Section 4. Since the ageing 
literature is relatively lacking in terms of papers on 
polyphenol intervention, we have tabulated effects of 
grape polyphenols reported for these identified 
targets in Table 1, citing relevant data that was 
mostly obtained in models other than ageing. The 
aim with this table was not to present all studies on 
grape-derived products; rather, it is an attempt to 
show the many models, species, and disease systems 
in which beneficial effects on oxidative stress and 
inflammatory status have consistently been reported. 
Also, although we have included doses used for in 
vivo studies for general comparison and again to 
illustrate the large variations in doses, these doses 
are product/extract specific and cannot be 
extrapolated across board. 
From Table 1, which is by no means a complete list of 
all studies reporting on grape-derived substances, 
grape derived products are undeniably beneficial in 
limiting the magnitude of the inflammatory response 
as well as to increase antioxidant activity and seem to 
have multiple targets. 
Of course, when considering potential anti-ageing 
modalities, it is also of interest to include evaluation 
of changes in quality of life. Since ageing is associated  
with natural muscle wasting or sarcopenia [83], it is 
important to note that, in this context, 
supplementation with grape polyphenols (50 
mg/kg/day) for 4 weeks mitigated skeletal muscle 
atrophy in a mouse model of chronic inflammation 
[84]. This was achieved via modulation of two distinct 
pathways: one directly linked to inflammation 
(decreased NF-κB activation) and the other due to 
antioxidant function (limited ROS-associated 
mitochondrial damage and caspase-3 and -9 
activation). Since caspase-3 activation is also a known 
pro-apoptotic signal [85], reduced activation and 
thus apoptosis may result in fewer mitotic cycles. 
This, in the context of the telomere hypothesis, may 
point to deceleration of ageing by the polyphenols. 
Very recently, grape proanthocyanidin treatment in 
rats was reported to have an anti-apoptotic effect 
which reduced damage after ischemia/reperfusion of 
the liver [86], which further substantiates this theory. 
Interestingly, a study in mice fed a high-fat diet 
indicated that grape polyphenols may modify gut 
microbial community structure to result in lower 
intestinal and systemic inflammation [87]. This 
extraordinary result serves to remind us of the 
potential complexity of plant medicines and the 
requirement for comprehensive investigation of 
mechanisms of actions and interactions of any 
potential product via the traditional clinical trial 
process followed for new pharmaceutical drugs. 
 
 (a) (b) (c) 
Figure 1: Typical neutrophil chemotaxis pathways for (a) a young participant (<25 yr), (b) an aged participant (>65 yr), and (c) an aged 
participant after acute in vitro treatment with grape-deed derived proanthocyanidin. The Olympus Cell system IX-81 inverted 
fluorescent microscope system with an F-view cooled CCD camera (Soft Imaging Systems) at 20x magnification was used to capture 
these images, which was analysed using Image J (Java software). 
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6. Conclusion 
Ageing and accelerated ageing are not new concepts, 
but rather the norm in modern society. With a 
population that is growing relatively older due to 
advances in medicine, we are however pressed for 
answers on how to alleviate the symptoms or slow 
the progression of this inevitable phenomenon. From 
the literature consulted, no negative effects of grape-
derived products became evident, while beneficial 
effects in the context of oxidative stress and 
inflammation were consistently reported in the 
context of numerous cellular targets. Huge variation 
in product content and prescribed dosage 
complicates interpretation of the fast growing body 
of literature on this topic. A recommendation for 
future studies is the inclusion of more parameters 
per study, so that a more comprehensive 
interpretation of specific mechanisms becomes 
possible. Measurement of only basic indicators of 
either antioxidant status or inflammatory status, 
while providing proof of efficacy of the product, does 
not contribute much information on its mechanism of 
action. Despite this shortcoming, the literature clearly 
indicates that grape-derived products are undeniably 
a therapeutic force to be reckoned in the combat of 
ageing and age-associated conditions. 
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Appendix B – Consent form 
PARTICIPANT INFORMATION 
LEAFLET AND CONSENT FORM 
TITLE OF THE RESEARCH PROJECT: Modulation of neutrophil migration patterns 
by in vitro treatment with grape seed-derived proanthocyanidolic oligomers 
REFERENCE NUMBER: N14/02/007 
PRINCIPAL INVESTIGATOR: Prof Carine Smith 
You are being invited to take part in a research project.  Please take some time to read the 
information presented here, which will explain the details of this project.  Please ask the study 
staff or doctor any questions about any part of this project that you do not fully understand.  It 
is very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved.  Also, your participation is entirely voluntary and you 
are free to decline to participate.  If you say no, this will not affect you negatively in any way 
whatsoever.  You are also free to withdraw from the study at any point, even if you do agree 
to take part. 
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This study has been approved by the Health Research Ethics Committee at 
Stellenbosch University and will be conducted according to the ethical guidelines 
and principles of the international Declaration of Helsinki, South African Guidelines for 
Good Clinical Practice and the Medical Research Council (MRC) Ethical Guidelines 
for Research. 
 
What is this research study all about? 
 The study will be conducted at the Dept. Physiological Sciences at Stellenbosch 
University. We aim to recruit a total of 24 individuals for this study, of which sixteen will 
be 18-25 years old and eight 65-75 years old. 
 It is known that certain types of stress, as well as ageing, can cause immune 
cells to have trouble locating problem areas in body tissue, so that they take 
longer to get there to solve to problem, and they may damage healthy cells in 
the process. All of this exacerbates inflammation. We would like to take some 
blood and test a new anti-inflammatory treatment in a test tube, to see how it 
produces it anti-inflammatory effect. 
 If you are within the older age group, we will need only two teaspoons of blood from 
you while you are completely rested. An experienced person will draw it from a forearm 
vein only once. If you are in the younger group, we will need a blood sample in a rested 
condition as for the older group, but then we will ask you to run on a treadmill until you 
decide you are too tired to continue, and then we will take another identical sample, so 
two teaspoons of blood in total. 
 You will not be required to take any medication, as we will be testing it in a test tube 
only. However, to make sure that no supplement that you are taking interferes with our 
test, you will be required to not take anti-oxidants or vitamins for two weeks before we 
take the blood sample. If you are not sure about supplements or medicine that you are 
taking, please ask the researcher if you should continue or stop using it. 
 
Why have you been invited to participate? 
 You have been invited because you fall within the specified age groups, are normally 
fit and healthy and do not smoke. 
 
Stellenbosch University  https://scholar.sun.ac.za
Oxidative Medicine and Cellular Longevity 80 
80 
 
What will your responsibilities be? 
 As explained above, you will have to sign the consent form if you agree, then stop 
taking supplements as specified for a period of two weeks .Then you will visit our 
laboratory once only, after a day in which you did not do any exercise. We will take a 
blood sample from you. If you are in the older group, that is the end of your direct 
involvement in the study. If you are in the younger group, you will also be asked to run 
on a treadmill until you are too tired to continue, and then we will take another blood 
sample from you, before you go home. 
 
Will you benefit from taking part in this research? 
 If we find any abnormal result – i.e. if your result deviate drastically from the 
others in your group – we will inform you. Although you will not get an immediate 
benefit, you will be contributing to our knowledge on how to limit the undesired 
effects of inflammation. 
 
Are there in risks involved in your taking part in this research? 
 Taking a blood sample carries a small risk of bruising or infection, but we will 
only use very experienced staff to draw blood, to minimise the risk to you. 
 If you are not used to running on a treadmill (younger participants only), there 
is the risk of falling off and hurting yourself. However, if you have not run on a 
treadmill before, we will show you how to do this at low speed when you start 
running, and we will have experienced staff to supervise the whole procedure. 
 
If you do not agree to take part, what alternatives do you have? 
 Your participation is voluntary and you may decide to take part, or not, with no 
consequence. 
 
Who will have access to your medical records? 
 We will not access your medical records. We will also label your blood with a code only, 
so that only the researchers will know your identity. 
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What will happen in the unlikely event of some form injury occurring as a direct result 
of your taking part in this research study? 
 We have an emergency team on standby during the procedures, should you be 
injured. In the unlikely event that you sustain any form of injury as a result of your 
participation in this study Stellenbosch University has insurance to cover medical 
expenses. Reasonable and appropriate medical treatment will then be provided to 
you without cost. 
 
Will you be paid to take part in this study and are there any costs involved? 
 
No, you will not be paid to take part in the study but your transport and meal costs will 
be covered for each study visit.  There will be no costs involved for you, if you do take 
part. 
 
Is there any thing else that you should know or do? 
 You can contact Prof Carine Smith at 082 821 3600 if you have any further 
queries or encounter any problems. 
 You can contact the Health Research Ethics Committee at 021-938 9207 if you 
have any concerns or complaints that have not been adequately addressed by 
your study doctor. 
 You will receive a copy of this information and consent form for your own 
records. 
 
Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled (insert title of study). 
 
I declare that: 
 
 I have read or had read to me this information and consent form and it is written in 
a language with which I am fluent and comfortable. 
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 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced 
in any way. 
 I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as 
agreed to. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2016. 
 
 ..............................................................   ........................................................ 
Signature of participant Signature of witness 
 
Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above 
 I did/did not use a interpreter.  (If a interpreter is used then the interpreter must 
sign the declaration below. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2016. 
 
 ..............................................................   ........................................................ 
Signature of investigator Signature of witness 
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Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
 I assisted the investigator (name) ………………………………………. to explain the 
information in this document to (name of participant) 
……………..…………………………….. using the language medium of 
Afrikaans/Xhosa. 
 We encouraged him/her to ask questions and took adequate time to answer them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....………2016 
 
 
 ..............................................................   ........................................................ 
Signature of interpreter Signature of witness 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
Oxidative Medicine and Cellular Longevity 84 
84 
 
Appendix C- Exercise Protocol 
1. Take lactate measurement by finger prick 
 Clean finger with alcohol swab. 
 Prick fingertip with lancet. 
 Switch on accucheck device and insert lactate measuring strip. 
 Place droplet of blood on lactate strip. 
 Close accucheck, wait 60 seconds and then read result. 
2. Pre-test blood draw 
 8ml of blood samples were drawn from antecubital area of the arm with sterile 10 
ml needle,1x Heparin vacutainer tube and 1x EDTA vacutainer tube 
 Label and place blood in white foam bucket 
 
3. VO2Max Test: 
 Place subject on treadmill and attach Oxycon as well as Heart rate monitor 
 Warm up of 8 minutes at (self-selected pace) 
 Initial speed of 7km/h for 30 seconds at 0% gradient 
 After 30 seconds increase speed by 0.5km/h  
 7.5km/h for 30 seconds 
 Repeat increase by 0.5km/h for 30 second periods until exhaustion. 
Read VO2max, calculate 80% and 50% of VO2max and the corresponding speed at which 
VO2 was 80% and 50%.   
4. HIIT Exercise Protocol 
– 3 mins : 50% (walking pace ±6km/hr) 
– 1 min : 80 % VO2max 
– 1 min : 50% VO2max 
– 1 min: 80% VO2max 
– Repeat until exhaustion 
5. Post-test blood draw 
 8ml of blood samples were drawn from antecubital area of the arm with sterile 10 
ml needle,1x Heparin vacutainer tube and 1x EDTA vacutainer tube 
 Label and place blood in white foam bucket 
6. 3 minutes post-test lactate measurement by finger prick 
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Appendix D-Neutrophil Isolation 
Whole Blood Count 
 Aliquot 300µl of whole blood into Eppendorf tube 
 Calibrate Cell Dyne 3700 machine 
 Enter sample for whole blood count 
 Read and print result 
 Neutrophil Isolation 
 2ml Histopaque1077(room temperature) is pipette into a 15ml falcon tube and then 
double volume (4ml) of Heparin anticoagulant added blood was carefully poured onto 
the Histopaque layer down the side of each tube. 
 Tubes are transferred to the centrifuge machine with swinging rotar and are spun at 
speed of 652xg for 30 minutes at 21°C, 1800rpm. 
* Four different layers of blood are formed*  
 Sediment containing neutrophils and erythrocytes is taken by aliquoting out the 
supernatant layer containing lymphocytes, monocytes and plasma layer on top 
respectively. 
 Plasma is aliquoted into eppi’s and frozen at -80°C, aliquot PBMC’s into eppi’s and 
freeze. 
 Sediment is mixed with equal volume of 6%(room temperature) filtered dextran (in 
Normal Saline) and incubated at 37°C for 45 minutes to allow the sedimentation of 
erythrocytes. 
 Pellet containing erythrocytes is discarded and the neutrophils rich supernatant is 
collected and mixed with 10ml of PBS. 
 Neutrophil PBS mixture is centrifuged at 290xg for 10 minutes at 4°C, 1500rpm. 
 The pellet containing the neutrophils is taken by removing the supernatant. 
 Washing with 1ml PBS was repeated once or twice depending on the amount of 
erythrocytes present as a contaminant. 
 The final neutrophils pellet was resuspended into desired volume of media to achieve 
the appropriate cell concentration usually 2x10-6 cells/ml. 
 Neutrophil count 
 Aliquot 200µl in eppi 
 Run sample on the CellDyne 3700 to determine neutrophil counts. 
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 Adjust to count of 2x10-6 cells/ml  
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Appendix D- Staining Protocol and Flow Analysis Guidelines 
Preparation for flow cytometry  
1. Spin down remaining neutrophil isolate (after chemotaxis assay sample has been 
aliquoted out)  
2. Remove supernatant  
3. Resuspend pellet in PBS 
4. Do cell count on Cell Dyne 3700 (background count) 
5. Aliquot 100 µl with 1x10-6 cells conc. 
6. Add surface markers antibodies : 5µl CD16 and 5µl CD66b 
7. Leave for 30 min at 4°C (fridge) 
8. Add 500µl PBS 
9. Vortex gently  
10. Centrifuge at 300g for 6 min 
11. Remove supernatant  
12. Resuspend in  250µl cytofix cytoperm 
13. Mix gently  
14. Leave for 25 min at 4°C 
15. Add 500µl BD perm wash 
16. Vortex gently  
17. Centrifuge at 300g for 6 min 
18. Remove supernatant  
19. Add 20µl MPO antibody with 80 µl PBS 
20. Leave for 30 at 4 °C 
21. Repeat wash with 250µl BD perm wash 
22. Vortex gently  
23. Centrifuge at 300g for 6 min 
24. Remove supernatant  
25. Resuspend in 500 µl 4% paraformaldehyde 
26. Leave in fridge at 4°C, covered in foil 
27. Perform flow cytometry analysis. 
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Flow cytometry analysis guidelines 
FACSDiva Version 6.1.3 
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Appendix F – ELISA Protocol 
1. Preparation of reagents 
1X Biotinylated anti-Human Myeloperoxidase  
 Add 1 µL Biotinylated anti-Human Myeloperoxidase antibody to 99 µL antibody Diluent 
buffer, mis thoroughly. Total volume should be 100 µL /well (± 200µl for pipetting error).  
 1X Avidin-Biotin-Peroxidase Complex 
 Add 1 µL Avidin-Biotin-Peroxidase Complex to 99 µL ABC Diluent Buffer, mix 
thoroughly.  Make up to end  volume of 100 µL/well (± 200µl for pipetting error). 
0.01 M TBS  
 Add 1.2 g Tris, 8.5 g NaCl and 700 µL of concentrated hydrochloric acid to distilled 
water. Adjust pH to 7.2 - 7.6. Adjust volume to 1 L with distilled water. 
 
2. Standards preparation 
1. Reconstituting the Myeloperoxidase standard with addition of 1 mL Sample Diluent 
Buffer, this makes standard no. 1 of concentration 10,000 pg/ml (Store at room 
temperature for 10 minutes).  
2. Label tubes #2 – 8, and add 300 μL Sample Diluent Buffer into tubes. 
3. Make up standard #2 by transferring 300 μL from Standard #1 to tube #2. Mix 
thoroughly, final concentration 5,000 pg/ml. 
4. Make up standard #3 by transferring 300 μL from Standard #2 to tube #3, mix 
thoroughly, 2,500 pg/ml final concentration 
5. Make up standard #4 by transferring 300 μL from Standard #3 to tube #4, mix 
thoroughly, 1,250 pg/ml final concentration.  
6. Make up standard #5 by transferring 300 μL from Standard #4 to tube #5, mix 
thoroughly, 625 pg/ml final concentration. 
7. Make up standard #6 by transferring 300 μL from Standard #5 to tube #6, mix 
thoroughly, 312 pg/ml final concentration.  
8. Tube #8 is the blank control and contains no protein, only 300 µl of sample diluent 
buffer. 
 
 
3. Sample preparation  
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 Plasma was collected from heparin containing Vacutaniners. Once spun down plasma 
was aliquoted and stored at -20°C. 
 MPO concentration is human plasma ranges from 20 - 200 ng/mL. Therefore a working 
dilution of 1:10was used. 10 μL of plasma was aliquoted into 90 μL of the sample 
diluent buffer. 
4. ELISA procedure 
1. 100 μL of prepared standards and diluted samples to was added to appropriate wells in 
duplicate. 
2. Plate was sealed and incubate at 37°C for 90 minutes. 
3. After 90 minutes, contents of each well was discarded and plate was blotted onto paper 
towel. 
4. 100 μL of 1X Biotinylated anti-Human Myeloperoxidase antibody was added to each 
well, and plate was incubated at 37°C for 60 minutes. 
5. Plate was washed three times with 300 μL 0.01 M TBS, with each wash washing buffer 
was left in plate for 1 minute. Then washing buffer was discarded plate was blotted onto 
paper towels. 
6. 100 μL of 1X Avidin-Biotin-Peroxidase Complex working solution was added into each 
well and plate was incubated at 37°C for 30 minutes. 
7. Plate was washed five times with 0.01M TBs leaving the washing buffer in wells for one 
minute each time and whereafter washing buffer was discarded and plate was blotted 
onto paper towels. 
8. 90 μL of prepared TMB color developing agent was added into each well and plate was 
incubated at 37°C wrapped in foil in the dark for 25 - 30 minutes. 
9. 100μL of prepared TMB Stop Solution was added to each well (the colour should 
change into yellow immediately). 
10. Read the optical density absorbance at 450 nm in a microplate reader within 30 minutes 
after adding the stop solution. 
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5. The standard curve from the results of the ELISA 
 
 
6. Concentration calculations 
Relative O.D. = (the O.D.450 of each well) – (the O.D.450 of Zero well).  
Concentration = the absorbance (relative O.D.0) – slope (0, 0013) ÷ y-intercept (0, 00002)  
Final MPO concentration of sample = concentration x dilution factor (10)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 2E-05x + 0.0013
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Appendix G – ORAC assay 
This protocol was developed by Dr F Rautenbach at the Oxidative Stress Research Centre at 
Cape Peninsula University of Technology. 
1. Regents preparation  
 
 Phosphate (ORAC) buffer (75mM, pH 7.4) 
o Weigh 1.035 g sodium di-hydrogen orthophosphate-1-hydrate (NaH2PO4.H2O) 
in a 100 mL media bottle, add 100 mL ddH2O and mix until dissolved.  
o Weigh 1.335 g di-sodium hydrogen orthophosphate dehydrate 
(Na2HPO4.2H2O Merck Cat nr. 5822880EM) in a 100 mL media bottle, add 100 
mL ddH2O and mix until dissolved.  
o Mix 18 mL of 1st solution with 82 mL of 2nd solution. 
o Check pH and adjust with either phosphate buffer if required. Store @ 4C. 
Recheck pH before each assay. 
 
 Fluorescein sodium salt (Sigma Cat nr.: F6377):  
o Stock solution: Dissolve 0.0225 g C20H10Na2O5 in 50 mL Phosphate buffer. 
Store @ 4 C in dark container. 
o When used in assay add 10 µl fluorescein stock solution in 2 mL ORAC buffer 
and then dilute 240 µl of this solution in 15 mL ORAC buffer. 
  
 Peroxyl radical: AAPH (2, 2’-Azobis (2-methylpropionamidine) dihydrochloride (Aldrich 
Cat nr. 440914): 25 mg/mL.  
o Weigh 150 mg (0.150g) of AAPH (Reagent rack) into a 15 mL screw cap tube. 
Fresh prepared by adding solution when samples are placed in wells. 
o When used for assay add 6 mL of the ORAC buffer, mix until dissolved. 
  
 PCA (70% Perchloric acid, SAARCHEM Cat nr.: 494612): 0.5M 
o In a 250 mL Media bottle add 195 mL distilled water and 15 mL 70% perchloric 
acid (store at room temperature). 
 
 Trolox (standard): 500 µM Stock solution.  
o Weigh 0.00625 g 6-Hydroxy-2,5,7,8-tetra-methylchroman-2-carboxylic acid 
(Aldrich Cat nr.: 238831) (Reagent rack) in 50 mL screw cap tube, add 50 mL 
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phosphate buffer and mix until dissolved. Dilute 2x when using to make up 
standards.  
Rooibos Tea was used as control sample 
2. Sample preparation  
 Plasma - 100µl of PCA was added to 100 µl of plasma and centrifuged.  Supernatant 
was aliquoted out into eppi’s and pellet discarded. (2 x dilution). 100µl of supernatant 
was added to 400µl of ORAC buffer (5x dilution). The resultant dilution factor was 10. 
 Neutrophils – cell suspension was centrifuged and 20 µl of supernatant was added to 
80µl of ORAC buffer (5x dilution). 
3. Standard preparation  
Standards were made up according to the table below in 6 Eppendorf tubes. 
Tube 
Standard 
concentration 
(M) 
Trolox stock 
solution (L) 
Phosphate 
Buffer (L) 
Well number 
A(Blank) 0 0 750 A1-A3 
B #1 83 125 625 A4-A6 
C #2 167 250 500 A7-A9 
D #3 250 375 375 A10-A12 
E #4 333 500 250 B1-3 
F #5 417 625 125 B4-6 
 
4. Assay procedure  
 12 l of blank and standards #1-5 was added to the first 18 wells (in triplicate) of a 
black plate. 
 12 l of the control (Rooibos) was added to the wells (B7-B12). 
 12 l of sample (in triplicate) was added to the wells (C1-H12). 
 Add 138 µl of flourescein solution (with a multichannel pipette) into each well of plate.  
 Place in plate reader and let incubate for 5 minutes  
 Add 50 l Peroxyl radical: AAPH solution to each well. 
 Start reading on fluorescence plate reader (reads every 1 minute). 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
Oxidative Medicine and Cellular Longevity 94 
94 
 
5. ORAC calculations 
 The ORAC values are calculated using a regression equation (Y = a + bX + cX2) 
between Trolox concentration (Y) (µM) and the net area under the fluorescence decay 
curve (X). 
 Data is expressed as micromoles of Trolox equivalents (TE) per liter or per milligram 
of sample. 
 The area under the curve (AUC) is calculated as: 
AUC = (0.5 + f2/f1 + f3/f1 + f4f1 + … + fi/f1) x CT 
Where f1 = initial fluorescence reading at cycle 1, 
fi = fluorescence reading at cycle i, and CT = cycle time in minutes. 
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Appendix H – FRAP assay 
1. Reagents preparation 
 Acetate Buffer (300 mM, pH 3.6) 
o In a 1 L media bottle add 1.627 g Sodium acetate, 16 mL Glacial acetic acid 
(SAARCHEM Cat Nr.: 1021000) and distilled water up to 1 L. 
 HCl (0.1M) (SAARCHEM Cat Nr.: 100319 LP) 
o In a 1 L media bottle add 1.46 mL concentrated HCl (32% HCl) and add distilled 
water to final volume of 1L. 
 TPTZ (2,4,6-tri[2-pyridyl]-s-triazine) (10 mM (Sigma Cat Nr.: T1253)) 
o In a 15 mL conical tube, add 0.0093g TPTZ to 3 mL of 0.1 mM HCl (must be 
prepared fresh for on day of assay). 
 Iron (III) chloride hexahydrate (20 mM (F2877)) 
o In a 15 mL conical tube, add 0.054 g FeCl3.6H2O to 10 mL distilled water (must 
be prepared fresh for on day of assay). 
 L-Ascorbic acid (Sigma Cat Nr.: A5960) Standard (1.0 mM) (Vitamin C) 
o Weigh 0.0088 g Ascorbic acid in a 50 mL centrifuge tube and add 50 mL 
distilled water. Mix until dissolved. (Stock solution) 
(Check: In an eppendorf tube, dilute 125 µl of this stock solution with 1375 µl water to 
obtain a concentration of 83 µM. This solution should give an absorbance of 0.830 
0.010 at 265nm.) 
Before starting the analysis the FRAP reagent needs to prepared 
 In a 50 mL conical tube add 30 mL Acetate buffer, 3 mL TPTZ solution, 3 mL FeCl3 
solution and 6.6 mL Distilled water. The solution should be straw colored, if not discard 
and prepare fresh solution.  
 
2. Sample preparation  
 Plasma was collected from whole blood (with EDTA anti-coagulant) after centrifugation 
and stored at -80. 
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3. Standard preparation  
Standards were made up according to the table below in 6 Eppendorf tubes. 
4. Assay procedure 
 In a clear 96-well plate add 10 l of the blank to wells A1-3. 
 Add ascorbic acid standards #1-5 (tubes B-E) per well in the designated wells (as 
directed in the table above). 
 Add 10 µl of samples (in triplicate) to the wells (B7-H12). 
 Add 300µ of the FRAP reagent to each well with a multichannel pipette. 
 Incubate the plate for 30 minutes in the incubating oven set at 37°C. 
 Run plate on Multiskan plate reader 
5. FRAP Calculations 
Data is expressed as micromoles of Vitamin C equivalents per liter of sample and calculated 
from a standard curve. 
Below is an example of one of the standard curves used for this data set. 
 
 
 
 
 
 
 
 
 
 
 
 
Tube Ascorbic acid 
stock solution 
L 
Distilled 
water 
L 
Standard 
concentration 
M 
Well number 
A (Blank) 0 1000 0 A1-A3 
B #1 50 950 50 A4-A6 
C #2 100 900 100 A7-A9 
D #3 200 800 200 A10-A12 
E #4 500 500 500 B1-3 
F #5 1000 0 1000 B4-6 
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Concentration is then calculated as: 
Conc = (average absobance of sample – average absorbance of blank) - the y intercept / the 
slope of the line of best fit. 
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Appendix I-Conjugated dienes assay 
1. Sample preparation  
 Plasma was aliquoted after EDTA anti-coagulated whole blood was centrifuged and 
stored at -80°C. 
 Neutrophils were isolated (via protocol above) and stored in PBS at 80°C. 
2. Reagents preparation 
 Chloroform and methanol were mixed in a 2:1 ratio 
 Cyclohexane was used as a blank 
3. Assay procedure 
 After thawing plasma (or neutrophils) samples were treated with 667ml of 
chloroform:methanol mixture and vortexed. 
 Mixture was centrifuged at 4800 rpm for 1 minute. 
 The upper layer was discarded along with protein pellet while 200µl of the lower 
chloroform layer was aliquoted into another eppi and left overnight at room 
temperature to dry out. 
 The residue was dissolved in 700µl cyclohexane 
 Cycloheaxne blank is added in triplicate to a clear 96-well plate. 
 200µl samples are added in triplicate to plate. 
 Plate is read in multiskan at absorbance of 233nm. 
4. Concentration calculation 
Beer Lamberts Law 
A = ɛ x C 
C = A/ɛ 
With the extinction co-effienct (ɛ) being 29500 
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Appendix J – TBARS (MDA) Assay  
1. Sample preparation 
 Plasma was aliquoted after EDTA anti-coagulated whole blood was centrifuged and 
stored at -80°C. 
2. Assay Procedure 
 In 2 ml Eppendorf 50µl of plasma is added to 6.25µl of 4 mM of cold BHT/ethanol and 
50µl 0.2M ortho-phosphoric acid 
 Vortex for 10 seconds 
 Add 6.25 µl TBA reagent (0.11M in 0.1M NaOH) 
 Vortex for 10 seconds 
 Heat in warm bath to 90°C for 45 minutes 
 Then put on ice for 2 minutes  
 Let stabilise at room temperature for 5 minutes  
 Add 500µl n-butanol and 50µl saturated NaCL 
 Vortex for 10 seconds 
 Centrifuge for 2 minutes at 4°C at 4800 rpm 
 Aliquot 300 µl from top butanol layer into clear 96-well plate wells (in triplicate) 
 Use just butanol as blank in first three wells. 
 Read on multiskan at absorbance at 535  
3. Concentration calculation 
Beer Lamberts Law 
A = ɛ x C 
C = A/ɛ 
With the extinction co-effienct (ɛ) being 240.98 
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Appendix K – ABTS (TEAC) Assay 
1. Sample preparation  
 Plasma was collected from whole blood (with EDTA) after centrifuging and stored at -
80°C. 
2. Reagents preparation (all reagents expect ABTS mix must be prepared fresh on day of 
assay) 
 ABTS (2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) Diammonium salt:7mM 
(Sigma Cat nr.: A1888)  
o Weigh out 0.0192 g of ABTS into a 15ml falcon tube and add 5 mL distilled 
water. Mix until dissolve.  
 
 Potassium-peroxodisulphate 140mM (Merck Cat Nr.: 105091)  
o Weigh out 0.1892 g K2S2O8 into a 15 mL falcon tube and add 5 mL distilled 
water. Mix until dissolve. 
 
 ABTS mix (This must be done 24 hours before starting the assay): 
o Add 88l of the potassium-peroxodisulphate solution to 5 mL of the ABTS 
solution in a 15 mL falcon tube. Mix well. Leave in the dark at room temperature 
for 24 hours before use. 
 
 Trolox Standard Stock 1.0mM (Aldrich Cat nr.: 238831) 
o Weigh 0.0125 g Trolox in a 50 mL falcon tube and add 50 mL of Ethanol 
(Saarchem Cat Nr: 2233540LP). Mix until dissolved.  
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3. Standards preparation 
In 6 Eppendorf tubes prepare the standards and blank according to the table below. 
 
4. Assay procedure 
 Add 25 µl of blank (in triplicate) into first 3 wells in 96 well clear plate. 
 Add 25 l of standards #1-5 (tubes A-E) in triplicate in the designated wells in a clear 
96-well plate. 
 Samples: 
o Pipette 100µl plasma into eppi and add 100 µl PCA (x2 dilution) 
o Centrifuge 
o Aliquot 25 µl supernatant (in triplicate) in clear 96 well plate 
 Add 275µl of ABTS mix to each well using a multichannel pipette. 
 Leave plate at room temperature for 30 minutes  
 Read on multiskan plate reader 734nm 
5. Concentration calculation 
A standard curve is used to calculate the concentration, with data expressed as µmole Trolox 
equivalents per litre of sample. 
An example of the standard curve used  
Tube 
Trolox standard 
(l) 
Ethanol (l) Trolox conc. (M) Well number 
A (Blank) 0 1000 0 A1-A3 
B #1 50 950 50 A4-A6 
C #2 100 900 100 A7-A9 
D #3 150 850 150 A10-A12 
E #4 250 750 250 B1-3 
F #5 500 500 500 B4-6 
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Concentration is then calculated as: 
Conc = (average absobance of sample – average absorbance of blank) - the y intercept / the 
slope of the line of best fit. 
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Appendix L – Glutathione Redox Analysis assay 
1. Sample preparation 
 3 x 50 µl whole blood (with EDTA) is aliquoted into eppi’s. 
 3 X 100µl whole blood (with EDTA) is alquoted into eppi’s and 10µl M2VP is 
added. 
 Samples are stored at -80°C  
2. Reagents required  
 Buffer A -500mM NaPO4 and 1mM EDTA of pH7.5) 
 M2VP (1-methyl-2-vinyl-pyridinium trifluoromethane sulfonate)solution of 30mM 
mixed with 0.1N HCl 
 NADPH( 1mM, 0.83mg/ml) in buffer A 
 DTNB (5,5’ Dithiobis-(2-nitrobenzoic acid) in 0.3mM(0.12mg/ml) mixed in buffer A 
 Glutathione reductase (GR) solution 0.02U/µl in buffer A. Dilute in buffer A from 
0.61U/µl stock solution(Roche) to 0.2U/µl so that 50µl contains 1U. eg for 1ml use 
16µl enzyme in 90.4 µl buffer A 
 Metaphosphoric acid (MPA) 5% 16.6g in 100ml 
3. Standard preparation 
In 6 eppendorf tubes prepare standards and blank according to the table below. 
 
Tube Buffer volume (µl) GSH (µl) 
1 (Blank) 1000 0 
2 #1 833 167 
3 #2 667 333 
4 #3 500 500 
5 #4 333 667 
6 #5 167 833 
 
4. Assay procedure 
 Sample treatment 
GSH samples 
350µl MPA add to 50µl of whole blood. Centrifuge at 4800 rpm for 1 minute. 
Take 10 µl supernatant and add 600 µl of buffer A 
GSSG samples 
290µl MPA add to 110 µl of whole blood + M2VP. Centrifuge at 4800 rpm for 1 
minute. Take 25µl of supernatant and add  350 µl buffer A 
 For GSH assay 
o Add 50µl of blank (in triplicate) to first three wells of 96 well clear plate 
o Add 50µl of standards (in triplicate) to wells (following blank) 
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o Add 50µl of GSH samples (in triplicate) to wells (following standards) 
o With multichannel pipette add 50µl DTNB to each well 
o Prepare GR by adding 80µl GR stock to 4920µl buffer A 
o With multichannel pipette add 50µl GR solution 
o Take to machine 
o Before starting assay add 50µl NADPH 
o Read absorbance at 412nm for 5 mins (taking reading at every 30 seconds) 
 For GSSG assay 
o Add 50µl of blank (in triplicate) to first three wells of 96 well clear plate 
o Add 50µl of standards (in triplicate) to wells (following blank) 
o Add 50µl of GSSG samples (in triplicate) to wells (following standards) 
o With multichannel pipette add 50µl DTNB to each well 
o Prepare GR by adding 80µl GR stock to 4920µl buffer A 
o With multichannel pipette add 50µl GR solution 
o Take to machine 
o Before starting assay add 50µl NADPH 
o Read absorbance at 412nm for 5 mins (taking reading at every 30 
seconds) 
 
5. Concentration calculation  
Samples are interpreted at ratio of GSH to GSSG using a standard curve to calculate GSH 
or GSSG concentration. Dilution factor for GSH is 488 and GSSG is 60 
An example 
Conc. std Slope Intercept RSQ 
0,0 3,01E-05 0,056 0,940 
0,5 6,34E-05 0,059 0,998 
1,0 8,75E-05 0,059 1,000 
1,5 1,48E-04 0,064 0,999 
2,0 1,79E-04 0,062 0,999 
2,5 2,12E-04 0,065 1,000 
    
Slope 0,00008   
Intercept 2,6E-05   
RSQ 0,988   
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The slope of decline for each sample of over time is calculated and plugged compared to 
the standards slope. As example below: 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
The ratio is calculated at  GSHtotal – 2GSSG/GSSG 
 
 
 
 
 
 
 
 
Sample 1 Sample 2 Sample 3 Sample 4 
Slope 0,000 0,000 0,000 0,000 
Intercept 0,062 0,065 0,064 0,062 
RSQ 0,999 1,000 1,000 0,999 
GSH 2,039 2,467 2,146 1,404 
DF 
  
60 60 
GSHt 
  
129 84 
Sample nr 
  
1 2 
y = 8E-05x + 3E-05
R² = 0.9876
0.00E+00
5.00E-05
1.00E-04
1.50E-04
2.00E-04
2.50E-04
0.0 0.5 1.0 1.5 2.0 2.5 3.0
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Appendix M – Supplementary data 
 
Neutrophil functional measures of pre- and post-exercise with in vitro PCO treatment and control 
conditions, for the young fit group. 
 
 
 
 
 
 
 
 
 
 
Figure M1.A & B CD66b and CD16for the young fit group pre- and post-exercise with PCO in 
vitro treatment and control neutrophils. Values are means and error bars indicate SEM. 
Statistical analysis: * and ** represent p<0.05 and 0.005 respectively. 
 
 
 
  
 
 
 
 
 
 
Figure M2 Intracellular MPO for the young fit group pre- and post-exercise with PCO in vitro 
treatment and control neutrophils. Values are means and error bars indicate SEM. Statistical 
analysis: * p<0.05. 
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Neutrophil chemokinesis data of young fit subjects before and after exercise intervention, with and 
without in vitro PCO treatment 
 
Table M1. Measures of total distance (TD), linear distance(LD) and the ratio of linear distance to total 
distance for the young fit group pre- and post-exercise with in vitro PCO treatment and under control 
conditions. Values are presented as mean(SD).  
 
Neutrophil anti-oxidant and oxidative stress measures of pre- and post-exercise with in vitro PCO 
treatment and control conditions, for the young fit group. 
 
 
 
 
 
Figure M3.A & B ORAC and FRAP for the young fit group pre- and post-exercise with PCO in vitro 
treatment and control neutrophils. Values are means and error bars indicate SEM. Statistical 
analysis: * and ** represent p<0.05 and 0.005 respectively. 
 TD (µm) LD (µm) Ratio LD/TD 
Pre-exercise(Ctrl) 188(47.96) 16.15(14.71)  0.08(0.05)  
Pre-exercise(PCO) 192(37.77) 32.53(15.81) 0.16(0.06) 
Post-exercise(Ctrl) 195(59.81) 25.07(16.14) 0.12(0.06) 
Post-exercise(PCO) 178(40.22) 46.54(39.54) 0.27(0.22) 
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Figure M4 Neutrophil conjugated diene content for the young fit group pre- and post-exercise 
with PCO in vitro treatment and control neutrophils. Values are means and error bars indicate 
SEM. 
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